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Abstract 
The application of organocatalytic Asymmetric Epoxidation 
 
Mohammed I. Alahmdi 
 
In the field of research of target natural product synthesis, catalytic asymmetric synthesis has 
become a vital tool to obtain enantiomerically pure compounds, and is often used in the 
synthesis of natural products as a key step.
1
 For example, the asymmetric dihydroxylation 
was used in synthesis of gibberellic acid (GA3)
2
 by E. J. Corey, who was awarded the Nobel 
Prize for his developments in the theory and methodology of organic synthesis.
2
  
This thesis is based on an ongoing research in the area of catalytic asymmetric synthesis that 
has been carried out in our group. Since 2005, metal-free catalytic asymmetric epoxidation 
using iminium salts such as 1 has been successfully employed to access chiral chromenes 
within the Page group. Iminium-catalysed asymmetric epoxidation methodology has been 
applied to the synthesis of levcromakalim, 
3
 trans-khellactone, and lomatin,
4
 which are based 
on a chromene-type structure. In this thesis, we offer a detailed discussion on the influence of 
iminium salts on flav-3-ene derivatives and their stability under oxidative conditions. We 
were also able to successfully apply our methodology towards the enantioselective total 
synthesis of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 2. The key epoxidation step 
proceeded in 70.4% ee and high yield, using chiral iminium salt catalyst 1 under aqueous 
conditions. The acid-catalysed epoxide ring-opening of epoxide 4 afforded trans-diol 3 in 
high yield. 
 
 
 
1 
Koskinen, A. Asymmetric Synthesis of Natural Products,Chichester: John Wiley & Sons Ltd, Hampshire, 1995. 
2
Nicolaou. K. C.; Sorensen. J. E. Classics In Total Synthesis, Wiley-VCH, New York, 2008.
3
 Page, P. C. B.; 
Appleby, L. F.; Day, D. P.; Chan, Y.; Buckley, B. R.; Allin, S. M.; McKenzie, M. J. Org. Lett. 2009, 11, 1991.
4 
Page, P. C. B.; Buckley, B. R.; Heaney, H.; Blacker, A. J. Org. Lett. 2005, 7, 375.
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Abbreviations 
Ac  acetyl 
Aq.  aqueous 
Ar  aromatic  
[α]D   Specific optical rotation at the sodium D Line 
aq.  aqueous 
Bn  benzyl  
n-Bu   normal butyl 
t-Bu   tert-butyl 
t-BuOH tert-butanol 
conc.  Concentrated 
°С  degrees Celsius 
cat.  catalyst (catalytic amount)  
cm
-1  
Wavenumber 
CSA  camphorsulfonic acid 
Δ  chemical shift  
DCM  dichloromethane 
DET  diethyl tartrate 
DIAD  Diisopropyl azodicarboxylate 
DMP  2,2-dimethoxypropane 
DMSO-d6 dimethylsulfoxide (deuteriated) 
DMF  N,N-dimethylformamide  
equiv.  equivalent(s)  
ee  enantiomeric excess 
EtOAc ethyl acetate 
EtOH  ethanol 
g  gram(s) 
h  hour(s) 
HMPA Hexamethylphosphoramide 
HPLC  High Performance Liquid Chromatography 
Hz  Hertz 
IR  infra-red 
J  coupling constant 
LDA  lithium diisopropylamide  
VI 
 
LG  leaving group 
M  molar 
m-  meta 
m-CPBA meta-chloroperoxybenzoic acid  
Me  methyl 
MeOH methanol 
MHz  megahertz 
mmol  millimole(s) 
ml  millilitre(s)  
min.  minutes 
m.p.  melting point 
m/z  mass to charge ratio 
NaH  Sodium hydride 
NBS  N-bromosuccinimide 
NMR  nuclear magnetic resonance 
Nu  nucleophile 
P-  para 
PCC  Pyridinium chlorochromate 
Ph  phenyl 
ppm  parts per million 
i-PrOH isopropanol 
Ph3P  triphenyl phosphine 
P-TSA  p-Toluenesulfonic acid  
RT  room temperature 
R  undefined group  
SM  starting material 
SN
2
  nucleophilic substitution second order 
SN
1
  nucleophilic substitution first order 
TEA  triethylamine 
Tf  trifluoromethanesulfonate 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TPPP  tetraphenylphosphonium monoperoxysulfate  
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1.0 Introduction 
1.1 Metabolism 
 
Metabolism may be defined as the set of chemical reactions that occur in living organisms to 
enable all organisms to "live, grow and reproduce" by transforming and interconnecting a vast 
number of organic compounds.
 1
 Metabolism involves two processes: the process of building up 
protoplasm is called anabolism; for example, proteins are generated from amino acids: whilst 
breaking it down is called catabolism; for instance carbohydrates are broken down into sugar 
units.
1
 Furthermore, plant physiologists separate metabolism into two categories: primary 
metabolism and secondary metabolism.
 1
 All organisms possess similar metabolic pathways by 
which they synthesize and utilise certain essential chemical species: carbohydrates, amino acids, 
and polymers derived from them (e.g. lipids, and proteins).
 1
 This is known as primary 
metabolism, and is essential for their survival and growth. In contrast to the compounds that are 
formed in primary metabolic pathways (primary metabolites), other organic compounds are not 
directly involved in the commonplace growth or development of organisms, which are precisely 
distributed in nature. Additionally they are produced by other metabolic pathways for different 
purposes than primary physiological functions; these are known as secondary metabolites, and 
the pathways for their synthesis and utilization constitute secondary metabolism.
 1
 Many of these 
secondary metabolites found in plants, animals and micro-organisms possess pharmacological 
properties.
 1
 Today many of these secondary metabolites are used to treat mild and serious 
human afflictions.
1
 Aspirin and menthol are two commonly used and widely recognised natural 
product drugs.
 1
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1.2 Some Natural Product Properties 
 
Since the beginning of mankind, the use of natural compounds has continued to grow with 
the development of chemical methods. Conventional extraction methods of flower and plant 
essential oils, such as maceration, have been used to isolate compounds whose taste, colour 
and odour could fulfil various purposes. Healing creams and liquids were derived from plant 
extracts to prevent and cure diseases, and even reduce pain in all ancient cultures. For 
instance, Xylocarpus granatum Koenig (Meliaceae) used to be a well-known medicine in 
Southeast Asia for the treatment of diarrhoea, cholera, and fever.
2
  
 
The name of the natural product is usually associated with the plant origin; for example, 
muscarine is derived from Amania muscaria (fly agaric). It can also be defined through the 
physiological action, as the natural product emetine causes vomiting (emetic). Although some 
aromatic compounds are very closely related in terms of structure, they can be very different 
in term of properties, such as taste, odour and colour. For example, strawberries and 
pineapples possess large amounts of furaneol, in contrast with cloudberries and canned 
mangoes, where a closely related structure is found (Figure 1).
 2 
 
 
Figure 1  
 
Also, the structural similarity of compounds issued from onions and their different properties 
is another illustration: the strong lachrymatory compound issued from enzyme activity, and 
the aroma compounds of fresh and boiled onions (Figure 2).
2 
 
 
Figure 2 
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1.3 Chirality 
 
Jean-Baptiste Biot conducted the first study of some natural isolates in polarized light in 
1815. However, it was not until 1874 that Jacobus van't Hoff first suggested that tetrahedral 
carbon atoms carrying four different substituents could explain the phenomenon of optical 
isomers. Chirality is a property of molecules which do not possess any element of symmetry, 
are non-superimposable on their mirror images and possess a different spatial arrangement 
with the same constitution. Molecules that are mirror images of each other are termed 
enantiomers and have identical physical properties (e.g. m.p., NMR spectra and molecular 
weight, etc.), although each enantiomer rotates the plane of plane polarized light in opposite 
direction. For example, lemons and oranges share the same limonene enantiomer R, which 
gives a characteristic citrus flavour and odour. Two compounds related to limonene, R- and 
S-carvone, smell of spearmint and caraway, respectively (Figure 3).
2,3
  
 
 
Figure 3: The two enantiomers of carvone and limonene. 
 
As a synthetic chemist, the production of natural products, their derivatives and analogues by 
synthetic methods in an attempt to secure them in an enantiopure form is a vital element. The 
most striking example is the drug (±)-thalidomide, which was prescribed to pregnant women 
for morning sickness during the late 1950s. A dramatic increase of miscarriages and birth 
defects in mothers who were taking (±)-thalidomide occurred. It was later proven that while 
(R)-thalidomide 1 helped relieve morning sickness and was non-toxic, (S)-thalidomide 2 was 
potently teratogenic and caused severe birth defects (Figure 4).
2
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Figure 4: The two enantiomers of thalidomide 
 
Therefore, as it becomes essential to obtain products in an enantiopure manner, the 
development of enantioselective techniques and methodologies to preferentially form a single 
enantiomer (or an enantioenriched mixture) are targeted.  
 
1.4 Asymmetric synthesis 
 
Asymmetric synthesis is defined as a chemical reaction which triggers chiral centres in the 
product in unequal amounts and thus delivers one of the isomers in excess over the other as a 
result of the influence of a chiral feature present in the substrate, reagent and/or catalyst. 
Asymmetric synthesis can also be accomplished using the following methods: chiral 
auxiliaries, synthesis using compounds from the chiral pool and asymmetric catalysis.
2,3
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1.4.1 Chiral auxiliaries 
 
A chiral auxiliary is an enantiomerically pure compound that binds to a prochiral starting 
material.
4
 Therefore, one single enantiomer is formed to influence the stereochemical 
outcome of a reaction creating one or more extra stereogenic centres, when the substrate 
undergoes a diastereoselective reaction. An illustration of the chiral auxiliary process is 
provided in Scheme 1.
4
  
Scheme 1: Use of a chiral auxiliary to control the stereochemistry of 7 
 
Single enantiomer 4, formed by the coupling reaction of a chiral auxiliary and 3, reacts with 
benzyl bromide in presence of LDA, creating two possible diastereoisomeric products 5 and 
6. Diastereoisomer 5 is then subjected to a hydrolysis reaction which cleaves the 
enantiomerically enriched product 7 from the chiral auxiliary.
 4
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1.4.2 Chiral pool synthesis 
 
The chiral pool synthesis is the most facile approach for asymmetric synthesis. The simplicity 
of the chiral pool synthesis relies on cheap, and enantiomerically pure starting materials, such 
as carbohydrates and amino acids.
3
 They are incorporated in a reaction without asymmetric 
induction to meet the chiral requirements of the target molecule. An obvious example of 
chiral pool synthesis is the preparation of artificial sweetener aspartame 10. An economical 
synthetic route to manufacture aspartame is through the condensation reaction of (S)-aspartic 
acid 8 and (S)-phenylalanine methyl ester 9 (Scheme 2).
3 
 
 
Scheme 2: Synthesis of aspartame 
 
1.4.3 Asymmetric catalysis  
 
Asymmetric catalysis involves the generation of new asymmetric centres from prochiral 
centres in one simple transformation with the help of a chiral catalyst. The most widely used 
prochiral starting materials are alkenes and carbonyl group-containing substrates. One of the 
simplest and most effective asymmetric transformations of a prochiral olefin into a chiral 
product is the epoxidation reaction. Asymmetric epoxidation of olefins is the most direct and 
effective approach to synthesizing enantio-enriched epoxides, and many research efforts have 
been devoted to the development of efficient catalysts for this process, such as the Sharpless 
epoxidation.
2,4
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1.5 Epoxides 
 
An epoxide, also known as oxirane, consists of a three-membered cycle which contains an 
oxygen atom and two carbon atoms (Figure 5).
 3
 It is an unstable cyclic ether, because of the 
high ring strain coming from the 60° angle between the bonds in the three-membered ring.
3 
 
 
Figure 5. The epoxide. 
 
Due to the strain present in the epoxide ring and the + charge caused on the two carbon 
atoms by the electronegative oxygen atom, epoxides react as electrophiles; one of the 
electrophilic carbons attached to the oxygen can be easily targeted with various nucleophiles 
to relieve the substantial ring strain. This reactivity allows various chemical transformations 
of an epoxide into many 1,2-difunctionalized products such as 11 and 12. An example of how 
either carbon can be targeted by acid or base catalysis is outlined below (Scheme 3 and 
Scheme 4).
 3 
 
Scheme 3: Acid-catalysed ring opening of an epoxide: the nucleophile attacks the most 
substituted carbon in the epoxide 
 
 
Scheme 4: Base-catalysed ring opening of an epoxide: the nucleophile attacks the least 
substituted carbon in the epoxide. 
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Indeed, a stereospecific ring-opening reaction in the presence of an acid is a constructive 
feature of the epoxide moiety and can be used to form complex natural products. For 
example, Paterson’s synthesis of etheromycin made excellent use of an epoxide ring-
opening/nucleophilic attack cascade strategy to efficiently construct the polycyclic ether 
skeleton 13 (Scheme 5).
5
 
 
Scheme 5: Paterson’s synthesis of etheromycin 
 
1.6 Epoxides in natural products 
 
To gain a comprehensive picture of the importance of asymmetric epoxidation techniques, we 
should demonstrate the effect of biological responses from two enantiomers. For instance, 
(+)-disparlure 14 or (+)-(7R,8S)-cis-7,8-epoxy-2-methyl-octadecane is used as the active 
compound to lure the male gipsy moth, Lymantria dispar (L) into traps and, thus, reduce the 
growth and copulation of these destructive insects. Similarity, the male tussock moth, Orgyia 
(walker) responds to the (6Z,9Z,11S,12S)-11,12-epoxyhenicosa-6,9-diene trans-isomer 
(posticlure 15), produced from the wingless females (Figure 6).
6,7
  
 
 
Figure 6: Natural products containing an epoxide functional group: (+)-disparlure 14, and 
posticlure 15 
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1.7 Epoxidation techniques 
 
1.7.1 Prilezhaev Epoxidation 
 
Peroxycarboxylic acids 16 were recognized as epoxidizing agents of isolated carbon-carbon 
double bond by Prilezhaev in 1909.
8
 Peroxycarboxylic acids 16 readily epoxidize alkenes via 
transition state 17 of the mechanism involving a nucleophilic attack on the peroxyacid 
oxygen-oxygen bond by the π-olefinic double bond (Scheme 9).9 Recently, Houk reported 
theoretical work in support of a spiro transition state.
10
 The reaction is stereospecific; the E- 
or Z- geometry of the alkene is retained in the epoxide product.
11
 
 
Scheme 6: Use of peroxycarboxylic acids 16 in Prilezhaev’s epoxidation of alkenes 
 
In their study, Henbest
12
 and Sharpless
13
 have shown that there is a syn-hydroxy-
stereodirecting effect in the example of allylic alcohols, meaning the epoxidation will take 
place preferentially on the face of the alkene bearing the hydroxyl group, because of 
hydrogen bonding with one of the oxygen of the peroxyacid (Figure 7) 
 
Figure 7: the peroxy-acid directed to more hindered face of alkene. 
 
Mulzer's total syntheses of epothilones B is an example of the directing effect of the hydroxy 
group in the epoxidation of 18. The Prilezhaev reaction was utilized to afford the syn-epoxide 
of the less hindered alkene (Scheme 7). 
 
 
14 
 
 
 
Reagents and conditions: (a) mCPBA (1.5 equiv.), CHCl3, –18 °C, 5h, 81%. 
Scheme 7: Use of the Prilezhaev reaction in syntheses of epothilones B 
 
1.7.2 Sharpless Asymmetric Epoxidation 
 
Sharpless and Katsuki invented a method to transform primary allylic alcohols into optically 
active epoxides in greater than 90% ee.
15
 The Sharpless asymmetric epoxidation has been one 
of the most important discoveries of the last 30 years in asymmetric catalysis. The 2001 
Nobel Prize was awarded to Professor Sharpless for a valuable contribution to chemistry and 
more particularly, asymmetric catalysis.
16,17
 The key part of the procedure is the formation of 
an enantiomerically pure chiral complex, such as 19, utilizing a hydroperoxide (usually t-
BuOOH) as the oxidizing agent, 6-12 mol% of an enantiomerically pure dialkyl ester of 
tartaric acid (usually either diethyl tartrate) and titanium isopropoxide. When one of the 
isopropoxide groups is replaced with the allylic alcohol substrate, asymmetric epoxidation is 
achieved. The most important aspect of the system is the capability for the production of 
either enantiomer of the desired epoxy-alcohol by employing either enantiomer of the 
commercially available tartrate ester, which establishes the direction of the epoxidation in the 
reaction (Scheme 8).
18
 
15 
 
Scheme 8: Stereochemical outcome of the Sharpless epoxidation 
 
The mechanism of the Sharpless asymmetric epoxidation is shown below. The initial 
exchange of tetraisopropoxide ligands with the optically active diethyl tartrate results in the 
formation of the dimeric complex 20.
13, 5
 The nucleophilic substitution of the hydroperoxide 
on the metal centre allows the formation of 21.
3
 Coordination of the allylic alcohol to the 
metal then occurs, forming intermediate 22, and delivery of the oxygen atom using the active 
catalyst follows (Scheme 9).
 13,15,18 
 
Reagents and conditions: (a) 
t
BOOH, (b) allylic alcohol 
Scheme 9: Sharpless’s epoxidation of allylic alcohols 
 
The success in obtaining high enantioselectivities (93% ee) was utilized to prepare chroman-
2-ylmethanol 25, which is a key intermediate in the synthesis of α-tocopherol (Vitamin E). 
Sharpless asymmetric epoxidation of allylic alcohol 23, using the natural L-(+)-diethyl 
tartrate, gave the enantiopure epoxide 24 in 85% yield (Scheme 10).
19
 
16 
 
 
Reagents and conditions: (a) 
t
BOOH, Ti(OPr
i
)4, L-(+)-diethyl tartrate, CH2Cl2, –24 °C, 20h, 85%.  
Scheme 10: The Sharpless epoxidation as a key step in total synthesis of chroman-2-yl-
methanol 25 
 
1.7.3 Jacobsen-Katsuki Epoxidation 
 
Jacobsen reported manganese-salen complex catalyst 27 to be the most efficient catalyst for 
the enantioselective epoxidation of unfunctionalized olefins among over fifty ligand 
modifications.
20
 Katsuki independently reported catalyst 28, with a similar skeleton to 27 
(Figure 8).
21
 In general, such Mn(III)-based catalysts consist of a tetradentate salen-ligand 
complex. Unlike the Sharpless epoxidation, the Jacobsen-Katsuki epoxidation does not 
require the substrate to be an allylic alcohol. It is a transition metal-mediated epoxidation, and 
a host of oxidizing agents have been used (e.g. iodosylbenzene, sodium hypochlorite, 
Oxone™, hydrogen peroxide and mCPBA) for the oxidation of the manganese (III) metal 
centre into manganese (V). 
22, 23, 24, 25, 26
 
 
Figure 8: Jacobsen’s and Katsuki’s general catalyst structure, 27 and 28, respectively. 
 
17 
 
The main difference lies in the substrate geometry: the Jacobsen epoxidation delivered the 
best results when Z-alkenes were used as substrates; while the Katsuki epoxidation performed 
effectively when E-alkenes were used as substrates.
22,23
 Both can be used at very low catalyst 
loadings; it is common for 1 mol% loadings to be used, and ees in the isolated epoxides can 
be above 99%.
27
 The reactions are not stereospecific, however. The active catalyst is a 
Mn(V)-oxo species, formed by the oxidation of the Mn(III)-salen complex, and is the most 
likely responsible intermediate for the oxygen transfer to the olefin.
25
 However, the 
mechanisms described by Jacobsen and Katsuki to explain the enantioselectivity in the 
epoxidation process differ. Jacobsen’s suggestion supports a ‘top-on’ approach to the axial 
oxygen, whereas Katsuki has suggested a ‘side-on’ approach (Figure 9). 23, 28 
 
 
Figure 9: The two suggested approaches from Katsuki and Jacobsen 
 
The mechanism has not been completely understood, and there are the three major 
mechanistic explanations for how the reaction proceeds.
 .29
 The first pathway I is a concerted 
reaction, much like the Prilezhaev epoxidation, where there is no C-C bond rotation around 
the intermediate species.
 28.29
 Thus, the reaction is stereospecific. The second pathway II is 
also stereospecific.
 .29
 However, in contrast to the first pathway, the reaction proceeds via a 
metalla-oxetane species 30, which then collapses to give the epoxide with the same 
stereochemistry as the substrate.
 27,28
 The third pathway III is a radical pathway, where the 
mechanism suggests that the trans-epoxide can be formed by a single electron transfer 
mechanism, due to C-C bond rotation around the intermediate species (Scheme 11). 
23,27,28.29
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Scheme 11: Summary of proposed pathways of Katsuki and Jacobsen epoxidations 
 
The importance of forming a chiral epoxide as the key step for the synthesis of 
pharmaceutical drugs can be illustrated: Hashimoto used Jacobsen’s catalyst to prepare chiral 
epoxide 32, a key intermediate in his synthesis of the dihydroquinoline core of Siomycin D1 
33, in 87% yield and 91% ee (Scheme 12).
30
 
 
Reagents and conditions: (a) 4-phenylpyridine N-oxide (50 mol%), NaOCl (aq.), CH2Cl2, Jacobsen's Catalyst (5 
mol%), r.t, 2.5h, 43%, 91% ee, 87%.  
Scheme 12: Hashimoto’s synthesis of the dihydroquinoline core of Siomycin D1 utilising the 
Jacobsen-Katsuki epoxidation 
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1.8 Organocatalysts 
 
In contrast to metal-based epoxidation catalysts, organocatalysts are purely organic 
molecules, consisting of carbon, hydrogen, nitrogen, sulfur and phosphorus, and no transition 
metals are needed for the reaction to proceed.
31
 The major advantages of organocatalysts lie 
in that they are inexpensive, readily available, not contaminated by metals, and usually non-
toxic. As long as 90 years ago, an asymmetric organocatalytic reaction was reported by Fiske 
and Bredig. Their study discussed the addition of HCN to benzaldehyde 34 catalysed by 
quinine 35, forming optically active cyanohydrin 36 in up to 10% ee (Scheme 13).
32
  
 
 
Scheme 13: The formation of optically active cyanohydrins 36 from the first asymmetric 
organocatalytic reaction 
 
In 1960, Pracejus attempted to improve quinine as a catalyst. Pracejus reported the use of O-
acetyl-quinine 37 with 1 mol% loading and 1.1 equivalents of methanol, in the addition to a 
ketene in toluene at −111 °C, to afford 38 in 93 % yield and 74% ee (Scheme 14).33  
 
20 
 
  
Reagents and conditions: (a) Methanol (1.1 equiv.), Toluene, –111 °C, 92%.  
Scheme 14: The formation of optically active 38 by Pracejus, using O-acetyl- quinine 
 
In the early 1970s and 1980s, Hajos and Parrish, alongside Wiechert, Sauer and Eder 
independently reported the use of chiral amines to catalyse enantioselective reactions.
34
 For 
example, the asymmetric intramolecular aldol reaction of trione 39 was catalysed by L-
proline 40, leading to the formation of the unsaturated Wieland–Miescher Ketone 41. 34 
 
 
Reagents and conditions: (a) 40 (3-47 mol%), CH3CN, 80 °C ,R.T. 83%,71-93% ee. 
Scheme 15: Formation of the Wieland-Miescher ketone using L-proline 
 
1.9 Non-Metal Catalysed Epoxidations 
 
Today, organocatalysis, using such reagents as chiral dioxiranes, oxaziridines, amines and 
oxaziridiniums, forms a major part of the asymmetric epoxidation techniques available to 
modern synthetic chemists. 
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1.9.1 Juliá-Colonna epoxidation  
 
Organocatalytic epoxidations of chalcone using poly-L-alanine 43 with H2O2 as the oxidizing 
agent were first reported by Juliá in 1980.
35
 Poly-amino acid-catalysed epoxidation of 
chalcone 42 was achieved to afford 44 in heterogeneous triphasic conditions with excellent 
enantiomeric excesses (Scheme 16).
 36
 The major advantage of using a triphasic system is the 
insolubility of poly-L-alanine in an aqueous solution of sodium hydroxide, allowing simple 
separation and then re-use of the catalyst.
 36
 However, continuous recycling of catalyst leads 
to reduced enantioselectivities, due to catalyst degradation under basic conditions. It has been 
explained that the chain length required for high enantioselectivity should consist of a 
minimum of 10 to 30 amino-acid residues.
36 
 
Reagents and conditions: (a) H2O2/NaOH, Toluene or CH2Cl2, r.t., 85%, 93% ee. 
Scheme 16: Epoxidation of chalcone by Juliá using poly-L-alanine. 
 
The capability of the triphasic system is limited, due to the reaction time required for the 
epoxidation of chalcone to occur (up to 24 h). Roberts used a biphasic reaction system to 
limit the reaction time to 30 minutes for chalcone.
 37
 This was achieved by replacing the 
oxidant H2O2 with urea-hydrogen peroxide, and the base with DBU, as both of them are 
soluble in organic solvents. Poly-L-leucine was used as the catalyst. 
37
 
 
1.9.2 Phase Transfer Catalysis 
 
Phase transfer catalysis (PTC) is an important concept in organocatalytic reactions, where the 
catalyst acts as a phase transfer agent, allowing substances which are located in an 
immiscible phase to pass into an organic phase.
3
 For example, alkylation of the acetal starting 
material 45 occurred using sodium hydroxide as the base in a water/dichloromethane biphasic 
22 
 
system.
3
 Although sodium hydroxide is not soluble in dichloromethane, the tetraalkyl 
ammonium salt was employed to transfer the hydroxyl anion from the aqueous layer into the 
organic layer by forming Bu4N
+
HO
-
, which is soluble in dichloromethane (Scheme 17).
3
  
 
Reagents and conditions: (a) Bu4N
+
 HSO4
-
, NaOH, H2O, CH2Cl2, 84%. 
Scheme 17: Example of phase transfer catalysis 
 
1.9.3 Chiral Dioxiranes as catalysts for asymmetric epoxidation. 
 
Dioxiranes 47 are three-membered ring systems that have a carbon and two oxygen atoms. 
Dioxiranes can be generated from ketones reacting in-situ with Oxone
TM
, and are powerful 
and unstable oxidants.
3
  
 
Figure 10: Generation of dioxiranes from ketones using Oxone
TM
 
  
In 1984, the first example of asymmetric epoxidation using chiral ketone catalysts was 
reported by Curci (Figure 11).
38
 Curci’s initial work involved readily available ketones 48 
and 49 with 1-methyl-1-cyclohexene as the substrate in a biphasic mixture of water and 
dichloromethane buffered to pH 7-8, with Bu4NHSO4 as a PTC. Drawbacks from the use of 
ketones 48 and 49 included poor epoxide ees (up to 12%), high catalyst loadings and poor 
reactivity.
38,39
 Curci also investigated electron-deficient ketones 50 and 51, and found these to 
be more reactive, but only moderate improvement in enantioselectivity were observed (13-
20% ee, Figure 11).
38,39
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Figure 11: The chiral ketone catalysts developed by Curci between 1984 and 1995 
 
In 1996, Yang was the first to develop an effective solution for the drawbacks of Curci’s 
research. She introduced a new biphasic solvent system: acetonitrile-water, utilizing C2-
symmetric binaphthalene-derived ketone 53. Catalyst 53 was capable of enantiomeric 
excesses of up to 87% at a loading of only 10 mol% which was a huge improvement on 
Curci’s ketone catalysts (Scheme 18).40 
 
Reagents and conditions: (a) 53 (10 mol %), Oxone
TM
 (5 equiv.), NaHCO3 (15.5 equiv.), MeCN/H2O, 0 °C, 
80%, 87% ee. 
Scheme 18: Dioxirane-mediated epoxidation protocol, using C2 symmetric binaphthalene-
derived catalyst 
 
To further improve the reactivity of the C2 symmetric binaphthalene-derived catalyst, 
structural modifications were necessary. Based on X-ray analysis, Yang suspected that the H-
3 and H-3’ atoms, which are closer to the chiral dioxirane moiety, behave as if the steric 
sensors in the oxygen transfer process.
 41
 By increasing the size of the groups at the 3 and 3’ 
positions, Yang believed the selectivity of the process could be further improved. 
Consequently, higher enantioselectivities were indeed observed (Table 1).
41,42
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Table 1: Effect of the size of the steric sensor on the isolated ee of trans-stilbene oxide 
 
X ee 
H 44% 
Cl 76% 
Br 75% 
I 32% 
Me 56% 
CH2OCH3 66% 
SiMe3 44% 
 
71% 
 
Song 
43
 published chiral ketones 55, and 56, with oxygen atoms at the β-positions to the 
carbonyl group. However, these catalysts were not as selective; the ee did not exceed 53% for 
the epoxidation of trans-stilbene with 1 equivalent of the catalyst 55. Adam also reported 
chiral ketones 57, and 58. They were able to afford ee’s similar to Song's ketones (Figure 
12).
44
 
Figure 12: Catalysts developed by Song and Adam 
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1.9.3.1. Shi's fructose-derived ketone catalysts 
 
In 1996, Shi reported the synthesis and use of D-fructose-derived ketone 61 for asymmetric 
epoxidation. Ketone 61 can be prepared from D-fructose 59 in two steps (Scheme 19).
45
 
Since then, this catalyst has been regarded as one of the most powerful and versatile 
organocatalytic asymmetric epoxidation catalysts. The key to success of the catalyst lies in 
the close proximity of the ketone and the stereogenic centres, significantly increasing the 
stereoinduction.
46
  
 
Reagents and conditions: (a) acetone, HCIO4, 0 °C, 53%. (b) PCC, CH2Cl2, rt, 93%. 
Scheme 19: Synthesis of Shi’s D-fructose-derived ketone 
 
Ketone 61 displayed high enantioselectivities for the asymmetric epoxidation of a range of 
unfunctionalized, trans- and trisubstituted olefins. For example, trans-stilbene oxide was 
obtained in 85% yield and 98% ee (Table 2). Low ees were, however, obtained for cis-
disubstituted and terminal alkenes.
47
 
 
Table 2 Shi’s epoxidation of trans- and trisubstituted olefins with chiral ketone 61 
 
Substrate Yield (%) ee (%) 
 
85 98 (R,R) 
 
94 96 (R,R) 
 
89 96 (R,R) 
 
94 98 (R,R) 
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However, a problem identified by Shi was the requirement for ketone 61 to be used in high 
catalyst loadings for the complete conversion of alkene to the corresponding epoxide to 
occur. Shi studied the relationship between the effect of pH on the epoxidation reaction and 
the high catalyst loadings. The result of that study showed that the reaction run at pH 7-8 
favours intermediate 62, which is prone to a Baeyer-Villiger oxidation, affording 
corresponding lactones 65 & 66. If the pH is increased to around 10, intermediate 63 is 
favoured and dioxirane 64 is generated (Scheme 20).
48
 
 
 
Scheme 20: Shi’s catalytic cycle showing the Baeyer-Villiger decomposition pathway 
 
Shi also reported the use of hydrogen peroxide as the oxidant. This system requires the use of 
acetonitrile, as peroxyimidic acid 67 is believed to be the active oxidant for generating the 
dioxirane (Scheme 21). High yields and enantioselectivities for a number of olefins were 
obtained.
49
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Scheme 21: Formation of the peroxyimidic acid 67 
 
The asymmetric synthesis of (+)-Heronapyrrole C was accomplished by Ding and co-
workers: the alkene substrate 68 was exposed to Shi’s ketone catalyst, forming key 
intermediate 69 in 82% yield. Ring-opening of the epoxide using an intramolecular 
nucleophile and deprotection of the N-Boz group led to the formation of the target molecule 
(Scheme 22).
50
  
Reagents and conditions: (a) Shi catalyst, Oxone, K2CO3, MeCN/DME/buffer (1:2:2), 0 °C, 83%. (b) TBAF, 
THF, 0 °C to rt, 1h, then 50 °C, 0.5 h, 80%. 
Scheme 22: Asymmetric synthesis of (+)-Heronapyrrole C using Shi’s catalyst 
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1.10 Oxaziridinium salts as catalysts for asymmetric epoxidation 
 
Oxaziridiniums species are three-membered rings, analogous to oxaziridines, which contain 
one oxygen, one carbon and one quaternized nitrogen atom.
3
 Their reactivity is due to the 
presence of the quaternized nitrogen atom which increases their efficiency as oxygen transfer 
reagents to nucleophilic substrates. The first report of the existence of an oxaziridinium 
species was reported by Lusinchi’s group in 1976.51 The preparation of an oxaziridinium 
species was the result of a peroxyacid oxidation of the steroidal pyrrolinic iminium salt 
70.
51,52 
Lusinchi demonstrated the capability of the oxaziridinium species for transferring 
oxygen to other nucleophilic substrates such as amines, sulfides, imines and alkenes (Figure 
13).
53
 
 
Figure 13: The first iminium salt 
 
In an effort to develop a catalytic version of the reaction, Lusinchi and co-workers chose N-
methyl-3,4-dihydroisoquinolinium tetrafluoroborate 71
54
 and Oxone
TM
 as the oxidant for the 
epoxidation reaction of a range of unfunctionalized olefins (Figure 14).
55 
 
 
Figure 14: Model iminium salt 
 
This work led to the iminium salt being used in catalytic amounts, generating the 
oxaziridinium by in-situ oxidation, avoiding extra synthetic steps (Figure 15). 
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Figure 15: Catalytic cycle of the iminium/oxaziridinium salt with Oxone
TM
 
 
An initial investigation of enantiomerically pure iminium salts for their potential as catalysts 
was conducted by Lusinchi’s group in 1993.56 Lusinchi’s group has produced the 
dihydroisoquinoline-derived oxaziridinium salt 77 as an oxygen transfer agent that exhibits 
respectable enantioselectivities in the epoxidation of olefins.
57,58
 Salt 77 is derived from 
(1S,2R)-(+)-norephedrine 72 and is prepared in a five-step sequence. Importantly, they were 
also able to determine the structure of the oxaziridinium salt using X-ray crystallography 
(Scheme 23).
 58
  
 
Reagents and conditions: (a) Benzaldehyde, NaBH4, EtOH (b) CF3CO2H, H2SO4. (c) NaOCl, NaOMe (d) 
Me3OBF4, MeOH. (e) mCPBA, CH2Cl2 NaHCO3. 
Scheme 23: Chiral oxaziridinium salt isolated by Lusinchi 
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An initial reaction with 5 mol% of 76 and Oxone
TM
 as the oxidant exhibited low 
enantioselectivities (35% ee) for the epoxidation of trans-stilbene.
58 
 
The catalytic oxaziridinium-mediated epoxidation is a highly efficient method. However, the 
issue of competing irreversible base-catalysed isomerization was addressed by Bohé.
 59
 Some 
common side reactions were observed in iminium salt-mediated epoxidation. They are 
identified as deleterious factors for the iminium salt catalytic process by reducing the 
catalytic efficiency of the epoxidation process: the loss of active oxygen from the 
intermediate oxaziridinium species 78 derived from the parent iminium catalysts can occur 
when the dihydroisoquinolinium 78 contains protons on the carbon α to the nitrogen. 59 The 
corresponding isoquinolinium salt 79 can be formed by dehydration. This is an acid-base 
pathway (Scheme 24).
 59
  
 
Scheme 24: Acid-base pathway 
 
Bohé has aimed to improve the efficiency of the catalytic activity by removing the possibility 
of isomerization by dehydration.
 59
 A gradual increase in catalyst efficiency is reported when 
3,3-disubstituted dihydroisoquinolium iminium salt 80 is utilized instead of the 
corresponding unsubstituted dihydroisoquinolinium catalyst, thus eliminating the base-
catalysed isomerization (Scheme 25).
59
 We have however never observed such processes in 
our iminium salt catalysts. 
  
Reagents and conditions: (a) catalyst 80 (10 mol%), 7h, 100%.  
Scheme 25: Bohé’s improved 3,3-disubstituted-dihydroisoquinolinium catalyst 80 
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Aggarwal reported the synthesis and the use of a binaphthalene-based catalyst 81, which has 
an achiral methyl group as the nitrogen substituent, to achieve fair enantioselectivities 
(Figure 16).
60
 1-Phenylcyclohexene and trans-stilbene epoxidation reactions were carried out 
with 5 mol% of catalyst, Oxone
TM
, and NaHCO3 in a mixture of acetonitrile/water at room 
temperature, affording 1-phenylcyclohexene oxide and trans-stilbene oxide in 71% and 31% 
ee, respectively.
60
  
 
Figure 16 
 
1.10.1 Armstrong’s Exocyclic Iminium Salts  
 
Armstrong was the first to explore a range of exocyclic iminium triflate salts and use them as 
epoxidation catalysts.
61,62
 These salts were prepared by intermolecular condensation of N-
trimethylsilyl pyrrolidine with various substituted aromatic aldehydes in the presence of 
trimethylsilyl triflate in anhydrous diethyl ether (Scheme 26).
61
  
 
Scheme 26: Formation of Armstrong’s exocyclic iminium triflate salts 82-87 
 
Armstrong found that catalyst 86, bearing an ortho-trifluoromethyl group, catalysed the 
epoxidation of various olefins with 10 mol% loading, using Oxone™ and NaHCO3 in a 
mixture of acetonitrile and water for 4 h at room temperature, affording the corresponding 
epoxides in 83% yield (Scheme 27).
61
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Reagents and conditions: (a) catalyst 86 (10 mol%), Oxone
TM
 ( 2 equiv.), NaHCO3 (4 equiv.),  
MeCN/H2O (99.6:0.4), rt, 4h, 83%. 
Scheme 27 
 
Likewise, in 2000, Komatsu studied ketiminium salts, derived from pyrrolidine and 
cyclohexanone in the presence of HBF4 under Dean-Stark conditions, and attempted 
asymmetric epoxidation of a range of olefins.
63
 The chiral ketiminium salt 88 was synthesised 
from L-prolinol, which afforded the epoxide of cinnamyl alcohol 89 in 39% ee (Scheme 
28).
63
  
 
Reagents and conditions: (a) catalyst 88 (10 mol%), Oxone
TM
 (1 equiv.), NaHCO3 (4 equiv.),  
MeCN/H2O (98.7:1.3), 25 °C, 16h, 79%. 
Scheme 28 
 
1.10.2 Yang’s chiral iminium salts 
 
A direct method for the in-situ generation of chiral iminium salts involved the condensation 
of a secondary amine with either an aldehyde or a ketone.
64
 This method allowed the 
screening of various iminium salts, under mild acidic conditions, without the need for 
purification. For example, amine 91 and aldehyde 92 (20 mol% loading for both 91 and 92) 
33 
 
afforded good conversions using Oxone
TM
 and NaHCO3 in a mixture of acetonitrile and 
water, and gave trans-stilbene oxide in 65% ee (Scheme 29).
64
  
 
Scheme 29: Yang’s asymmetric epoxidation of trans-stilbene 
 
1.10.3 Page’s iminium salts  
 
Page and co-workers have pursued a study based on cyclic chiral iminium salts containing the 
asymmetric centre in an exocyclic substituent on the iminium nitrogen.
 65
 This was expected 
to improve the potential enantioselectivity by bringing the enantiocontrolling asymmetric 
centres closer to the site of the oxygen transfer reaction. Thereby, Page has adopted a 
cognitive approach to design a class of chiral iminium salts bearing an exocyclic substituent 
at the nitrogen for the organocatalytic asymmetric epoxidation of olefins.
65
 In 1998, Page 
revealed a synthetic route to facilitate the creation of a library of iminium salts, based on the 
reaction of primary amines with bromoaldehyde 94 to furnish dihydroisoquinolinium salts 95 
(Scheme 30).
65 
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Reagents and conditions: (a) i) Br2, CCl4, reflux, 1h; b) HBr (conc.), reflux, 10 min, 65%; c) R*NH2, NaBPh4, 
EtOH, MeCN, 2h, 0°C to RT, 30-65 %  
Scheme 30: Synthesis of dihydroisoquinolinium salts 95 
 
Dihydroisoquinolinium salt catalysts 96-99 were screened using model substrate 1-phenyl 
cyclohexene to gain insight into their reactivity and enantioselectivity. The N-
isopinocamphenyl-derived catalyst 99 performed best and achieved ees of up to 73% (Table 
3).
65
 
 
Table 3 
 
Catalyst 
Catalyst 
Loading/ 
(mol %) 
Yield/ (%) ee/ (%) 
96 0.5 47 15 
97  5 54 0 
98  1 45 32 
99 5 68 73 
Reagents and conditions: (a) Iminium Salt, Oxone (2 equiv.), Na2CO3 (4 equiv.), MeCN/H2O, 0°C 
 
The process employed in the synthesis of the catalyst gained various advantages from the 
nature of the catalyst produced.
65
 It involves simple synthetic steps, does not require 
chromatography and is easily scaled up (70 g). The bromide salts often are formed as oily 
products which are difficult to purify by conventional methods. This problem was solved by 
35 
 
anion exchange using the appropriate inorganic salts. Tetraphenylborate was used as counter-
ion to obtain pure crystalline iminium salts.
65
 
 
 1.10.3.1 Mechanistic analysis  
 
The catalytic asymmetric epoxidation of a simple alkene is thought to proceed through the 
proposed mechanism depicted below (Scheme 31).
66
 Reversible nucleophilic attack of 
persulfate oxidant at the si or re face of the iminium species 100 leads to the formation of two 
diastereoisomeric species 101 or 102.
66
 Irreversible ring closure with concomitant expulsion 
of a sulfate anion delivers oxaziridinium species 103 and 104, which is believed to be the 
rate-determining step under the reaction condtions.
66
 Each diastereoisomer might then deliver 
the oxygen atom to either of the prochiral faces of the alkene substrate with a different degree 
of enantiocontrol.
66
  
 
Scheme 31 
 
Unfortunately, it is impossible to isolate the active oxaziridinium intermediate(s) due to 
its/their high reactivity and instability. Therefore, it is not fully understood whether one or 
both of the two oxaziridinium diastereoisomers 103 and 104 are involved in the process.
 66
 
An early NMR study, however, showed the presence of only one diastereoisomer. 
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1.10.3.2 Catalytic oxidation conditions 
1.10.3.2 .1 Effect of the solvent 
 
Various solvents were tested by Page: dichloromethane gave the lowest reactivity, due 
perhaps to low solubility of Oxone
TM
 in the organic phase. The best results were obtained 
when a biphasic acetonitrile/water system was used. It was reported that even at low catalyst 
loading (0.5 mol%) a significant increase of the rate of reaction was observed for a 1:1 
mixture of acetonitrile and water without affecting epoxide ees.
66
 For example, this solvent 
system was used in the asymmetric epoxidation of 1-phenylcyclohexene with 
tetraphenylborate iminium salt 99, yielding 1-phenylcyclohexene oxide in 30% ee after 1 
hour. However, at a higher catalyst loading (5 mol%), the use of any water/acetonitrile 
solvent system, using ratios from 1:9 to 9:1, led to full conversion in less than 20 minutes.
66
 
Thereby, this solvent system was found to be the best solvent system used, in terms of both 
enantioselectivity and reactivity.
 66
  
 
1.10.3.2 .2 Effect of Temperature 
 
Page and co-workers attempted to carry out reactions below 0 °C, but were limited by the 
freezing point of water and by extent the solvent mixture. When employing an 
acetonitrile/water solvent system (1:1) at –10 °C, the biphasic mixture froze and the reaction 
rate decreased.
66
 For example, at –10 °C with catalyst 99 and an acetonitrile/water mixture 
(3:1), 1-phenylcyclohexene oxide was obtained in 35% ee, while at 0 °C, phenylcyclohexene 
oxide was obtained in 40% ee. More importantly, this made little difference to the ee of the 
isolated epoxide. Negligible conversion to the epoxide was observed at between 27–32 °C, 
due to rapid decomposition of Oxone above room temperature.
 66
 
 
1.10.3.2 .3 Effect of Catalyst Loading 
 
No epoxide was detected when the epoxidation reaction of 1-phenylcyclohexene in the 
absence of an iminium salt catalyst in an acetonitrile/water solvent system (1:1) at 0 ºC, with 
Oxone
TM
 and sodium carbonate.
66
 However, increasing catalyst loading from 0.1 to 6 mol% 
37 
 
was successful in improving the enantioselectivity of the epoxidation reaction; above 6 mol% 
only negligible improvement was observed.
 66
  
 
Figure 17: Effect of catalyst loading on the enantioselectivity of the asymmetric epoxidation 
of 1-phenylcyclohexene utilizing iminium salt 99 
 
Since 1998, Page has made significant contributions towards designing iminium salts using a 
range of chiral amines in an attempt to potentially increase enantioselectivity. Page has 
introduced the dioxane-containing chiral amine 105, which was proven to give better 
catalysts than amine 99. Therefore, nowadays, amine 105 and derivatives are used 
exclusively in Page’s most recent and successful catalyst designs (Figure 18). 67 
 
Figure 18: The dioxane-containing chiral amine 105 
 
Dihydroisoquinolinium salt 106 was used in the epoxidation of a range of simple alkenes, 
showing higher enantioselectivities, when compared to catalyst 99.
67
 For example, 
epoxidation of triphenylethylene was carried out using catalyst 106 (5 mol%) employing 
Oxone
TM
 and sodium carbonate in an acetonitrile/water solvent system (1:1) at 0 °C, 
affording triphenylethylene oxide in 90% yield and 59% ee (compared with 100% yield and 
5% ee when catalyst 99 was used under the same conditions).
 67
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Figure 19 
 
Further work was focused on the development of more selective catalysts, based on the 
replacement of the dihydroisoquinolinium moiety with a biphenyl structure, featuring a 
seven-membered ring system.
68
 After screening various simple alkenes for asymmetric 
epoxidation, azepinium salt 107 was found to be more reactive in the epoxidation reaction 
than the six-membered ring dihydroisoquinolinium catalysts and demonstrated good 
enantiocontrol in the epoxidation process (Table 4).
68 
 
Table 4: Biphenyl-azepinium catalyst 107 prepared by Page and co-workers 
 
Catalyst Time/min 
conv/ 
(%) 
ee/ (%) 
 
10 100 24  
 
3 90 59 
 
31 100 60 
 
3 41 41 
Reagents and conditions (a) 107 (5 mol%), Oxone (2 equiv.), Na2CO3 (4 equiv.), MeCN/H2O (1:1), 0 °C. 
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Page’s group synthesised iminium salt catalyst 108 with a binaphthalene backbone (Figure 
20).
69
 The binaphthalene-azepinium salt 108 showed excellent enantioselectivities in the 
asymmetric epoxidation of 1-phenylcyclohexene (91% ee) and 4-phenyl-1,2-
dihydronaphthalene (95% ee), while exhibiting poor enantioselectivities for 2-phenyl-2-
propene (42% ee) and triphenylethylene (12% ee).
69
 
 
Figure 20: Binaphthalene-azepinium catalyst prepared by Page and co-workers 
 
Regarding the low solubility of Oxone
TM
 in many organic solvents, Page’s group conducted 
an investigation on the use of many stoichiometric oxidants under non-aqueous conditions. 
Tetraphenylphosphonium monoperoxysulfate (TPPP) turned out to possess a superior 
reactivity without any background epoxidation observed.
70
 This positive finding was applied 
to develop a non-aqueous epoxidation system mediated by iminium salt catalysts.
70
 Hence, 
performing the epoxidation reaction under the non-aqueous conditions at lower temperatures 
led to excellent enantioselectivities for the epoxidation of cyclic cis-disubstituted alkenes.
71
 
For example, 6-cyano-2,2-dimethylchromene oxide 110 was formed in a highly 
enantioselective fashion (97% ee) using iminium salt catalyst 107 (Scheme 32).
71
 
 
Reagents and conditions (a) Catalyst 107 (5 mol%), TPPP (2 equiv.), 20 h, 0 °C, 90%, 97% ee. 
Scheme 32: Asymmetric epoxidation of 109 under non-aqueous conditions  
 
Subsequently, Page was able to use chiral iminium salts under non-aqueous conditions for the 
formation of epoxides in high enantioselectivity as the key step in the synthesis of natural 
products.
72
 For example, in 2005, the total synthesis of anti-hypertensive agent 
levcromakalim 114 was achieved using an asymmetric epoxidation reaction mediated by 111 
(Scheme 33).
72
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Reagents and conditions (a) Catalyst 111 (10 mol%), TPPP (2 equiv.), CHCl3, 24 h, −40 °C, 85%, 97% ee; b) 
Pyrrolidin-2-one. NaH, DMSO, RT, 52%. 
Scheme 33: Synthesis of levcromakalim 112 
 
Epoxide intermediate 110 was subjected to a ring-opening reaction using pyrrolidin-2-one to 
give levcromakalim.
72
 Natural products trans-khellactone 114 and lomatin 115 were also 
prepared using an asymmetric epoxidation as the key step (Scheme 34).
73
 
 
Reagents and conditions: (a) Catalyst 111 (10 mol%), TPPP (2 equiv.), CHCl3, 24 h, −30 °C, 65%, 97% ee; 
 d) 1M H2SO4 (aq.), acetone, RT, 95%. c) NaBH3CN (1 equiv.), BF3·OEt, THF, 0 °C, 92%. 
Scheme 34: Total syntheses of trans-khellactone 114 and lomatin 115 
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1.11 Kinetic resolution 
  
In all living cells and organisms, complex processes naturally occur to synthesize chiral 
compounds that exist in an enantiomerically pure form, for instance, carbohydrates, proteins, 
and DNA in contrast with chemical reactions which usually produce racemic mixtures.
2
 The 
racemic mixtures can then be separated into the two enantiomeric forms.
4
 The process of 
separating a racemic mixture into its enantiomers is known as resolution.
4
 One way of 
achieving separation is using a kinetic resolution. Kinetic resolution is a term defined as 
transformation of one of enantiomer faster than the other into the product in high 
enantiomeric purity, mediated by a chiral catalyst. The process depends on each enantiomer 
in the racemic mixture reacting at a different rate KR≠KS (Figure 20).
2,74
  
 
Figure 20 
 
The selectivity factor (krel ) is calculated by the equation reported by Kagan, which is related 
to the rate constant of the reaction of the R and S enantiomers, proceeding to a signal product. 
74
 
 
S = 
               
                
 
S = Krel = Kfast/Kslow,  ee = enantiomeric excess, c = conversion 
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1.11.1 The use of kinetic resolution in catalytic asymmetric epoxidation 
 
The major advantages of a kinetic resolution process using asymmetric epoxidation lie in the 
following: racemic starting materials are cheap and readily available; a catalytic kinetic 
resolution can proceed at low loading; the catalyst is inexpensive and can be reused; and the 
unreacted substrate and product can be obtained with excellent enantioselectivities.
 75 
 
1.11.2 Sharpless’ kinetic resolution 
 
An early report of a successful kinetic resolution using asymmetric epoxidation was 
published by Sharpless in 1981.
75
 The asymmetric epoxidation reaction conditions previously 
reported were applied to a racemic allylic alcohol.
4
 Although both enantiomers of the allylic 
alcohol can be epoxidized from the same face, the stereochemical outcome of the epoxidation 
of chiral allylic alcohols is settled by different rates of reaction for each enantiomer. For 
instance, racemic secondary allylic alcohols 116 that have one chiral centre at C1 (attached to 
the OH group) were tested under Sharpless epoxidation. One enantiomer is consequently 
expected to react faster than the other, if the rates of epoxidation of two enantiomers are 
fundamentally different.
4
 Sharpless was able to obtain epoxide 117 and allylic alcohols in 
high enantioselectivity. Sharpless determined that the rate of epoxidation of (S)-116 is 700 
times higher than (R)-116 (Scheme 35).
4
  
 
Reagents and conditions: (a) (+)-DIPT, Ti(OPr
i
)4,TBHP. 
Scheme 35: Stereochemical outcome of the epoxidation of secondary allylic alcohols 
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1.11.3 Page’s kinetic resolution 
 
In 2013, Page first reported the kinetic resolution of racemic chromenes using an iminium 
salt-mediated epoxidation reaction.
77
 The first example explored by Page, 6-cyano-2-methyl-
chromene substrate 118, was based on a 2-substituted benzopyran with the chiral centre at the 
C2 position. Chromene 118 was initially subjected to iminium salt-catalysed epoxidation, 
allowing a perceptive insight into the outcome of the kinetic resolution methodology.
77
 The 
reaction was carried out with iminium salt 111 under non-aqueous conditions, affording the 
major epoxide diastereoisomer 119, where the epoxide moiety is trans with regard to the 
methyl group at the C2 position, in 86% ee, the minor epoxide diastereoisomer 120 in 97% 
ee, and the unreacted starting material 121 in 37% ee (Scheme 36).
 77
  
 
 
Reagents and conditions: (a) iminium salt 111 (10 mol%), TPPP (4 equiv.), 
CHCl3, –30 °C, 24 h (The upper structures of each pair are the major isomers in each case). 
Scheme 36  
 
Page was able to confirm the configuration of the major epoxide product by: 1) based on 
previous outcomes observed within the group for the epoxidation of prochiral olefins with 
catalyst 111, the si face of the substrate appeared to be favoured; 2) the unreacted starting 
materials were recovered as enantioenriched mixtures and their optical rotations were 
matched by analogy with chiral chromenes of known absolute configuration and optical 
rotation which had been previously synthesized or isolated as single enantiomers (Figure 
21).
77 
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Figure 21 
 
Increasing the size of the substituent at the C2 position, from methyl to phenyl, particularly 
favoured the formation of the major epoxide, where the epoxide moiety is trans with regards 
to the phenyl group without any observation of the cis analogue.
77
 Importantly, the absolute 
configuration of the major epoxide enantiomer was confirmed by single crystal X-ray 
analysis of a sample of compound 125 (Scheme 37).
 77
 
 
Reagents and conditions: (a) Catalyst 111 (10 mol %), TPPP, CHCl3, −30 °C, 24 h, 74 % ee; (b) Pd/C, H2 (1 
atm.), MeOH, RT, 20 min, quantitative; (c) (10S)-(+)-camphorsulfonyl chloride (1 equiv.), Et3N (2 equiv.), 
toluene, RT, 24 h, 43%. 
Scheme 37 
 
45 
 
 
1.12 Flavonoids 
 
Phenolic compounds form one of the main classes of secondary metabolites and occur in a 
vast range of plants.
78,79
 They possess a large number of structures with extreme diversity, for 
instance, benzoquinones, chromones, stilbenes, and flavonoids.
 79
 Phenolic compounds play a 
significant role in the organoleptic and nutritional qualities of fruit and vegetables.
78 
Thus, 
certain colour and taste properties have been attributed to phenolic compounds in a number of 
plants and derivatives such as berries, tea, beer, grapes, olive oil, cocoa and coffee.
78,79,80 
Among these compounds are flavonoids, which are generally termed to indicate a wide range 
of compounds and constitute one of the major classes of all plant secondary metabolites. 
Flavonoids are categorized by subclasses, which arise from a change in oxidation state, 
skeletal modification and oligomer formation.
81,82
 They have the basic skeleton of 1,3-
diphenyl propane (C6-C3-C6), depending on the position of the linkage of the aromatic ring 
(ring C) to the benzopyran. Therefore flavonoids may be divided into three categories: 
flavonoids (2-phenylbenzopyrans) 126, isoflavonoids (3-phenylbenzopyrans) 127, and 
neoflavonoids 128 (Figure 22). These categories also possess similar biological 
activity.
81,82,83
  
  
Figure 22: Structures of flavonoids 126, isoflavonoids 127, and the neoflavonoids 128 
 
1.12.1 2-Phenylbenzopyrans (C6-C3-C6 backbone) 
 
The degree of oxidation and saturation present in the heterocyclic C-ring and a basic 
chemical structure (C6-C3-C6 backbone) are fundamental factors in the sub-division of 2-
phenylbenzopyrans into the following groups (Figure 23): 
81
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Figure 23 
 
1.12.2 flavan-3-ol 
 
 Repeated condensation of flavan-3-ol results in the formation of a polymeric proantho- 
cyanidin, which may be defined as natural condensed tannin.
79,80
 It exists as a mixture 
consisting of several 3-flavan-3-ols with different numbers of phenolic hydroxyl groups on 
the C ring.
 80,84
 Many flavan-3-ols have been identified and characterized according to the 
degree of hydroxylation of ring C; they are thought to have one (afzlechin/epiafzlechin), two 
(catechin/epicatechin), and three (gallocatechin/epigallocatechin) hydroxyl groups as well as 
different stereochemistry at the asymmetric carbon atoms in the heterocyclic ring C; 
examples include (+)-afzlechin, (−)-epiafzlechin, (+)-catechin, (−)-epicatechin, (−)-
gallocatechin and (−)-epigallocatechin (EGC) (Figure 24). 79,80,84  
47 
 
 
Figure 24: subclasses of flavan-3-ol 
 
 
Although the majority of flavan-3-ols possess powerful antioxidant properties, many also 
have other biological activities attributed to them.
79
 They show anticancer, antimutagenic, 
and immunomodulatory activities, promote cardiac recovery after ischamia, and inhibit 
bacterial adhesion to the urinary tract.
85,86
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1.12.3 Synthesis of (-)-Gallocatechin 
 
The enantioselective synthesis of (−)-gallocatechin 134 was reported by Krohan.87 Reduction 
of ketone 129 followed by dehydration using ethyl chloroformate and sodium borohydride 
led to the olefin 130 in 57% yield, followed by protection of hydroxyl group using tert-
butyldimethylsilyl chloride.
87
 A Sharpless asymmetric dihydroxylation of the double bond 
provided the key intermediate 132 in high enantiomeric purity (93.6% ee). Treatment of the 
TBS-ether 132 with tetrabutylammonium fluoride (TBAF) afforded the triol 133 in 92% 
yield. Cyclisation of the triol took place under Mitsunobu conditions, giving (−)-
Gallocatechin 134 in 71% yield and 97.7% ee. 
80,87
  
 
Reagents and conditions: a) ClCOOEt, Et3N, THF.; b) NaBH4, H2O–EtOH, 0–5 °C ,57%; c) TBSCl, DMF, 
imidazole, 93%; d) AD-mix α, t-BuOH–H2O (1:1), 82%, 93.6% ee; h) TBAF, THF, r.t., 1.5h, 92%; f) DEAD, 
Ph3P, THF, r.t., 3h,71%, 97.7% ee. 
Scheme 38: Syntheses of (−)-Gallocatechin 134 
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2.0 Results and discussion 
2.1 Project Structural Analysis  
 
Chromenes are heterocyclic compounds and are potential targets for laboratory synthesis. 
They exhibit a broad range of pharmacological profiles, including anti-oxidant, anti-
inflammatory, anti-cancer, and anti-HIV activity.
1
 Preparation of racemic chromenes has 
been widely reported,
 
although the number of examples of enantioselective synthesis of 
chromenes appears limited.
2,3
 The asymmetric epoxidation reaction is a recently developed 
approach that can offer synthesis of optically active tetrahydropyrans in a highly 
enantioselective fashion.
4
 Indeed, since 2005, metal-free catalytic asymmetric epoxidation 
using iminium salts such as 1 has been successfully employed to access chiral chromenes 
within the Page group. The iminium-catalysed asymmetric epoxidation methodology has 
been applied to the synthesis of levcromakalim 2,
4
 trans-khellactone 3, and lomatin 4,
1
 which 
are based on a chromene-type structure (Figure 1).  
 
  
Figure 1: Chiral chromenes obtained using iminium salt catalysed epoxidation 
 
We have also used Page’s organocatalytic asymmetric epoxidation methodology towards the 
kinetic resolution of racemic chromene substrates. A successful protocol of kinetic resolution 
was developed by Page’s group and involved the use of chiral iminium salts and the oxidant 
TPPP (Tetraphenylphosphonium monoperoxysulfate), soluble in organic solvents.
 5
 The aim 
of this study was to oxidize racemic alkenes, based on a chromene-type structure such as 5, to 
afford epoxides in a diastereoselective and enantioselective fashion. The less reactive alkene 
enantiomer was also recovered in a low enantiomeric excess (14% ee) Scheme 1.
 5
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Reagents and conditions: (a) Catalyst (10 mol %), TPPP, CHCl3, -30 °C, 24 h, 74 % ee; (b) Pd/C, H2 (1 atm.), 
MeOH, RT, 20 min, quantitative; (c) (10S)-(+)-camphorsulfonyl chloride (1 equiv.), Et3N (2 equiv.), toluene, 
RT, 24 h, 43%. 
Scheme 1: Oxidation of racemic chromene 5. 
 
Our group has a continuing interest in the application of the kinetic resolution to the flavan-3-
ol family, with stereogenic centres at C2 and C3, which could be accessed through the 
selective oxidation of a racemic alkene using chiral iminium salts. This is due to the 
stereochemical outcome provided in the reaction described above (Scheme 1), which would 
allow us to access our target (-)-epigallocatechin (EGC) 9 from racemic alkene (±)-10.
 6,7,8
  
 
Figure 2: Retrosynthesis of epigallocatechin. 
 
A concise enantioselective synthesis of chiral natural product 9 and its analogues was devised 
through a number of steps, including an asymmetric epoxidation reaction of a chromene-type 
structure as the key selective step. The absolute configuration of the stereogenic carbon atoms 
C-2 and C-3 from epigallocatechin and analogues will be accessed as shown below (Scheme 
2) using chiral iminium salts as catalyst to transfer oxygen to the electron-rich racemic alkene 
10, where one enantiomer reacts faster than the other, resulting in the favoured formation of 
the chiral epoxide 11 with the desired configuration at C-2 and C-3.
5
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Scheme 2: Kinetic resolution of racemic alkene 10 
 
The preferential formation of one epoxide enantiomer 11 would be followed by a two-
reaction sequence to form epigallocatechin (Scheme 3). The first step would be the reductive 
ring opening (Step 1) of the epoxide moiety followed by the removal of the protecting groups 
(Step 2). 
 
 
Scheme 3: Synthesis of epigallocatechin and analogues 
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2.2 Synthesis of flav-3-ene A  
 
Figure 3: Targeted flav-3-enes. 
 
Our concise approach for the synthesis of chromene 12 is based on an intramolecular Claisen 
rearrangement of propargylic ether 13. During this process, aryl ethers are heated under 
reflux with a high boiling point solvent, such as ethylene glycol. The structure of the 
chromene is built by the linking of two ring fragments, namely A and B. Propargylic ether 13 
can be potentially accessed through the condensation reaction of a phenol and a propargyl 
alcohol.
9
 A synthetic route through which to form the aryl ethers can be achieved by 
nucleophilic attack of phenol 14 onto propargylic alcohol 15 in order to displace the alcohol 
moiety in the presence of acid (Scheme 4). 
10, 11
  
 
Scheme 4: Retrosynthetic approach towards 12. 
 
2.2.1.1 Synthesis of 3,5-dibenzyloxyphenol  
 
Our initial target was 3,5-bis(benzyloxy)-phenol (Compound 14 where R=Bn). Attempts to 
obtain the desired bis-protected phenol from 1,3,5-benzenetriol 16 failed, with statistical 
mixtures obtained. Several studies have revealed that 3,5-dibenzyloxyphenol could be 
obtained through mono-protected 1,3,5-benzenetriol 17.
 12,13
 The protected compound was 
57 
 
obtained using benzoyl chloride and pyridine in anhydrous tetrahydrofuran under reflux, 
giving benzoate 17 in 48% yield after three days (Scheme 5). 
14
  
 
Reagents and conditions: (a) BzCl, pyridine, THF, reflux, 3 d, 48%. 
Scheme 5: Mono-protection of 1,3,5-benzenetriol 16. 
 
The remaining hydroxyl groups were protected with benzyl groups. Compound 17 underwent 
the protection reaction using benzyl bromide and potassium carbonate in anhydrous 
tetrahydrofuran, affording 18 in 66% yield. When 18-crown-6 was also used, the reaction 
yield increased to 79%.
 15
  
 
Reagents and conditions: (a) BnBr, K2CO3, THF, reflux, 24h, 66%; (b) BnBr, K2CO3, 18-crown-6, THF, reflux, 
24h, 79%. 
Scheme 6 
 
Saponification of the benzoyl group using potassium hydroxide in methanol failed to yield 
19, with only starting material 18 recovered.
 14
 LiAlH4 was then used to reduce the ester, 
leading to 19 in 68% yield.  
 
Reagents and conditions: (a) LiAlH4, THF, overnight, 68%. 
Scheme 7: Removal of the benzoyl protecting group 
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2.2.1.2 Synthesis of propargyl alcohol 24 
 
During the next stage towards the synthesis of epigallocatechin, we attempted to prepare 
the C-ring fragment. Benzyl groups were chosen to mask the three nucleophilic and acidic 
hydroxyl groups of methyl 3,4,5-trihydroxybenzoate 20 to prevent any side reaction. This 
was achieved using a general method for the benzylation of phenols, involving a nucleophilic 
substitution reaction on benzyl bromide in the presence of K2CO3, and dimethylformamide to 
produce 21 in 89% yield. 
16
 Conversion of the ester to the corresponding alcohol was 
completed overnight, using LiAlH4 in anhydrous tetrahydrofuran to give the desired 
compound 22 in 90% yield. Finally, the alcohol moiety was then oxidized to form the 
benzaldehyde 23 using PCC in 81% yield. 
17 
 
Reagents and conditions: (a) BnBr (4.5 equiv.), K2CO3 (3.3 equiv.), DMF, RT, overnight, 89%; (b) LiAlH4 
(1.55 equiv.), THF, 0 C to RT, overnight, 90%; (c) PCC (1.5 equiv.), CH2Cl2, RT, overnight, 81%. 
Scheme 8 
Benzaldehyde 23 was subjected to the addition of a suitable organometallic reagent to 
synthesise racemic alcohol 24. Propargylic alcohol 24 would play a significant role as a 
building block between ring C and rings A and B using a condensation reaction, and 
establishing the crucial C-O bond. The formation of secondary alcohol 24 containing a new 
carbon-carbon bond was achieved successfully using a Grignard reaction through the slow 
addition of ethynyl magnesium bromide to 3,4,5-tris-benzyloxy-benzaldehyde 23 under 
anhydrous conditions at −78 °С, yielding 66% of the desired compound as a yellow solid 
(Scheme 9). 
18,19
  
 
Reagents and conditions: (a) Ethynylmagnesium bromide (5 equiv.), NH4Cl, THF, 78 C, 2h, 66%. 
Scheme 9 
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2.2.1.3 Synthesis of propargyl ether 25 
 
A considerable amount of literature has been published in relation to the synthesis of 
chromenes.
19,20
 For example, a simple and straightforward approach is the cyclo-
condensation reaction of a phenol and a propargyl alcohol, which are easily accessible 
starting materials.
19
 The proposed mechanism of the condensation reaction may be described 
as a sequence: firstly, 3,5-bis(benzyloxy)phenol 19 would be condensed with propargylic 
alcohol 24 to give propargyl ether 25 in the presence of an acid. During the second step, a 
Claisen rearrangement of propargyl ether 25 would occur to give allene 26. Rearrangement of 
the allene moiety would give conjugated ketone 27, and finally 3-flav-3-ene 28 would be 
obtained through cyclization of 27.
 21
 
 
Scheme 10: Proposed mechanism for the formation of alkene 28. 
 
According to the literature,
19,20,21
 the synthesis of flav-3-enes can be achieved easily under 
acidic conditions (Scheme 10). The propargylic alcohol 24 was treated with phenol 19 in the 
presence of camphorsulfonic acid (0.05 equiv.) in anhydrous dichloromethane for 48 h at a 
room temperature. Unfortunately, no significant change in the reaction mixture was observed 
using 
1
H NMR spectroscopic analysis, and only the starting materials were recovered. 
Increasing the amount of camphorsulfonic acid (0.1 equiv.) led to the formation of propargyl 
ether 25 in a moderate yield (28%) rather than flav-3-ene 28 (chart 1); and further yield 
increases were also observed as the amount of camphorsulfonic acid was increased.  
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Chart 1: Optimisation of the synthesis of propargyl ether 25  
 
Relatively few methods have been described for the preparation of 2H-chromenes by one step 
condensation of a phenol and a propargyl alcohol using a Lewis acid as the catalyst.
 19,22
 The 
condensation reaction of 2-naphthol and a diaryl propargyl alcohol under acidic alumina 
catalysis to obtain diaryl-naphthopyrans in 32% yield has been reported.
23
 In our hands, the 
condensation reaction occurred as a result of the treatment of the propargylic alcohol 24 with 
the phenol 19 in the presence of acidic alumina in toluene under reflux overnight, leading to 
propargyl ether 25 in 21% yield. 
  
Reagents and conditions: (a) Al2O3, toluene, reflux, overnight, 21%. 
Scheme 11 
 
A Claisen rearrangement of the propargyl ether 25 into the corresponding chromene 28 was 
then attempted.
9,11
 First, a high boiling point solvent, N,N-dimethylaniline, was used in order 
to promote a thermal Claisen rearrangement (Table 1). 
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 Table 1: Thermal Claisen rearrangement attempts. 
  
Conditions  Temp Solvent Time Yield 
a Reflux N,N-dimethylaniline 24 h decomposition 
b 150 °С N,N-dimethylaniline 4 h decomposition 
Reagents and conditions: (a) thermal reaction; (b) microwave-assisted synthesis. 
 
Unfortunately, the thermal rearrangement was unsuccessful and led to the decomposition of 
our starting material. A microwave-assisted synthesis was then attempted at a lower reaction 
temperature; only decomposition products were observed. 
 
Another possible methodology involves the use of copper(I) chloride in the presence of 
copper as a catalyst to activate the alkyne moiety (Table 2).
 11
  
 
Table 2  
 
Entry Temp. Solvent Catalysts Time Yield 
1 Reflux Toluene Cu/CuCl 24 hours decomposition 
2 Reflux Toluene Cu/CuCl 24 hours decomposition 
 
Alkyne 25 was dissolved in toluene in presence of copper chloride and copper metal, and the 
reaction mixture was heated under reflux; as observed above, only decomposition products 
were observed under these reaction conditions. The instability of the flav-3-ene precursor 
under thermal conditions influenced the outcome of the Claisen rearrangement, regardless of 
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whether or not a Lewis acid was used. As reported in the literature, a possible degradation 
pathway involves the highly reactive orthoquinone methide 27, which is in resonance with 
the corresponding allylic cation 29 (Scheme 12).
 24,25
 
 
Scheme 12: Possible degradation pathway 
 
As the orthoquinone methide 27 is also a possible intermediate during the Claisen 
rearrangement of propargyl ether 25 (Scheme 10), a change of strategy was needed to 
improve the stability of the desired product.
 24,25
 
  
From a synthetic point of view, we believe the presence of highly electron-rich groups such 
as the benzyloxy groups on alkyne 25 may be destabilizing the flavene moiety. Replacing the 
benzyloxy with acetoxy groups would bring a reduced electron density into the conjugated π 
system to stabilize the flav-3-ene 30 or the corresponding orthoquinone methide intermediate. 
The synthesis would follow the same route as above, where a Claisen rearrangement of 
alkyne 31 would afford the desired flavene 30 (Scheme 13). Propargyl ether 31 can be 
prepared from the coupling of alkyne 24 and phenol 32.  
Scheme 13 
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3,5-Diacetoxyphenol 32 was prepared by treatment of phloroglucinol 16 with acetic 
anhydride in pyridine under reflux for 15h. The desired diacetoxy compound 32 was obtained 
in 58% yield, alongside the corresponding triacetoxy derivative 34 in 26% yield.
 27 
 
Reagents and conditions: (a) Ac2O, pyridine, reflux, 15h, [(32, 58%); (34, 26%)]. 
Scheme 14 
 
Phloroglucinol triacetate 34 can be converted to the desired diacetate 32 using a simple 
saponification reaction. Indeed, compound 34 was dissolved in dimethylformamide followed 
by the addition of sodium hydride (0.5 equiv.) at 60 C to afford phenol 32 in 53% yield. 28 
 
Reagents and conditions: (a) NaH, DMF, 60 C, 4h, 53%. 
Scheme 15 
 
The acid-catalysed condensation of a phenol and a propargyl alcohol was then attempted to 
prepare the propargyl ether 31 (Scheme 16). 3,5-Diacetoxyphenol 32 and alkyne 24 were 
dissolved in anhydrous dichloromethane in the presence of camphorsulfonic acid for 18h to 
synthesise the propargyl ether 31 in 16% yield.
 19,20
 
 
Reagents and conditions: (a) camphorsulfonic acid, RT, CH2Cl2,18h, 16%; (b) DIAD, PPh3, toluene, 0 C to 
RT, 18h, 43%; (c) DIAD, PPh3, THF, 0 C to RT, 18h, 65%. 
Scheme 16 
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As the yield obtained using the acid-catalysed methods were disappointing, another strategy 
was devised. A common way to form ethers involves the Mitsunobu reaction.
 29
 The phenol 
32, the propargyl alcohol 24 and triphenylphosphine were dissolved in anhydrous toluene at 0 
°С, followed by the addition of diisopropyl azodicarboxylate (DIAD). TLC analysis showed 
that the propargyl ether 31 was gradually formed over 16 hours, and the desired product was 
obtained in 43% yield. When tetrahydrofuran was used in place of toluene, the yield was 
increased to 65%. 
 
The final drive towards the target molecule was attempted as described above. The treatment 
of propargyl ether 31 with a high boiling solvent, such as N,N-dimethylaniline would be 
expected to afford the intermediate 35 through a Claisen rearrangement. Once formed, 
orthoquinone methide 35 would undergo a [3,3]-sigmatropic rearrangement, to give flav-3-
ene 30 (Scheme 17).
 9,11
 
 
Scheme 17 
 
When propargyl ether 31 was dissolved in N,N-dimethylaniline and the reaction mixture was 
heated at 180 °С, the desired chromene 30 was not obtained, but we were pleased to observe 
that no decomposition of the starting material had occurred. The reaction was also attempted 
using microwave-assisted synthesis for 6 h without any improvement. Likewise, in the 
presence of catalytic amounts of copper and copper chloride in toluene heated under reflux, 
propargyl ether 31 was the only compound detected using TLC and 
1
H NMR spectroscopy. 
When compound 31 was submitted to microwave irradiation for 18 h, complete 
decomposition of the starting material was observed. 
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Table 3 
 
Entry Catalyst Solvent Temperature Time Conversion 
1 - N,N-dimethylaniline 180 °С 24h SM 
2 - N,N-dimethylaniline Microwave 
(180 °С) 
6h SM 
3 - N,N-dimethylaniline Microwave 
(220 °С) 
18h decomposition 
4 Cu/CuCl Toluene Reflux 24h SM 
5 Pd(OAc)2 Toluene Reflux 24h  10% (36) 
 
A palladium-catalysed cyclization was also attempted:
 30 
the alkyne 31 and palladium acetate 
were dissolved in toluene and the mixture was heated under reflux. No starting material was 
detected after 24h. However, purification only yielded alkene 36 in 10% yield, presumably 
obtained through a palladium-catalysed rearrangement (Scheme 18). 
 
 
Scheme 18: the formation of 36  
 
To the best of our knowledge, we do not have a rational explanation of the mechanism of the 
reaction. However, it is thought that the rearrangement occurs through complexation of allene 
37, with palladium. Oxidation of Pd(0) to Pd(II) may occur with coordination of Pd(0) with 
the allene generating a tetracoordinated Pd(0) complex containing both single carbon bonds 
bonded to the palladium centre.
11 
Subsequently, the alkene 36 was obtained in 10% yield. 
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Evidence for the formation of compound 36 includes the presence of a terminal alkene 
moiety using 
1
H, 
13
C NMR and mass spectra analysis. Firstly, in the 
1
H NMR spectrum, three 
sets of signals corresponding to protons on sp
2
 carbons appeared as doublets of doublet with 
different J values (17.5, 10.8, 0.7) in 3 regions, confirming the presence of a terminal alkene. 
Using 
13
C NMR spectroscopy, the sp
2
 carbon atoms corresponding to the alkene moiety were 
observed at 137.9 and 112.1 ppm. Finally, a molecular ion at m/z 422.51 g/mol was observed 
using mass spectrometry, which matches the molecular weight of compound 36. 
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2.3 Synthesis of flav-3-ene B 
2.3.1 Retrosynthetic analysis 
  
Another potential route towards the synthesis of flav-3-ene derivatives is outlined in the 
retrosynthetic approach below (Scheme 19). Flav-3-enes can be obtained through cyclization 
of the corresponding α,β-unsaturated ketones or chalcones 41. One of the most convenient 
methods described is a base-mediated cyclization carried out in alcohol under reflux. The 
chalcone would be formed as a result of an intermolecular aldol condensation followed by 
dehydration. The aldol reaction is a two-step process: first, formation of the enolate at the α-
carbon of the corresponding hydroxyacetophenones under basic conditions; then, addition of 
the enolate ion onto the electrophilic benzaldehyde to form the new carbon-carbon bond. 
Dehydration follows to generate the corresponding α,β-unsaturated ketone, such as 41. 7, 32  
 
Scheme 19 Retrosynthetic analysis of 3-flav-3-ene 
 
Benzylation using benzyl bromide (2 equiv.) was carried out as a preliminary experiment to 
protect 1-(2,4,6-trihydroxyphenyl) ethanone 42 using different bases in polar aprotic solvents 
(Table 4).
33,34,35,36
 The ketone group was thought to sterically hinder one or both of the 
hydroxyl groups in the ortho position of compound 42, hence preventing the reaction with 
benzyl bromide.  
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Table 4: Synthesis of ketone 43. 
 
 
However, when potassium carbonate was used as the base, significant amounts of the 
tribenzylated compound 44 were obtained alongside the desired ketone 43. Increasing the 
reaction time also led to increased yields of 44 at the expense of the desired compound. When 
n-butyllithium was used at low temperature, the desired ketone 43 was obtained in 56% yield 
without the undesired side-product 44. 
 
One way to increase the efficiency of the reaction would be to recycle compound 44 and 
convert it to the desired ketone 43. The use of titanium tetrachloride has been reported to 
selectively remove one of the benzyl protecting groups in compound 44.
15
 Selective mono-
deprotection of one of the benzyl groups of 44 was conducted in anhydrous dichloromethane 
using TiCl4 at 0 °С for 1 hour, forming the desired compound 43 in 51% yield (Scheme 20). 
 
Reagents and conditions: (a) TiCl4 (0.7 equiv.), CH2Cl2, 1h, 0 °C, [(43, 51%); (45, 8%)]. 
Scheme 20 
 
 BnBr Base Solvent Time T (°С) conversion 
a 2 equiv. K2CO3 (2 equiv.) DMF 1.5 h 70 43 (46%) / 44 (10%) 
b 2.1 equiv. K2CO3 (2 equiv.) DMF overnight 70 43 (40%) / 44 (30%) 
c 2.5 equiv. K2CO3 (3 equiv.) HMPA overnight 90 43 (26%) / 44 (60%) 
d 2.15 equiv. n-BuLi (2 equiv.) THF 48 h –76 to 0 43 (56%) 
69 
 
However, titanium tetrachloride may have activated the benzyl group towards intermolecular 
electrophilic aromatic substitution (Scheme 21), giving compound 45 in 8% yield. The 
outcome of the reaction was comparable to the result of a reaction reported in the literature.
 15
 
 
Scheme 21 
 
In order to optimize the synthesis of 43 and to simplify purification, optimisation of the 
synthesis of 44 was attempted. The amounts of base and benzyl bromide were increased and 
ketone 44 was obtained in up to 90% yield (Table 5).
 37
  
 
Table 5: Synthesis of ketone 42. 
 
 BnBr K2CO3 Solvent Time T (°С) Yield 
a 4.5 equiv. 4.5 equiv. DMF 24h 100 66% 
b 6 equiv. 6 equiv. DMF 24h 100 90% 
 
The chalcone 46 was synthesized using an aldol condensation following a literature 
procedure. The treatment of acetophenone 43 and benzaldehyde 23 with sodium hydride in 
dimethylformamide gives the corresponding chalcone 46 in 55% yield. Sodium borohydride 
was then added to a dilute solution of the chalcone in a mixture of tetrahydrofuran and 
methanol (1:1) at room temperature resulting in the disappearance of the yellow colour. The 
reaction was then heated at 68 °C overnight affording flav-3-ene 28 in 14% yield. 
32
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Reagents and conditions: (a) NaH (1.5 equiv.), DMF, R.T., 6h, 55 %; (b) NaBH4 (1 equiv.), THF/MeOH, R.T. 
to reflux, overnight, 14%. 
Scheme 22 
 
Racemic flav-3-enes can also be prepared through direct cyclization of the corresponding 
chalcone using reducing agents followed by the addition of Lewis acids.
38
 In an effort to 
improve the reaction yield, a stepwise process, where reduction of the ketone occurs followed 
by a Lewis acid-catalysed cyclization, was attempted (Scheme 23). Ketone 46 was reduced 
using sodium borohydride in a mixture of tetrahydrofuran and methanol. Removal of the 
solvents followed by an extraction yielded the alcohol 47 alongside some starting material. 
Literature precedents indicated that such a compound was prone to decomposition. Hence, 
the unpurified alcohol 47 was immediately redissolved in anhydrous dichloromethane and a 
catalytic amount of boron trifluoride etherate was added. Compound 28 was obtained in 21% 
yield. 
 
Reagents and conditions: (a) NaBH4 (1 equiv.), THF/MeOH, R.T., 2h; (b) BF3,OEt (10 mol%), CH2Cl2, R.T., 
3h, 21%.  
Scheme 23 
 
The epoxidation of flav-3-ene 28 was then attempted using meta-chloroperoxybenzoic acid 
with 4 equivalents of sodium hydrogen carbonate at 0 °C (Scheme 24). Unfortunately, 
neither the epoxide 48, nor the starting material were observed using thin layer 
chromatography and 
1
H NMR spectroscopy of the unpurified reaction mixture. The 
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instability of flav-3-ene 28 could explain the decomposition of the starting material under 
such conditions.
 24,25 
 
Reagents and conditions: (a) m-CPBA (2 equiv.), NaHCO3 (4 equiv.), CH2Cl2, 0 °C, 10 min. 
Scheme 24 
 
In an attempt to utilize milder reaction conditions, the oxidizing agent was replaced by a 
tandem iminium salt/Oxone®. The chiral biphenyl iminium salt 52 was synthesised following 
a three-step procedure starting from 2,2’-biphenylmethanol 49 (Scheme 25).[39] The first step 
was an acid-catalysed displacement of the two hydroxyl groups of 46 using HBr (48% aq.) to 
give dibromo compound 50 in 90% yield. Formation of the azepine 51 was readily achieved 
using a 1:1 mixture of 50 and isopropylamine in acetonitrile under reflux overnight in the 
presence of K2CO3. The formation of the tetraphenylborate biphenyl iminium salt 51 was 
effected by exposure to NBS and subsequent anion exchange in 80% yield. 
Reagents and conditions: (a) HBr (48% in H2O), 100 °C, 1 h, 90 %; (b) Isopropylamine (1 equiv.), K2CO3 (3 
equiv.), MeCN, reflux, overnight, 84%; (c) N-bromosuccinimide (1.2 equiv.), CH2Cl2, reflux, 3 h; (d) NaBPh4, 
EtOH/MeCN, 5 min, 80% for the two steps. 
Scheme 25 
 
With the catalyst in hand, the epoxidation reaction was then attempted (Table 6). 
Unfortunately, the use of iminium salt-catalysed epoxidation also led to the decomposition of 
the starting material 28 and no epoxide was detected using spectroscopic analysis. The low 
stability of flav-3-ene 28, which might well lead to the reactive orthoquinone which is in 
equilibrium with the corresponding allylic cation, during the reaction, could increase the 
decomposition rate of the starting material 28.  
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Table 6: Epoxidation using iminium salt catalyst 52. 
 
 Reaction conditions Conversion 
a 52 (10 mol%), TPPP (2 equiv.), CHCl3, - 20 °C, 24h. Decomposition 
b 52 (10 mol%), Oxone® (2equiv.), NaHCO3 (4 equiv.), 
MeCN/H2O (10:1), 0 °C, 1h. 
Decomposition 
 
As mentioned above, flav-3-ene 28 is unstable under epoxidation conditions. Therefore, we 
must first find alternative protecting groups to increase the stability of the flavenes under 
oxidative conditions.  
 
Selection of the most suitable protecting group for each hydroxyl moiety is essential, since it 
may hold the key to a successful oxidation of the flavene. The 2-methoxyethoxymethyl ether 
protecting group was introduced for their stability under mild conditions.
 34
 Treatment of 1-
(2,4,6-trihydroxyphenyl) ethanone 42 with 2-methoxyethoxymethyl chloride (2.4 equiv.) in 
the presence of diisopropylamine (3 equiv.) in dichloromethane led to product 53 in 43% 
yield.
40
 Using N,N-diisopropylethylamine under identical conditions led to increased 
solubility of reaction intermediates in dichloromethane, as exhibited by a quick change of 
reaction mixture colour from yellow into white over 25 min of stirring at room temperature, 
yielding 90% of compound 53. 
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Reagents and conditions: (a) 2-Methoxyethoxymethyl chloride (2,4 equiv.), (i-Pr)2NEt (3 equiv.), CH2Cl2, R.T., 
overnight, 90 %. 
Scheme 26 
 
As described above, the aldol condensation is our preferred route towards the chalcone 
derivatives. Ketone 53 was dissolved in a solution of potassium hydroxide in ethanol. This 
was followed by the dropwise addition of benzaldehyde 23. The aldol adduct underwent in-
situ dehydration, leading to α,β-unsaturated chalcone 54 in 35% yield (Scheme 27). 
 
Reagents and conditions: (a) KOH, EtOH, 35%. 
Scheme 27 
 
Slow addition of NaH to a solution of acetophenone 53 in DMF followed by addition of the 
aldehyde 23 resulted in the formation of the chalcone 54 in 70% yield. The reason for the 
improved yield was that the use of a stronger base increased the formation of the enolate 
derived from acetophenone 53. As an initial attempt, the reduction of chalcone 54 using 
NaBH4 was carried out in a mixture of tetrahydrofuran and ethanol under reflux to reduce the 
carbonyl group at the 3-position. TLC visualization revealed that full conversion of the 
starting material had occurred. However, the desired product 55 was not observed; similar 
results were obtained using NaBH4 in a mixture of methanol and dichloromethane under 
reflux, with the starting material fully converted after two hours. As mentioned in the 
literature review, the alcohol intermediate has the tendency to cyclize in-situ to form the 
corresponding 3-flav-3-ene without the need for a catalyst. In an attempt to catalyse the 
cyclization, a few drops of boron trifluoride diethyl etherate were added to the reaction 
mixture; unfortunately, flav-3-ene 55 was not isolated and only degradation products were 
observed (Scheme 28). 
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Reagents and conditions: (a) NaBH4, MeOH, CH2Cl2 (1:10). 
Scheme 28 
 
Due to our repeated failed attempts to prepare 55, an alternative shorter synthetic route to 55 
was proposed (Scheme 29).  
 
 
Scheme 29 
 
The fundamental features of chalcone 54 include an alkene moiety with an adjacent carbonyl 
group and a phenolic hydroxyl group. This could allow an acid-catalyzed intramolecular 
cyclization to occur giving ketone 56. Following the reduction of the carbonyl group, which 
should lead to an alcohol in-situ, an elimination reaction could afford 3-flav-3-ene 55.41 The 
reaction was attempted in a solution of sodium acetate in ethanol under reflux for 2 days; the 
only product observed was the starting material 54. A cyclization reaction was also 
performed under the same conditions in the presence of water (a few drops) to improve the 
solubility of sodium acetate, but no improvement was observed. We believe the problem with 
this approach was the lack of carbonyl group activation. An acid-catalysed reaction was then 
attempted: chalcone 54 was dissolved in a mixture of ethanol and HCl (0.2M) and heated 
under reflux overnight. Only starting material was recovered. 
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We next turned our attention to another potential protecting group: the methoxy group. 1-(2-
Hydroxy-4,6-dimethoxyphenyl)ethanone 57 was synthesised according to literature methods. 
The general method for methylation of 2,4,6-trihydroxyacetophenone 42 involves treatment 
with dimethyl sulfate in acetone under reflux. The desired product is easily purified, giving 
ketone 57 in 90% yield.
 42 
 
 
Reagents and conditions: (a) dimethyl sulfate (1.2 equiv.), K2CO3 (3 equiv.), acetone, reflux, overnight, 90%. 
Scheme 30 
 
An aldol reaction using ketone 57 and aldehyde 58 was then carried out to prepare the desired 
chalcone 59. Acetophenone 57 and 3,4,5-trimethoxybenzaldehyde 58 were dissolved in a 
solution of potassium hydroxide in ethanol (1.0 g in 10 mL). The chalcone 59 was formed in 
93% yield as a yellow solid and did not require further purification.
 43
 
 
Reagents and conditions: (a) KOH, ethanol, R.T., overnight, 93%. 
Scheme 31 
 
The cyclization of α,β-unsaturated ketone was achieved using NaBH4 in propan-2-ol 
overnight, giving the desired flav-3-ene 60 in 20% yield (Scheme 32).  
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Reagents and conditions: (a) NaBH4 (3 equiv.), 2-propanol, R.T., overnight, 20%. 
Scheme 32 
 
Epoxidation reactions were then carried out on flav-3-ene 60. Both sets of conditions 
described above (Table 6) were used and the results were identical: only decomposition of 
the starting material was observed. Strongly electron-donating groups, such as methoxy and 
benzyloxy, on aromatic ring A increased the instability of flav-3-ene 60 under oxidative 
conditions, even when a mild iminium salt-mediated epoxidation was used. In an effort to 
stabilize the flav-3-ene under epoxidation conditions, the cleavage of the methoxy groups 
using boron tribromide was carried out to replace them by moderately activating groups, such 
as sulfonate and acetate groups. Compound 60 was dissolved in anhydrous dichloromethane 
at –78 °C and boron tribromide was added, the reaction mixture was then allowed to reach 
room temperature overnight.
 44
 Unfortunately, the deprotection failed and starting material 
was decomposed (Scheme 33). 
 
Reagents and conditions: (a) BBr3 (7 equiv.), CH2Cl2, –78 
°
C to R.T., overnight. 
Scheme 33 
 
Because the cleavage of the methoxy groups did not occur and compound 61 was not 
isolated, alternative methods were attempted to install the desired groups on ring A of the 
flav-3-ene. Two possible routes were planned towards chalcone 64: the first one involved an 
aldol condensation between benzaldehyde 58 and acetophenone 42; the second route targeted 
silyl-protected chalcone 63, prepared by aldol condensation of benzaldehyde 58 and phenone 
62. Removal of the silyl protecting groups should afford chalcone 64. Then the key step in 
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the synthesis, the ring closing of the flavene, could be attempted, followed by protection of 
the remaining hydroxyl groups. The protection could also be attempted before the ring-
closing step (Scheme 34). 
 
Scheme 34 
 
The synthesis of chalcone 64 commenced with an aldol reaction between phenone 42 and 
3,4,5-trimethoxybenzaldehyde 58. However, using either KOH or Ba(OH)2 as the base, no 
product was observed and the starting material was recovered (Table 7).
45 
In the presence of 
hydroxyl groups in 42, the formation of the enolate was probably disfavoured. We next 
turned our attention to the second possible route involving the use of silyl protecting groups. 
 
Table 7 
 
Entry Base Solvent  Temperature  Time  Conversion  
a KOH Ethanol 80 °С 24 h SM 
b Ba(OH)2 Ethanol R.T. 24 h SM 
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The t-Butyldimethylsilyl moiety is a popular protecting group and is widely used among 
organic chemists. This is due to the fact that the protecting group is stable in the presence of 
basic reagents and is easily cleaved. Silyl-protected acetophenone 62 was prepared by 
treatment of 2,4,6-trihydroxyacetophenone 42 with t-butylchlorodimethylsilane and pyridine 
with a catalytic amount of 4-dimethylaminopyridine in dichloromethane in 90% yield 
(Scheme 35).
 46,47
 
 
Reagents and conditions: (a) t-Butylchlorodimethylsilane (2.5 equiv.), pyridine (3 equiv.), DMAP (0.1 equiv.), 
CH2Cl2, overnight, 90 %. 
Scheme 35 
 
After protection of two free phenolic hydroxyl groups, the reaction of 62 with 3,4,5-
trimethoxybenzaldehyde 58 proceeded with the addition of NaH at room temperature, 
affording chalcone 63 in 21% yield (Scheme 36).
 46
  
 
Reagents and conditions: (a) NaH (0.8 equiv.), THF, R.T., 50 min, 21%.  
Scheme 36 
 
The desired key intermediate 63 having been obtained, we turned our attention to its 
cyclization. Reduction of compound 63 took place smoothly in a mixture of EtOH/ 
tetrahydrofuran (1:3) to give flav-3-ene 66 in a poor yield (10%). It should be noted that some 
decomposition of flav-3-ene 66 was observed by 1 hour after purification through column 
chromatography.
46
 The epoxidation reactions were attempted using standard conditions, but 
perhaps, due to the observed instability of the alkene 66, only decomposition of the starting 
material was observed (Scheme 37). 
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Reagents and conditions: (a) NaBH4, EtOH/THF (1:2), 10 %; (b) m-CPBA (2 equiv.), NaHCO3 (4 equiv.), 
CH2Cl2, 0 °C, 10 min; (c) Iminium salt 52, Oxone, MeCN/H2O (1:0.1), 0 °C, 5 min. 
Scheme 37 
 
Due to the instability of compound 66, we decided to interchange the protecting groups 
before the cyclization. We attempted to remove the silyl protecting groups of 63 using HBr in 
methanol under reflux. The reaction unexpectedly gave product 68, rather than 64, in 
excellent yield (97%) resulting from intramolecular cyclization in the presence of the strong 
acid (Scheme 38). 
47
  
 
 Reagents and conditions: (a) MeOH/HBr( 48 %), reflux, 97%, overnight.  
Scheme 38 
 
The formation of compound 68 provided us with an alternative pathway to the desired flav-3-
ene. As mentioned above, a reduction followed by an in-situ dehydration (or a stepwise 
process) should afford the flav-3-ene 69 from flavanone 68. Indeed, exposure of compound 
68 to NaBH4 in methanol under reflux furnished compound 69, which then underwent 
dehydration to flav-3-ene 65 in the presence of camphorsulfonic acid in toluene under reflux 
for 1 hour (Scheme 39). 
44
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Reagents and conditions: (a) NaBH4 (3 equiv.), MeOH, reflux, 1h; (b) CSA (3 equiv.), toluene, reflux, 1h. 
Scheme 39 
 
The stage was then set to attempt to minimize the destabilization of the unpurified alkene 65 
or the corresponding epoxide by installing moderately electron-donating group on ring A. We 
first turned our attention to the use of a sulfonate ester protecting groups. The treatment of 
compound 65 with K2CO3 and 4-toluenesulfonyl chloride in acetone under reflux furnished 
flav-3-ene 70 in 65% yield (Scheme 40).
 47,48
 
 
Reagents and conditions: (a) K2CO3 (4 equiv.), 4-toluenesulfonyl chloride (4 equiv.), acetone, reflux, overnight, 
65%. 
Scheme 40 
 
Alternatively, flavene 70 could also be synthesized through a smaller number of steps. 2,4,6-
trihydroxyacetophenone 42 was protected using K2CO3 and 4-toluenesulfonyl chloride in 
acetone under reflux, giving the tosylated compound 71 in 95% yield (Scheme 41).  
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Reagents and conditions: (a) K2CO3 (4 equiv.), 4-toluenesulfonyl chloride (4 equiv.), acetone, reflux, overnight, 
95%. 
Scheme 41 
 
A successful attempt was made to synthesize the compound 70: Sodium hydride was utilized 
in anhydrous tetrahydrofuran: first, the aldol reaction occurred with concomitant mono-
deprotection of a sulfonate ester to yield chalcone 72.
 48
 Furthermore, the toluenesulfonate 
esters played a significant role in the stability of flavene 70 under the reaction conditions as 
compound 70 was obtained in high yield (98%), when 72 was treated with NaBH4 in a 
mixture of ethanol and tetrahydrofuran (Scheme 42).
 32,49
  
 
Reagents and conditions: (a) NaH (2.1 equiv.) THF, overnight, 22%; (b) NaBH4, EtOH:THF (1:1), 50 
°
C, 
overnight, 98%. 
Scheme 42 
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2.4 Catalyst synthesis 
  
The amine used for the synthesis of catalyst 78 is (S)-(−)-2-amino-3-phenyl-1-propanediol 
73, which is commercially available. The procedure reported by Thomas was employed to 
offer protection of the amine groups as the formyl group was required prior to the acetonide 
protection of the diol moiety with acetone and 2,2-dimethoxypropane.
50
 Sodium methoxide 
and methyl formate were added to amine 73 to achieve formylation, affording the 
intermediate 74 in quantitative yield. The acetonide generation was carried out immediately 
on compound 74 with 2,2-dimethoxypropane and camphorsulfonic acid in acetone to give 
acetal 75 in 77% yield. A solution of aqueous hydrazine monohydrate (80%) was used to 
remove the formyl protecting group by heating at reflux for 2 h to furnish 76 in 89% yield 
(Scheme 43).  
 
Reagents and conditions: (a) NaOMe (0.1 equiv.), MeOCHO (1.5 equiv.), MeOH, rt., 24h; (b) DMP (10 equiv.), 
CSA (0.15 equiv.), acetone, R.T., 4 h, 77% ; (c) Hydrazine monohydrate (98%), reflux, 2 h, 89%. 
Scheme 43 
 
Cyclocondensation of amine 76 with 2,2’-bis(bromomethyl)biphenyl 50 proceeded under 
basic conditions in acetonitrile under reflux for 24 h to form the amine 77. The resulting 
amine was converted to the corresponding iminium bromide by addition of N-
bromosuccinimide, followed by counter-ion exchange using sodium tetraphenylborate. 
Catalyst 78 was isolated and purified through recrystallization from hot ethanol in 78% yield 
(Scheme 44).
 39
 
83 
 
 
Reagents and conditions: (a) 76 (1 equiv.), 50 (1 equiv.), Cs2CO3 (2 equiv.), CH3CN, reflux, 24 h (b) 77 (1 
equiv.), NBS (1.1 equiv.), CH2Cl2, R.T., 6 h; (c) NaBPh4 (1.1 equiv.) in minimum CH3CN, EtOH, R.T., 10 min, 
78%. 
Scheme 44 
 
Alkene 70 was subjected to a standard racemic epoxidation protocol, using meta-
chloroperoxybenzoic acid and NaHCO3 in anhydrous dichloromethane at 0 ºC for 24 h. The 
same reaction was also attempted in the absence of base. Unfortunately, no conversion to the 
epoxide product 79, and only starting material, was observed by TLC and 
1
H NMR spectral 
analysis.  
 
Reagents and conditions: (a) m-CPBA (1 equiv.), NaHCO3 (2 equiv.), CH2Cl2, 0 °C, 24 min; (b) m-CPBA (2 
equiv.), CH2Cl2, 0 °C, 24 min. 
Scheme 45 
 
Epoxidation of alkene 70 also failed under the standard non-aqueous conditions with catalyst 
78 at 0 and −20 ºC for 24 hours (Table 5). The low reactivity observed towards catalyst 78 
and oxidant could be due to the presence of the sulfonyl protecting groups, which could 
deactivate the alkene moiety towards the oxidant.  
 
Table 5 
 Reaction conditions Conversion 
a 78 (10 mol%), TPPP (2 equiv.), CHCl3, −20 °C, 24h. SM 
b 78 (10 mol%), TPPP (2 equiv.), NaHCO3 (4 equiv.), 
MeCN 0 °C, 24h. 
SM 
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2.5 Synthesis of flav-3-ene analogues. 
 
The major objective of our research is to synthesize epigallocatechin and its analogues. Thus, 
we turned our attention towards methyl group substitution at the C-2 positions. The 
underlying synthetic strategy is illustrated in Scheme 46, inspired by multicomponent 
reactions, which are defined as one-pot convergent reactions in which three or more starting 
materials react to form a product which contains portions of all the components after a 
cascade of elementary reactions.
51
 Gu has recognized the potential for a one-pot, two step 
transformation to deliver chromane 81, which is a key target towards the formation of 
chromene 80.
52
  
 
Scheme 46: Retrosynthesis of chromene (±)-80 
 
Under acidic conditions, formaldehyde becomes an excellent electrophilic acceptor for 
aromatic electrophilic substitution. Condensation of protonated formaldehyde with the phenol 
83 affords the formation of a new C-C bond, followed by dehydration to yield methylene 
intermediate 84 (Scheme 47).
 52
 
 
Scheme 47: Proposed mechanism for the formation of methylene intermediate 84 
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The hetero-Diels–Alder reaction is the cyclocondensation of a 4π electron system with a 2π 
electron system, creating new carbon-carbon and carbon-oxygen bonds to form a six-
membered ring in one efficient step. The scope and the utility of this intermolecular [4+2] 
hetero cycloaddition process in the literature for the formation of six-membered ring 
chromanes is limited. Gu reported that 2-substituted-5,6-benzochromanes could be formed by 
the trapping of methylene intermediates, such as 84, with a suitable alkene under thermal 
conditions. Therefore, methylene intermediate 84 could undergo hetero-Diels–Alder reaction 
(HDA) with dienophile 82 for the facile construction of chromane 1 (Scheme 48).
 52,53
 
 
Scheme 48: Hetero-Diels–Alder reaction of intermediate 84 with dienophile 82 
  
The reaction of Grignard reagents with esters is an important method to access tertiary 
alcohols, which are then frequently converted to the corresponding alkene in the presence of 
a base or an acid. Thus, large excesses of methylmagnesium bromide (3.0M in diethyl ether) 
were added to a solution of methyl 3,4,5-tris(benzyloxy)benzoate 6 at –78 °C to give tertiary 
alcohol 86 in 97% yield.
54 
The treatment of a solution of 3,4,5-tris(benzyloxy)phenyl)propan-
2-ol 86 in anhydrous toluene with camphorsulfonic acid induced dehydration providing the 
desired compound 87 in 71% yield (Scheme 49).
 55
  
 
Reagents and conditions: (a) MeMgBr (3 equiv.), THF, –78 °C to R.T., 17h, 97%; (b) camphorsulfonic acid (3 
equiv.), toluene, reflux, 24h, 71%. 
Scheme 49 
In the key step towards the synthesis of chromanes, 3,5-bis(benzyloxy)phenol 19 and 
formaldehyde were dissolved in acetic acid in an attempt to give adduct 89, followed by the 
addition of dienophile 87.
52
 The reaction mixture was then heated under reflux for three 
hours. Unfortunately, the reaction failed to give chromane 90 (Scheme 50).  
86 
 
 
Reagents and conditions: (a) AcOH, 3h, reflux, 120 ˚C 
Scheme 50: Hetero-Diels–Alder reaction using formaldehyde 
 
The cause of the reaction failure was not specified. However, the failure might be due to a 
faster side reaction occurring between formaldehyde and electron-rich alkene 87, rather than 
phenol 19. Dienophile 87 possesses significant nucleophilic potential enhanced by the three 
activating benzyl groups. Furthermore, the intermediate carbocation 91 can be stabilized by 
the presence of two alkyl groups and a phenyl group. Deprotonation of carbocation 91 affords 
alkene 92 (Scheme 51).
 56
  
 
Scheme 51: The formation of alcohol 92 
 
Another possibility for the synthesis of chromenes (or flav-3-enes), such as 93, is through the 
rearrangement of suitable propargyl ethers, such as 94; this pathway would also allow for 
many different substitution patterns and groups. A particularly interesting factor would be the 
potential for diverse groups to be inserted using different propargyl alcohols 95. The 
rearrangement of propargylic ethers bearing electron-withdrawing groups into chromenes has 
87 
 
already been reported.
57
 The desired propargyl ether could, in principle, be prepared by 
condensation of phenol 19 and propargyl alcohol 95 (Scheme 52). 
 
Scheme 52: Retrosynthesis of chromenes (±)-14 
 
Initially, we decided to focus on the methyl series (such as 99) to develop our methodology. 
The synthesis of propargylic alcohol 99 commenced with the addition of a Grignard reagent, 
methylmagnesium bromide (3.0M in diethyl ether), to a solution of 3,4,5-tris-(benzyloxy)-
benzaldehyde 23 at 0 °C in anhydrous diethylether for 4 h.
 58
 The crude alcohol was purified 
by recrystallization using hexane at low temperature for 2 days, giving secondary alcohol 97 
in 87% yield as a colourless solid. The alcohol moiety was then oxidized to the corresponding 
ketone 98 using PCC in 91% yield.
59
 The ketone was treated with ethynyl magnesium 
bromide (3.5 equiv.) in anhydrous tetrahydrofuran to afford propargyl alcohol 99 in 55% 
yield. Increasing the amount of ethynyl magnesium bromide (5 equiv.) caused a decrease in 
the yield of 99 (down to 25%), and a complex mixture of unidentified products was observed 
(Scheme 53).
60
  
 
 
Reagents and conditions: (a) MeMgBr (3 equiv.), Et2O, 0 °C, 7h, 87%; (b) PCC (1.5 equiv.), CH2Cl2, 7h, R.T., 
90%; (c) THF, NH4Cl (aq.), 0 °C -R.T., 2h, 55%. 
Scheme 53: Synthesis of propargyl alcohol 99 
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With a methyl and ethyne group bearing centre in tertiary alcohol 99, the formation of the 
corresponding carbocation might be expected to favour a reaction with a phenolic hydroxyl 
group from phenol 19. Exposure of a mixture of the propargyl alcohol 99 and the phenol 19 
in dichloromethane at 25 °C to a catalytic amount of camphorsulfonic acid for one hour did 
not result in the formation of propargyl ether 100 (Scheme 54). The propargyl alcohol 99 
might, in principle, be converted into a tertiary carbocation, which is a common intermediate 
to both the E1 elimination and the SN1 reaction. The tertiary carbocation intermediate is 
sterically hindered which might prevent the SN1 reaction from proceeding. Thus, the 
carbocation intermediate is probably more prone to an E1 reaction rather than the 
corresponding SN1 reaction. Indeed, the E1 reaction is favoured leading to the alkene 101. 
The 
1
H NMR spectrum of the crude reaction mixture was compared with the 
1
H NMR spectrum of the propargyl alcohol 99: disappearance of both OH and methyl signals 
and appearance of alkene signals at 5.62 ppm and 5.75 ppm were observed (Figure 4). 
 
  
 
Reagents and conditions: (a) Camphorsulfonic acid (10 mol.), CH2Cl2, 1h. 
Scheme 54: synthesis of propargyl ether 100 
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Figure 4: 
1
 H NMR spectra of the propargyl alcohol 99 and the crude reaction mixture 
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In an effort to avoid acid-catalysed dehydration of propargyl alcohol 99, the conversion of the 
alcohol moiety into a good leaving group may speed up a SN1 reaction with phenol 19. 
However, all attempts to convert the propargyl alcohol into the corresponding chloride or 
bromide were unsuccessful, using hydrochloric acid, hydrobromic acid or thionyl 
chloride.
61,62
 Furthermore, the treatment of propargyl alcohol 99 with methanesulfonyl 
chloride and triethylamine in dichloromethane in an attempt to form the methanesulfonyl 
ester 102 also failed (Scheme 55) and the starting material decomposed.
47
 
 
 Reagents and conditions: (a) Methanesulfonyl chloride (1 equiv.), NEt3 (1.1 equiv.), CH2Cl2, 0 °C, 0.45h. 
Scheme 55: Attempts to form propargyl methanesulfonyl ester 102 
 
A literature search showed that the procedures reported by Crombie
63
 and Camps
64 
would be 
suitable to access the targeted chromenes. They reported that the condensation of α,β 
unsaturated carbonyl compounds in pyridine with phenols led to the formation of substituted 
benzopyrans in moderate to good yields. For example, cyclization occurred when phenol 103 
was treated with an excess of dimethyl acetal 104 in pyridine, giving 2H-benzopyran 105 in 
63% yield (Scheme 56). 
 
Reagents and conditions: (a) pyridine, 140 °C, 2.5h, 63%. 
Scheme 56 
 
In 1995, North developed an excellent method for the synthesis of 2-substituted chromene 
structures: condensation of a phenol, such as 106, with 3-methyl-2-butenal diethyl acetal 107 
in the presence of an acid catalyst, such as fumaric acid, in p-xylene at 120 °C, results in the 
formation of 2-substituted chromenes, such as 108 (Scheme 57).
 65
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Reagents and conditions: (a) Fumaric acid (0.13 equiv.), p-xylene, 120 °C, 6h, 79%. 
Scheme 57: The conditions reported by North 
 
The target chromene could be, in principle, obtained from acetal 109 and the corresponding 
phenol. As neither the desired acetal 109 nor the corresponding aldehyde 110 was 
commercially available, two strategies to access 110 were devised (Scheme 58). One 
potential route involves a Heck coupling between iodobenzene 111 and crotonaldehyde. The 
other potential route would allow us to use propargyl alcohols, such as 112: a Meyer-Schuster 
rearrangement would lead to aldehyde 110.  
 
Scheme 58: Retrosynthesis of acetal 30 
 
The Meyer-Schuster rearrangement involves a formal 1,3 shift of the hydroxyl moiety of the 
alkynol such as 99 followed by an internal redox-type process involving simultaneous 
oxidation of the resulting alcohol and reduction of the C≡C triple bond.66,67 Recently, 
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transition metal-mediated Meyer-Schuster rearrangements have been used to synthesize α,β-
unsaturated aldehydes. Indium (III) chloride and iron (III) chloride have showed a remarkable 
regioselectivity towards the Meyer-Schuster product in high yields. The strength of this later 
approach is a short reaction time and catalytic amounts of the water-compatible and 
inexpensive Lewis acids used under microwave irradiation and thermal activation.
68,69
 The 
proposed mechanism for the Meyer–Schuster rearrangement is depicted in Scheme 59. 
 
Scheme 59: The Meyer–Schuster rearrangement 
 
Therefore, a reported procedure was followed: propargyl alcohol 99 (1 equiv.) was exposed 
to a catalytic amount of InCl3 (1 mol%) in water under microwave irradiation at 160 °C. 
Despite increased amounts of catalyst and temperature, the desired compound was not 
detected. Iron (III) chloride (1.1 equiv.) was also utilized as the Lewis acid in tetrahydrofuran 
under reflux for 10 hours. No conversion of alcohol 99 was observed. Possible side reactions, 
such as the Rupe rearrangement or an elimination reaction, might occur due to the presence 
of a C–H bond in the β-position with respect to the alcohol group (Scheme 60). 66,67 The Rupe 
rearrangement could be promoted under the Meyer–Schuster rearrangement conditions, and 
is another possible fate of the propargyl cation.
66
 The Rupe rearrangement involves β-
elimination of the propargyl cation, and therefore results in the formation of an enyne 
intermediate.
67
 Subsequent protonation of the C≡C triple bond would lead to the formation of 
the vinyl cation, followed by tautomerization to afford 144.
66,67 
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Scheme 60: Possible side reactions 
 
At this point, we decided to follow the other route to obtain α,β-unsaturated aldehyde 113. 
The Heck reaction is a powerful tool for the preparation of disubstituted olefins from 
monosubstituted ones, discovered by T. Mizoroki and R.F. Heck independently in the late 
1960s.
70
 The regioselectivity observed when electron-deficient crotonaldehyde is used in a 
Heck coupling is particularly well-suited to our synthesis; under steric control, the addition 
occurs almost exclusively on carbon atom C3 (Figure 5).
71
  
 
Figure 5: Regioselectivity of migratory insertion in the Heck coupling. 
 
The Heck reaction proceeded by treatment of 5-iodo-1,2,3-trimethoxybenzene 115 (1 equiv.) 
and crotonaldehyde (1.2 equiv.) with palladium acetate (5 mol%) and silver acetate (2 equiv.) 
in acetonitrile under reflux for 19 hours giving aldehyde 113 in 44% yield (Scheme 61).
71,72
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Scheme 61: Cationic mechanism of Heck reaction 
 
 
The Heck reaction follows a three-step mechanism. Firstly, oxidative addition occurs as the 
palladium inserts in the carbon-iodine bond to form an I-Pd(II)–Ph complex, followed by loss 
of the iodide using silver acetate. Secondly, after complexation of the alkene to the palladium 
centre, insertion of the palladium complex in the alkene bond occurs to form the new carbon-
carbon bond. Finally, β-hydride elimination results in the formation of the product 113 and 
reductive elimination regenerates the palladium(0) centre. 
 
It is interesting to note the change in the reaction yield when the Heck coupling proceeds 
through a neutral pathway. In the absence of silver acetate, the iodide remains attached to the 
metal centre using caesium carbonate (1.1 equiv.) as the base under the same conditions.
71
 
Indeed, a large increase in the yield was observed, and aldehyde 113 was obtained in 73% 
yield. The regiochemistry of the neutral pathway is governed by steric control, which affords 
the desired compound (Scheme 62).
72
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Scheme 62: Neutral pathway for Heck reaction 
 
α,β-Unsaturated aldehyde 113 was submitted to acetalisation reaction conditions. 15 North’s 
methodology has been utilised to synthesize various acetals within the group. The 
acetalization reaction was attempted with ammonium nitrate and triethylorthoformate in 
ethanol until full conversion of α,β-unsaturated aldehyde 113, generally overnight. 
Unfortunately, the acetal 116 was found to be unstable and underwent rapid decomposition, 
even when stored at 0 °C for short periods of time (Scheme 63).
 64
  
 
Reagents and conditions: (a) (EtO)3CH (1.1 equiv.), NH4NO3 (0.25 equiv.), ethanol (4 mL), R.T., overnight. 
Scheme 63 
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An examination of the literature
75
 provided a relatively simple example to follow to 
synthesise the targeted chromenes without the requirement for an acetal group: 
cyclocondensation of an α,β-unsaturated aldehyde 117 and 5-hydroxycoumarin into 
chromene 118 was the key step for an elegant synthesis of pyranocoumarin derivatives which 
possess antiproliferative activity against breast cancer cell lines (Scheme 64).
 75 
 
Reagents and conditions: (a) 117 (1.5 equiv.), PhB(OH)2 (1 equiv.), propionic acid (3 ml), toluene, 140 °C, 
83%. 
Scheme 64 
 
Thus, we attempted the procedure above for the formation of the desired chromene. Initially, 
the Lewis acid activation of the carbonyl group in compound 113 causes the formation of α-
alkoxy-carbocation 119 due to the use of phenylboronic acid (Scheme 65).  
 
Scheme 65: The formation of α-alkoxy-carbocation 119 
 
We believe the mechanism of the reaction should follow this pathway: carbocation 119 reacts 
with phenol 103, affording intermediate 120. Rearomatization of 120 with loss of a proton 
then leads to compound 122. Elimination of trihydroxy(phenyl)borate affords intermediate 
123 and chromene 124 is obtained by [3,3]-electrocyclic rearrangement of 123 (Scheme 66). 
97 
 
 
Scheme 66: Proposed mechanism for synthesis of chromene (±)-124 
 
When the α,β-unsaturated aldehyde 113 was submitted to the cyclization reaction with phenol 
103 in presence of acetic acid and phenylboronic acid in toluene under reflux overnight, the 
ester compound 125 was obtained in 90% yield. 
 
Reagents and conditions: (a) 113 (1.5 equiv.), PhB(OH)2 (1 equiv.), acetic acid (1 mL), toluene, reflux, 90%. 
Scheme 67 
 
 
 
 
 
 
 
 
 
98 
 
In order to avoid the esterification of the phenol, acetic acid was replaced with Amberlyst, 
which is a strongly acidic cation exchange resin. However, cyclization did not occur under 
these conditions (Scheme 68). 
 
Reagents and conditions: (a) 113 (1.5 equiv.), amberlyst, PhB(OH)2 (1 equiv.), p-xylene, 140 °C, overnight; (b) 
113 (3 equiv.) amberlyst, PhB(OH)2 (2 equiv.), toluene, reflux, overnight.  
Scheme 68 
 
In a further attempt to synthesize flav-3-ene 80 with a methyl analogue, we followed a 
promising route towards the synthesis of flav-3-ene derivatives as outlined in the 
retrosynthetic approach below (Scheme 69). Chalcones, such as 126, would be prepared from 
ketones, such as 125, through an aldol reaction with acetophenone 39. Cyclisation of the 
corresponding α,β-unsaturated ketones or chalcones 126 should lead to the formation of flav-
3-enes, such as 80. 
 
Scheme 69: Retrosynthesis of racemic chromene 80 
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Lithium diisopropylamide was used to generate the enolate of ketone 43 to attack compound 
98 in an attempt to form chalcone 127. The chalcone is a suitable precursor for the chromene 
80 and could be submitted to a cyclization reaction to afford chromene 80 (Scheme 70). 
Unfortunately, due to the low quantity of base present, only starting material was observed 
due to a faster deprotonation of the phenolic hydroxyl rather than the desired formation of the 
enolate.
75
 The reaction was also attempted using a larger quantity of base (3 equiv.) , giving 
only starting material.  
 
Reagents and conditions: (a) 43 (1 equiv.), 98 (1 equiv.), LDA (2 equiv.), THF, 0 °C, overnight; (b) 43 (1 
equiv.), 98 (1 equiv.), LDA (2 equiv.), THF, –20 °C, overnight; (c) 43 (1 equiv.), 98 (1 equiv.), LDA 
 (3 equiv.), THF, –78 °C, overnight. 
Scheme 70 
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2.6 Application of the Page asymmetric epoxidation in the synthesis of 
trans-3,4-dihydroxy-3,4-dihydromollugin. 
 
The root of the African medicinal plants, Pentas longiﬂora (Rubiaceae),76 and Rubia 
cordifolia,
77
 is the source of a benzochromene antibiotic: it contains mollugin 128 and its 
analogues trans-3,4-dihydroxy-3,4-dihydromollugin 129 and epoxymollugin 130.
78,79
 These 
plants appear to possess antitumour, antimutagenic, anti-leukaemia, anti-inflammatory, anti- 
colon cancer and antiallergic activities.
77,80
 They are used to treat skin diseases such as 
pityriasis versicolor, itchy rashes, and malaria (mixed with milk), tapeworm, gonorrhea, and 
are used as a purgative in Kenya and Rwanda.
80,81
 
  
Figures 6: Mollugin and analogues 
 
A reliable method for the synthesis of mollugin 128 was reported by Wang et al.
82
 An 
intermolecular cyclization reaction was the key step in the formation of mollugin: 2-methyl-
3-butenal and 1,4-dihydroxy-2-naphthoic acid were heated under reflux in the presence of 
benzene boronic acid and acetic acid in toluene, giving 128 in 91% yield. The synthesis of 
racemic trans-3,4-dihydroxy-3,4-dihydromollugin 129 was achieved in 31% yield by 
oxidation of mollugin using Oxone in a mixture of acetone/water in a 1:2 ratio for 12 h 
(Scheme 71).
76
  
 
Reagent and conditions: a) Oxone ( 3 equiv.), acetone/water (1:2), 80 ˚C, 12h, 31%. 
Scheme 71: The formation of racemic trans-3,4-dihydroxy-3,4-di-hydromollugin 129  
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O-Methoxymethyl-(3S,4S)-cis-3,4-dihydroxy-3,4-dihydromollugin 132 was prepared using a 
Sharpless asymmetric dihydroxylation of mollugin methoxymethyl ether in 30% yield and 
86% ee (Scheme 72).
83
 
 
Reagent and conditions: a) AD-Mix β, K2CO3, K3F2(CN)6, K2OsO2(OH)4, (DHQD)2-PHAL, t-BuOH:H2O:THF 
(8:8:1) 0 ˚C to rt, 24h, 32%, 86% ee. 
Scheme 72: The formation of O-methoxymethyl-(3S,4S)-cis-3,4-dihydroxy-3,4-
dihydromollugin 132 
 
Removal of the MOM group gave cis-diol 132 and trans-diol 129 in 60 and 20% yield, 
respectively. Indeed, when the deprotection of the MOM group was attempted using a large 
excess of hydrochloric acid, inversion of the configuration at the C4 position led to the 
formation of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 129.
83
 The author reasoned 
that a free hydroxyl group at position 4 was protonated and the resulting oxonium ion was 
displaced by an electron push mechanism starting from the lone pair of the pyranyl-oxygen. 
Thereby, trans-diol 129 was formed by nucleophilic attack on the reactive ortho-quinone 
methide intermediate 135 (Scheme73). Moreover, they commented that ''the lower yields and 
side products are the drawbacks of this protocol''
83
 and ''routes were paved with 
difficulties''.
82 
Reagent and conditions: a) 6N HCl/THF (1:1), 0 ˚C to rt, 3h, 20%. 
Scheme 73: The formation of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 129 
 
We have recently reported the highly enantioselective epoxidation of xanthyletin 136 in 99% 
ee as the key step towards the total synthesis of (+)-scuteflorin A 139, using chiral iminium 
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salt catalyst 75 under non-aqueous conditions. The acid-catalysed epoxide ring-opening of 
epoxide 136 afforded trans-diol 138 in high yield. Thus, we envisaged that the synthesis of 
(3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 129 could be effected by a similar 
epoxidation of mollugin 128 to install the stereocentres and functionality required.
 84
  
 
 
Reagent and conditions: (a) Catalyst 75 , TPPP, CHCl3, −30 °C, 30 h, 97%, 99 % ee; (b) acetone/1 M H2SO4 
(2:1), rt, 10 min, 60%. 
Scheme74: Total synthesis of (+)-scuteflorin A using iminium-catalysed asymmetric 
epoxidation. 
 
In our retrosynthetic analysis, trans-diol 129 could be derived in a straightforward manner 
from ring-opening of chiral epoxide 130. Asymmetric epoxidation of cyclic cis-disubstituted 
mollugin 128 could secure the formation of enantioenriched epoxide intermediates 130. 
Mollugin 128 could be accessed using Wang’s methodology (Scheme75).  
 
Scheme 75: Retrosynthetic analysis of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 
129. 
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2.6.1 Synthesis of mollugin 
 
The first objective was the synthesis of 1,4-dihydroxynaphthalene-2-carboxylic ester 141. 
Commercially available 1,4-dihydroxynaphthalene-2-carboxylic acid 142 was treated with 
sulfuric acid in methanol. Unfortunately, the desired product 141 was obtained in a very low 
yield (5%), alongside a major undesired product 143, formed in 90% yield.
85
 However, 
compound 143 can be converted to the desired 1,4-dihydroxynaphthalene-2-carboxylic ester 
141 by demethylation of the methoxy group. Indeed, the treatment of a solution of 143 in 
anhydrous dichloromethane with aluminium chloride at 0 ºC produced the compound 141 in 
91% yield (Scheme76). 
 
Reagent and conditions: (a) CH3OH, H2SO4, 8 h, 0 ºC-reflux, [141 5%; 143 90%]; (b) AlCl3 (2 equiv.), 0 ºC, 2 
h, 91%. 
Scheme 76: The synthesis of 141 
 
Another esterification method applied to 1,4-dihydroxynaphthalene-2-carboxylic acid 
resulted in the formation of the compound 141 in high yield: methyl iodide was used with 
anhydrous sodium hydrogen carbonate in dimethylformamide overnight at room temperature, 
giving 141 in 96% yield (Scheme 77). 
 
Reagent and conditions: (a) MeI (1.5 equiv.), NaHCO3 (1.2 equiv.), 0 ºC-rt, overnight, 96%. 
Scheme 77: The formation of 141 in a high yield 
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It is then possible to achieve the synthesis of mollugin by ortho-directed cyclisation on a 
phenol with an enal species. Thus, the intermolecular phenylboronic acid-mediated 
cyclization of 3-methyl-2-butenal with 141 was achieved in 53% yield (Scheme 78).
85
  
 
Reagent and conditions: (a) 3-Methyl-2-butenal (2.0 equiv.), PhB(OH)2 (1.0 equiv.), toluene/AcOH, reflux, 17 
h, 53%. 
Scheme 78: Synthesis of mollugin 
 
In order to improve the yield, we believed that the reaction could be carried out using North's 
procedure,
44
 where a phenol is cyclized with an α,β-unsaturated acetal under basic conditions. 
In order to achieve that, α,β-unsaturated acetal 145 was initially formed by reacting aldehyde 
144 and diethyl orthoformate in the presence of a catalytic amount of ammonium nitrate in 
anhydrous ethanol under nitrogen in 48% yield. The acetal was directly used after work up, 
due to its instability. (Scheme 79).  
 
Reagent and conditions: (a) 3-Methyl-2-butenal (1 equiv.), NH4NO3 (0.25 equiv.), triethylorthoformate (1.2 
equiv.) 0 ºC-rt, 24 h, 48%. 
Scheme 79: Formation of the α-β-unsaturated acetal 145 
 
The cyclisation reaction using the α,β-unsaturated acetal 145 was carried out as described by 
North. Treatment of 141 with 3-picoline as the base in p-xylene resulted in the attack of 
oxocarbenium ion 146 to form dienone 147. Elimination of ethanol led to ortho-quinone 
methide 149. Finally, electrocyclic ring closure provided mollugin 128 in 64% yield.  
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Reagents and conditions: (a) 141 (1 equiv.), acetal 145 (1 equiv.), 3-picoline (0.25 equiv.), p-xylene, reflux, 24 
h, 64%. 
Scheme 80: Synthesis of mollugin 129 using North’s procedure 
 
In an effort to increase the yield of mollugin 128, alternative syntheses were sought. A 
promising study by Smith et al. involves the derivatization of methyl 4-hydroxybenzoate 151 
with 3-chloro-3-methyl-1-butyne 150, forming propargyl ether 152 which was then cyclised 
at high temperature in N,N-diethylaniline (Scheme 81).
86 
 
  
Reagents and conditions: (a) 151 (1 equiv.), 3-chloro-3-methyl-1-butyne 150 (3 equiv.), K2CO3 (1 equiv.), KI (1 
equiv.), acetone, 49-53 ºC, 48 h, 79 %; (b) N,N-diethylaniline, 210 ºC, 97%. 
Scheme 81: Synthesis of 6-carbomethoxychromene 153 
 
Hence, the synthesis of mollugin 128 commenced with the chlorination of commercially 
available 2-methyl-3-butyn-2-ol 154 using cold concentrated hydrochloric acid, forming 150 
in 56% (Scheme 82).  
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Reagents and conditions: (a) Methyl-3-butyn-2-ol 154 (3 equiv.), CaCl2 (1 equiv.), CuCl (1 equiv.), Cu (3 
mol%), HCl, 0 ºC, 1 h, 56 %. 
Scheme 82: Chlorination of methyl-3-butyn-2-ol 154 
 
When starting materials 150 and 141, a catalytic amount of copper powder, cuprous chloride 
and potassium carbonate were stirred at 53 ºC in acetone for 24h, mollugin 128 was produced 
in 19% yield (Scheme 83).
84
 Interestingly, only product 128 was isolated alongside recovered 
starting material 141 (79% recovery). Since 154 was found to be thermally unstable and to 
rearrange into 128, the reaction conditions were modified by replacing acetone with toluene 
and increasing the temperature from 53 °C to reflux. Thereby, the desired product 128 was 
obtained in 81% yield.  
 
Reagents and conditions: (a) 3-Chloro-3-methyl-1-butyne 150 (3.1 equiv.), CuCl (1 equiv.), Cu (5 mol%), 
K2CO3 (2 equiv.), KI (2 equiv.), acetone, 53 ºC, 24 h, 19 %. 
Scheme 83: Alternative route used for the synthesis of 128 
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2.6.2 Synthesis of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 129 
2.6.2.1 Synthesis of racemic mollugin oxide 130 
 
The synthesis of racemic mollugin oxide 130 was first attempted using standard epoxidation 
conditions. Unfortunately, m-CPBA oxidation of mollugin 128 in anhydrous dichloromethane 
was unsuccessful and decomposition of the starting material was observed. Non-chiral 
iminium salt 52 was also used to attempt the epoxidation of mollugin 128 in both aqueous 
and non-aqueous conditions, and only starting material was observed (Table 7).  
 
Table 7: Standard epoxidation conditions  
 
 
 Conditions  Temp Solvent Time Yield 
a 0 °С CH2Cl2 20 min decomposition 
b 0 °С MeCN/H2O (10:1) 24 h SM 
Reagents and conditions: (a) m-CPBA (1 equiv.), NaHCO3 (2 equiv.); (b) 52 (10 mol%), NaHCO3 (4 equiv.), 
Oxone
TM
 (2 equiv.) 
 
As the free phenolic hydroxyl was believed to interfere with our oxidation or destabilize the 
epoxide moiety, protection using a benzyl group was targeted. Benzyl bromide, mollugin, and 
potassium carbonate were mixed in dimethylformamide at 70 °C to give benzylated product 
155 in 86% yield. Attempts to oxidise 155 using m-CPBA and sodium hydrogen carbonate in 
anhydrous dichloromethane led to decomposition (Scheme 84). 
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Reagents and conditions: (a) BnBr (1.5 equiv.), K2CO3 (1.5 equiv.), DMF, 70 °C, 4h, 86%; (b) m-CPBA (1 
equiv.), NaHCO3 (2 equiv.), 0 °С, 50 min. 
Scheme 84: Synthesis of 156 
 
It is possible, given these results, that strongly electron-donating groups can destabilize the 
epoxide moiety under standard epoxidation conditions. We then turned our attention towards 
milder electron-donating groups: acetylation of 128 was achieved using acetic anhydride and 
pyridine in anhydrous dichloromethane to give acetate 157 in 95% yield.
87
 The formation of 
racemic epoxide 158 was successful utilizing m-CPBA and iminium salt 52 under aqueous 
conditions, affording epoxide 158 in 47% and 31% yield, respectively (Table 8). 
Unfortunately, we were unable to resolve the peaks corresponding to each enantiomer using 
chiral HPLC. 
Table 8: Synthesis of racemic epoxide 158. 
  
Conditions  Temp Solvent Time Yield 
b 0 °С CH2Cl2 20 min 47% 
c 0 °С MeCN/H2O (10:1) 24 h 31% 
Reagents and conditions: (a) Pyridine (19 equiv.), Ac2O (19 equiv.), CH2Cl2, rt, overnight, 95%; (b) m-CPBA (1 
equiv.), NaHCO3 (2 equiv.); (c) 52 (10 mol%), NaHCO3(4 equiv.), Oxone
TM
 (2 equiv.).  
 
To overcome the poor separation of enantiomers of the racemic epoxide using HPLC, the 
installation of more polar protecting groups on the free phenolic hydroxyl of compound 128 
was targeted. We first turned our attention towards the trifluoromethanesulfonate (or triflate) 
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group: treatment of mollugin 128 with triethylamine and trifluoromethanesulfonic anhydride 
in anhydrous dichloromethane afforded the desired product 159 in 98% yield.
88 
The racemic 
epoxide 160 was prepared in 81% yield using m-CPBA (Scheme 82). Crucially, separation of 
the enantiomers the racemic product 160 was observed, and the chromatogram exhibited two 
peaks of not equal areas at 23 and 33 minutes with an acceptable resolution (Figure 8).  
 
Reagents and conditions: (a) TEA (2 equiv.), (CF3SO2)O (3 equiv.), DCM, 0 °C-RT, 24h, 91 %; (b) m-CPBA (1 
equiv.), Na2CO3 (2 equiv.), 0 °С, 2 h, 81%. 
Scheme 82: Synthesis of 160 
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UV Results     
Retention Time Area Area % Height Height % 
23.020 536527579 46.02 7973912 55.25 
33.303 629307034 53.98 6458123 44.75 
Totals     
 1165834613 100.00 14432035 100.00 
 
Figure 8: Chromatogram of racemic 160 
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2.6.2.2 Asymmetric epoxidation of 159 
 
The synthesis of key non-racemic intermediate 160 was expected to require the use of the 
biphenyl-azepinium catalyst 74 prepared by our group. We screened catalyst 74 under 
aqueous conditions and non-aqueous conditions for asymmetric epoxidation of 159. 
Somewhat surprisingly, epoxidation of 159 under non-aqueous conditions was unsuccessful 
at −30, −10 and 0 °C and the starting material was recovered in each case. However, under 
aqueous conditions, the reactivity of biphenyl catalyst 75 is excellent, and the desired epoxide 
was obtained in very high yields (Table 9).  
 
Table 9: Synthesis of chiral epoxide 160 
 
Conditions  Temp Solvent Time Yield 
a −30 °С CHCl3 24 h SM 
b −10 °С CHCl3 24 h SM 
c 0 °С CHCl3 24 h SM 
d 0 °С MeCN/H2O (10:1) 15 min 91% 
Reagents and conditions: (a), (b), (c) catalyst 75 (10 mol%), TPPP (2 equiv.); (d) catalyst 75 (10 mol%), 
Na2CO3(5 equiv.), Oxone
TM
 (2 equiv.).  
 
Full conversion to (−)-(S,S)-epoxide 160 was observed after 15 min, and the product was 
isolated in 91% yield and 70.5% ee (Figure 9).
  
The absolute configuration at the C3 and C4 
position was established as being (S), (S) for major enantiomer 160 based on the epoxidation 
of number of cyclic cis- chromene structures under aqueous conditions by our group, which 
their absolute configurations were determined by comparison of optical rotation with values 
reported in the literature.
 4
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UV Results     
Retention Time Area Area % Height Height % 
22.227 74846313 14.75 1316297 21.90 
32.600 432671896 85.25 4692895 78.10 
Totals     
 507518209 100.00 6009192 100.00 
 
Figures 9: Chromatogram of non-racemic 160 
 
The next step towards the synthesis of (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin 
129 was the acid-catalysed ring-opening of the epoxide moiety to form the corresponding 
trans-diol as described above for the synthesis of (+)-scuteflorin A or trans-khellactone 
117.
84,56
 The non-racemic epoxide 160 was treated with a mixture of acetone and 1M 
H2SO4 to yield (+)-(3S,4R)-trans-diol 163 in 74% yield (Scheme 85). Characteristic diol 
signals were observed using 
1
H NMR spectra analysis: the protons at the C3 position 
(3.59 ppm, J=7.3 Hz), and C4 position (4.80 ppm, J=7.3 Hz). 
19
F NMR data analysis also 
supported the presence of the trifluoromethanesulfonate group. High resolution mass 
spectrometry suggested that a molecular ion at m/z 468.092 g/mol was detected 
corresponding to a molecular ion matching 163. Unfortunately, we were unable to obtain 
crystals suitable for X-ray analysis.  
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Reagents and conditions: (a) acetone/1M H2SO4 (2:1), RT, 1 h, 74%. 
Scheme 85: Acid-catalysed ring-opening of the epoxide 
 
The final stage is the removal of the trifluoromethanesulfonate group. Using potassium 
hydroxide in a mixture of water and ethanol (1:1), the reaction was heated under reflux for 30 
min until complete disappearance of 163 was observed using TLC.
 62
 Unfortunately, 
compound 129 was not observed and hydrolysis of the methyl ester led to the formation of 
carboxylic acid 164. The signal corresponding to the methyl ester group was absent when the 
1
H NMR spectra of the crude reaction mixture was analysed, and the presence of the 
trifluoromethanesulfonate group was confirmed using 
19
F NMR spectroscopy (Scheme86).  
 
Reagents and conditions: (a) KOH (1 equiv.), H2O/EtOH (1:1), reflux, 30 min.  
Scheme 86: Attempt to remove the trifluoromethanesulfonate group 
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The cleavage reaction of the trifluoromethanesulfonate group was also attempted using 2 
equivalents of tetraethylammonium hydroxide in dioxane. Thus, the disappearance of 
trifluoromethanesulfonate group was eventually observed using 
19
F NMR spectroscopy, but 
the two signals corresponding to the diol moiety were not observed using 
1
H NMR 
spectroscopy (Scheme 87).
89
 We also attempted to remove the triflate group using caesium 
carbonate (3 equiv.) according to a literature procedure,
90
 but no reaction was seen under 
these conditions after 19h, and 163 was recovered.   
 
Reagents and conditions: (a) Et4NOH (2 equiv.), dioxane, RT, 20 min; (b) Cs2CO3 (3 equiv.), PhMe, 0 °С, 19 h. 
Scheme 87: Further attempts to remove the trifluoromethanesulfonate group 
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2.7 Conclusions  
 
There is no doubt that the scope of academic and industrial organic synthesis has been deeply 
extended by developments in the field of asymmetric catalysis. At the beginning of this work, 
we challenged ourselves to develop a wide variety of reaction processes that could be used to 
synthesize flav-3-ene derivatives, and particularly the effect of a variety of protecting groups 
in stabilizing flav-3-ene derivatives. In all cases, I found that flav-3-ene containing protecting 
groups such as benzyloxy groups on the aromatic rings were unstable to the epoxidation 
reaction conditions. However, the toluenesulfonate moiety played a significant role in the 
stability of flav-3-ene under oxidative conditions. The findings of this study have important 
implications for the asymmetric epoxidation on flav-3-ene substrates. 
. 
 
 
We have also used three straightforward approaches to synthesize mollugin 128. The journey 
to synthesize trans-3,4-dihydroxy-3,4-dihydro-mollugin 129 in an enantioselective manner 
began with the employment of catalyst 75 to install an epoxide moiety. An acid-catalysed 
ring-opening of the epoxide was also successful and (+)-(3S,4R)-trans-diol 163 was obtained 
in 74% yield.  
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2.8 Future Work 
 
We will undertake an extensive investigation of the effect of a variety of protecting groups on 
the stability of 3-flav-3-enes and their reactivity towards iminium salt catalysed epoxidation 
within our group. In addition, we will seek novel methods to synthesize 3-flav-3-ene 
analogues. This should allow us to use iminium salts to achieve enantioselective kinetic 
resolution as indicated at the beginning of this chapter. Moreover, it should permit us to gain 
access to polyphenol natural products, for example, the anti-cancer agent (−)-
epigallocatechin.  
 
 
Despite our inability to observe any conversion to the desired trans-3,4-dihydroxy-3,4-
dihydro-mollugin 129 from diol 163, we will continue to seek to achieve the deprotection of 
the trifluoromethanesulfonate group within our group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
116 
 
2.9 Results and Discussion References
 
 
1
 Page, P. C. B.; Appleby, L. F.; Day, D. P; Chan, Y.; Buckley, B. R.; Allin, S. M.; 
McKenzie, M. J. Org. Lett. 2009, 11, 1991. 
2
  Heaney, H.;  Jablonski, J. M. Chem. Commun. 1968, 18, 1139. 
3 
Qiang, D.; Shi, J. B.; Song, B.; Liu, X. RSC Adv. 2014, 4, 5607. 
4 
Page, P. C. B.; Buckley, B. R.; Heaney, H.; Blacker, A.J. Org. Lett. 2005, 7, 375. 
5
 Page, P. C. B.; Appleby, L. F.; Day, D. P; Chan, Y.; Buckley, B. R.; Allin, S. M.; 
McKenzie, M. J. Org. Lett. 2013, 78, 8074. 
6
 Ohmori, K.; Ushimaru, N.; Suzuki, K. Tetrahedron Lett. 2002, 43, 7753. 
7
 Grotewold, E. The Science of Flavonoids, Springer Science, Ohio, 2006. 
8
 Harborn, J. B. The flavonoids-advances in research, Chapman & Hall, Florida, 1986. 
9 
Subramanian, R. S.; Balasubramanian, K. K. Tetrahedron Lett. 1988, 29, 6797. 
10
 Barluenga, J.; Trincado, M.; Marco-Arias, M.; Ballesteros, A.; Rubio, E.; González, J. 
Chem. Commun. 2005, 2008. 
11
 Castro. A. M. Chem. Rev. 2004, 104, 2939. 
12 
Chow, H.; Lau, T.; Wang, Z. Tetrahedron. 1998, 54, 13824. 
13 
Buechi, G.; Francisco, M.A.; Liesch, J. M.; Schuda, P. J. Am. Chem. Soc. 1981, 103, 
3497. 
14
 D, Pham.; Betrah, C. J.; Olmstead. M.; Mascal, M.; Balch, A. Org. Lett. 2005, 7, 
2805. 
15
 Nay, B.; Arnaudinaud, V.; Vercauteren, J. Eur. J. Org. Chem. 2001, 2379. 
16 
(a) Percec, V.; Peterca, M.; Sienkowska, M. J.; Ilies, M.; Aqad, E.; Smidrkal, J.; 
Heiney, P. A. J. Am. Chem. Soc. 2006, 128, 3324; (b) Chen, C.; Wharton, R. E.; Patel, 
P. A.; Oyelere, K. Bioorg. Med. Chem. 2007, 15, 7288. 
17
 Davis, N. E.; Koltover, I; Zhuravel, M. A.; Nguyen, S.; Zhuravel, M. J. Am. Chem. 
Soc. 2004, 126, 9883. 
18
  Ghosh, N; Nayak, S; Sahoo, A. K. J. Org. Chem. 2011, 76, 500.  
19
  Madabhushi, S; Jillella, R; Godala, K. R.; Mallu, K. R; Beeram, C. R; Chinthala, N. 
Tetrahedron Lett. 2012, 53, 5275. 
 20 
Zhao, W.; Carreira, E. M. Org. Lett. 2003, 5, 4153. 
21
  Gabbutt, C. D.; Heron, B. M.; Kolla, B. S.; Mcgivern, M. Eur. J. Org. Chem. 2008, 
2031. 
117 
 
21
 Achilonu, M. C.; Bonnet, S. L.; van der Westhuizen, J. H. Org. Lett. 2008, 10, 3865.  
22
  Queiroz, A.; Plasencia, M.S.; Dubest, R.; Aubard, J.; Guglielmetti R. Tetrahedron. 
2003, 59, 2567. 
23 
Meng, Q.; Wang, G.; Jiang, H.; Wang, Y.; Xie, S. J. Mater. Sci. 2013, 48, 5862. 
24  
Vaiana, N.; Rizzi, L.; Pezzano, M. G.; Restelli, R.; Rota, F.; Stefanini, S.; Vicentini, 
S; Romeo, S. Lett. Org. Chem. 2007, 4, 288. 
25
  Nay, B.; Peyrat. J.; Vercauteren, J. Eur. J. Org. Chem. 1999, 2234. 
27  
Sapkota, K.; Ha, E.-M.; Roh, E.; Kim, Y.; Lee, E.; Kwon, Y.; Yang, J.; Lee, E.; 
Younghwa, N. Bioorg. Med. Chem. 2011, 19, 2168. 
28 
Hamura, T.; Ibusuki, Y.; Uekusa, H.; Matsumoto, T.; Siegel, J. S.; Baldridge, K. K.; 
Suzuki, K. J. Am. Chem. Soc. 2006, 128, 10032. 
29 
Subramaniana, S.; Balasubramaniana, K. K. Synth. Commun. 1989, 19, 1255. 
30 
Garcias, X.; Ballester, P.; Saa, J. M. Tetrahedron Lett. 1999, 32, 7739. 
31 
Amy, B.; Larry, E. O. Chem. Rev. 2003, 103, 2945. 
32 
Zaveri, N. T. Org. Lett. 2001, 3, 843 
 
33 
Ichino, K.; Tanaka. H.; Ito, K. J. Nat. Prod. 1988, 51, 906.  
34 
Deme, E. J. Org. Chem. 1972, 41, 3769.  
35  
Yamasaki, K.; Kato, E.; Kawabata, J.; Hishiki, R. Med. Chem. Lett. 2011, 2, 17. 
36
 Liu, G. B.; Geng, M.; Hui, R,; Zhao, J. W.; Li, J.; Xu, J. L.; Xu, R.; Xu, Q.; Xu, H.  
Bioorg. Med. Chem. 2010, 18, 2864. 
37 
Minehan, T. G.; Salehani, B; Yepremyan, A. Org. Lett. 2010 , 12, 1580. 
38 
Arnaudinaud, V.; Deffieux, G.; Merillon, J.; Monti, J. P.; Nay, B.; Nuhrich, A.; 
Vercauteren, J. Tetrahedron Lett. 2001, 42, 1279. 
39 
Page, P. C. B.; Farah, M. M.; Buckley, B. R.; Blacker, A. J. J. Org. Chem. 2007, 72, 
4424. 
40 
St. Denis, J. D.; Gordon IV, J. S.; Carroll, V. M.; Priefer, R. Synthesis. 2010, 1590. 
41 
Bu, X.; Zhao, L.; Li,Y. Synthesis. 1997, 1247. 
42 
Aponte, J. C.; Hammond, G. B.; Zimic, M.; Quiliano, M; Vaisberg, A. J.; Verastegui, 
M; Malaga, E; Gilman, R. H. J. Med. Chem. 2008, 51, 6230. 
43 
Juvale, K.; Pape, V. F. S.; Wiese, M. Bioorg. Med. Chem. 2012 , 20, 346. 
44 
Oshitari, T.; Okuyama, Y.; Miyata, Y.; Kosano, H.; Takahashi, H.; Natsugari, H. 
Bioorg. Med. Chem. 2011, 19, 7085. 
45 
Deodhar, M.; Wood, K.; StC. Black, D.; Kumar, N. Tetrahedron Lett. 2011, 53, 6697. 
118 
 
46
 Zhang, M.; Jagdmann Jr., G. E.; Van Zandt, M.; Beckett, P.; Schroeter, 
H. Tetrahedron: Asymmetry. 2013, 24, 362. 
47 
Wuts, P. G. M.; Greene, P.G. Greene's Protective groups in Organic synthesis, Wiley, 
New Jersey, 2007. 
48
  Xia, L.; Lee, Y. R. Bull. Korean Chem. Soc. 2012, 33, 2087. 
49 
Buisson, D.; Quintin, J.; Lewin, G. J. Nat. Prod. 2007, 70, 1035. 
50 
Nordin, I. C.; Thomas, J. A. Tetrahedron Lett. 1988, 29, 5177. 
51  
Hulme, C.; Gore, V. Curr. Med. Chem. 2003, 10, 51. 
52 
Gu, Y.; Barrault, J.; Jerome, F. Adv. Synth. Catal. 2009, 351, 3269. 
53 
Weinreb, S. M.; Scola, P. M. Chem. Rev. 1989, 89, 1525. 
54 
Matsuo, T.; Miyoshi, N.; Wada, M. Eur. J. Org. Chem. 2005, 4253. 
55 
Tadpetch, K.; Rychnovsky, S. D. Org. Lett. 2008, 10, 4839. 
56 
Choi, J.; Norton, J. R.; Tang, L. J. Am. Chem. Soc. 2007, 129, 234. 
57 
Bigi, F.; Carloni, S.; Maggi, R.; Muchetti, C.; Sartori, G. J. Org. Chem. 1997, 62, 
7024. 
58
  Kaupp, G.; Marquardt, T. Angew. Chem. 1994 , 106, 1527.  
59
 Hunsen, M. Tetrahedron Lett. 2005, 46, 1651. 
60 
Jiang, H.; Gao,Y.; Wu, W.; Huang,Y. Org. Lett. 2013, 15, 238.  
61 
Hartsel, J. A.; Craft, D. T.; Chen, Q.; Ma, M.; Carlier, P. R. J. Org. Chem. 2012, 77, 
3127. 
62
 Barnett, D. S.; Schaus, S. E. Org. Lett. 2011, 13, 4020. 
63 
Bandaranayake, W. M.; Crombie, L.; Whiting, D. A. J. Chem. Soc., Chem. Commun. 
1969, 970. 
64  
Camps, F.; Coll, J.; Messeguer, A.; Pericás, M. A. J. Heterocycl. Chem. 1980, 17, 
1377. 
65
 North, J. T.; Kronenthal, D. R.; Pullockaran, A. J.; Real, S. D.; Chen, H. Y. J. Org. 
Chem. 1995, 60, 3397. 
66
 Cadierno,V.; Crochet, P.; Garrido, S. G.; Gimeno. Dalton Trans. 2010, 39, 4015. 
67
  Engel, D. A.; Dudley, G. B. Org. Biomol. Chem. 2009, 7, 4149. 
68
  Cadierno, V.; Francos, J.; Gimeno, J. Tetrahedron Lett. 2009, 50, 4773. 
69
  Douhaibi, A.S. ; Judeh, Z. M. A.;  Basri, H.;  Moussa, Z.;  Messali, M.  Qi, G.  Synth. 
Commun. 2011, 41, 533. 
70  
Dounay, A. B.; Overman, L. E. Chem. Rev. 2003, 103, 2945. 
71
  http://stoltz.caltech.edu/litmtg/2003/tambar-lit-4_17_03.pdf; accessed 17/05/14 
119 
 
72
 Cabri, W.; Candiabi, I. Acc. Chem. Res. 1995, 28, 2. 
73 
Beletskaya, I. P.; Cheprakov, A.V. Chem. Rev. 2000, 100, 3009.
  
74 
Mao, W. W.; Wang, T.; Zeng, H. P.; Wang, Z.; Chen, J. P.; Shen, J. G. Bioorg. Med. 
Chem. Lett. 2009, 19, 4570. 
75 
Chong, J. M.; Shen, L.; Taylor, N. J. J. Am. Chem. Soc. 2000, 122, 1822. 
76 
Mudiganti, N. V. S.; Claessens,S.; Habonimana, P.; De Kimpe, N. J. Org. Chem. 
2008, 73, 3867. 
77
 a) Itokawa, H.; Ibraheim, Z.; Qiao, Y.F.; Takeya, K. Chem. Pharm. Bull. 1993, 41, 
1869; b) Lee, Y. R.; Kim, Y. M. Helv. Chim. Acta. 2007, 90, 2401. 
78 
Son, J. K.; Jung ,S. J.; Jung, J. H.; Fang, Z.; Lee, C. S.; Chang, S. S.; Moon, D. C.; 
Min, B. S.; Kim, M. R.; Woo, M. H. Chem.Pharm.Bull. 2008, 56, 213. 
79 
Jacobs, J.; Claessens, S.; Huygen, K.; Tehrani, K. A.; De Kimpe, N. Pure Appl. 
Chem. 2011, 83. 1651. 
80 
Lv, L.; Chen, H.; Ho, C.-T.; Sang, S. Fitoterapia. 2011, 82, 704. 
81 
El-Hady, S.; Bukuru, J.; Kesteleyn, B.; Van Puyvelde, L.; Van, T. N.; De Kimpe, N. 
J. Nat. Prod. 2002, 65, 1377. 
82 
Wang, X.; Lee, Y. R. Tetrahedron Lett. 2007, 48, 6275. 
83
  Mudiganti, N. V. S.; Claessens, S.; De Kimpe, N. Tetrahedron Lett. 2008, 49, 6983. 
84
  Page, P. C. B.; Bartlett, C. J.; Day, D. P.; Chan, Y.; Allin, S. M.; McKenzie, M. J.; 
Slawin, A. M. Z. J. Org. Chem. 2012, 77, 772. 
85 
 Jung, H. W.; Oh, J. S.; Lee, S. H.; Liang, J. L.; Kim, D. H.; Rahman, A. F. M.; Jahng, 
Y. Bull. Korean Chem. Soc. 2007, 28, 1863. 
86 
Smith, L. R.; Mahoney, N.; Molyneux, R. J. Nat. Prod. 2003, 66, 169. 
87 
Kumar, J. A.; Raju, B. C.; Saidachary, G; Jain, N.; Kalivendi, S. V.; Sridhar, V.; 
Mallesham, G.; Rao, V. J.; Raju. C. Eur. J. Med. Chem. 2013, 65, 389. 
88 
Gosmini, C.; Kazmierski, I.; Perichon, J.; Paris, J.M. Synlett. 2006, 881. 
89 
Ohgiya, T.; Nishiyama, S. Tetrahedron Lett. 2004, 45, 6317. 
90 
Green, A. E.; Agouridas, V.; Deniau, E. Tetrahedron Lett. 2013, 54, 7068. 
  
120 
 
3.0 Experimental  
3.1 General Experimental  
3.1.1 Physical Characterisation and Spectroscopic Techniques 
Infrared spectra were acquired using a Perkin Elmer System 2000 FT-IR spectrophotometer. 
Solid samples were run as nujol mulls or as thin films of their solution in dichloromethane on 
sodium chloride plates. Liquid samples were run neat. 
1
H and 
13
C NMR spectra were 
measured respectively at 400.13 and 100.62 MHz using Varian Unity Plus (400 MHz) 
spectrometers, at 300.05 and 75.45 MHz using a Varian Gemini 200 (300 MHz) instrument, 
at 400.13 and 100.03 MHz using a 400 MHz Bruker Avance III 2 channel nanobay NMR 
spectrometer, or at 500.21 and 125.05 MHz using a Bruker Avance III 500 MHz NMR 
spectrometer. The solvent used for NMR spectroscopy was deuteriated chloroform unless 
stated otherwise, using tetramethylsilane as the internal reference. Chemical shifts are given 
in parts per million (ppm) and J values are given in Hertz (Hz). High resolution mass spectra 
were obtained from the EPSRC Mass Spectrometry Service at the University of Swansea. 
Melting points were recorded using a Büchi B-545 melting point instrument and are reported 
uncorrected. Optical rotation values were measured with a Bellingham and Stanley ADP-440 
instrument, operating at =589 nm, corresponding to the sodium D line at the temperatures 
indicated. The solvents used for these measurements were of spectrophotometric grade. The 
solutions for these measurements were prepared in volumetric flasks for maximum accuracy 
of the volume of solvent used. Enantiomeric excesses were determined by Chiral High 
Performance Liquid Chromatography, (Chiral HPLC). HPLC samples were prepared by silica 
based chromatography. Data was recorded using Hitachi Elite LaChrom software fitted with 
a L2400 UV detector (256 nm unless stated otherwise), a L2300 column oven, a L2200 
autosampler, a L2130 pump, and a Knaver Eurocel 01 5µm particle size column. All HPLC 
samples were run under hexane – isopropanol conditions. 
Reactions requiring anhydrous conditions were carried out using glassware dried overnight at 
150 °С, unless otherwise stated. Reaction solvents were obtained commercially dry, except 
dichloromethane, which was distilled from calcium hydride; tetrahydrofuran (THF) and 
diethyl ether (Et2O), which were distilled under a nitrogen atmosphere from the 
sodium/benzophenone ketyl radical.   
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3.2 Experimental Procedures Related to the Synthesis of flav-3-ene: 
 
3.2.1 3,5-dihydroxyphenyl benzoate (17)
 1 
 
Pyridine (1.26 mL, 15.7 mmol, 2 equiv.) was added to a solution of anhydrous phloroglucinol 
(1.0 g, 7.92 mmol) in anhydrous tetrahydrofuran (50 mL). Benzoylchloride (1.26 mL, 7.92 
mL) in anhydrous tetrahydrofuran (20 mL) was added dropwise to the solution. The cloudy 
mixture was heated under reflux under nitrogen for 3 days. A solution of Cu2SO4 was poured 
into the cooled mixture. The resulting mixture was extracted with ethyl acetate (2×10 mL). 
The organic phase was washed with diluted aqueous HCl (1M, 2×5 mL), water (10 mL), and 
brine (5 mL). The organic layer was dried over MgSO4 and the solvents were removed under 
reduced pressure. The crude mixture was purified using silica gel column chromatography 
(1:3.5 ethyl acetate- petroleum ether) to afford compound 17 (0.88 g, 49%). 
mp 75-78 °С; νmax (neat)/cm
-1 
3297, 3088, 3068, 1610, 1144.8; δH (400 MHz; d6-acetone) 
6.26 (d, 2 H, J = 2.1 Hz, ArH-2,6), 6.30 (t, 1 H, J = 2.1 Hz, ArH-4), 7.65-7.70 (m, 2 H, ArH-
10,12), 7.67 (t, 1 H, J = 3.0 Hz, ArH-11), 8.12 (m, 2 H, ArH-9,13), 8.59 (s, 2 H, OH); δC 
(100 MHz; d6-acetone) 100.4 (CH-4), 100.9 (CH2-2,6), 128.9 (CH2-10,12), 130.0 (CH2-
9,13), 133.8 (C-8) 153.0 (CH-11), 159.2 (C-1), 162.0 (C2-3,5), 164.5 (CO-7). 
 
3.2.2 3,5-bis(Benzyloxy)phenyl benzoate (18)
 2  
 
2-(3,5-Dihydroxyphenyl)-1-phenylethanone 17 (0.55 g, 2.4 mmol) was dissolved in 
anhydrous tetrahydrofuran (100 mL). Potassium carbonate (0.99 g, 7.0 mmol) and 18-crown-
6 (0.12 g, 0.2 equiv.) were added to the solution and the mixture was stirred at room 
temperature for 15 min. followed by the addition of benzyl bromide (0.65 mL, 5.5 mmol). 
The reaction was heated under reflux for three days under a nitrogen atmosphere. Water (5 
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mL) and diluted HCl (1M, 5 mL) were added to the reaction mixture. The aqueous layer was 
extracted with ethyl acetate (3x20 mL) and the organic layer was washed with brine (5 mL), 
and diluted aqueous HCl (1M, 5 mL). The organic layer was dried over anhydrous MgSO4 
and the solvents were removed under reduced pressure. The crude mixture was purified by 
column chromatography on silica gel (ethyl acetate : petroleum ether, 1:2). The product 18 
was obtained as a yellow solid (0.86 g, 79%). 
mp 97-100 °С; νmax (neat)/cm
-1 
2866, 1698, 1247, 712. δH (400 MHz; CDCl3) 4.96 (s, 4 H, 
C2H4-14,15), 6.10 (d, 2 H, J = 2.1 Hz, ArH-2,6), 6.22 (t, 1 H, J = 2.1 Hz, ArH-4), 7.28-7.62 
(m, 10 H, Ph2C2H4O2), 7.47 (t, 2 H, J = 7.8 Hz, PhH-10,12), 7.61 (t, 1H, J = 7.4 Hz, PhH-
11), 8.16 (m, 2 H, PhH-9,13); δC (100 MHz; CDCl3) 70.1 (C2H4-14,15), 95.0 (CH-4), 95.5 
(CH2-2,6), 127.8 (CH2-10,12), 128.2, 128.7, 128.8, 129.4 (Ph2C2H4O2), 130.4 (CH2-9,13), 
134.1 (C-8), 136.9 (CH-11), 157.7 (C-1), 160.9 (C-3,5), 172.4 (CO-7). 
 
3.2.3 3,5-bis(Benzyloxy)phenol (19)
 3
 
 
3,5-bis(Benzyloxy)phenol (4.00 g, 9.75 mmol) was dissolved in anhydrous tetrahydrofuran 
(15 mL) and LiAlH4 (1.85 g, 48.76 mmol) was cautiously added to the stirring solution under 
a nitrogen atmosphere at 0 °С (ice bath). The reaction was left overnight and followed by 
TLC (ethyl acetate/petroleum ether 1:4). The reaction was quenched by addition of water (10 
mL) and washed using aqueous HCl (2M, 10 mL). The solution was washed using ethyl 
acetate, the organic layer was separated and the aqueous layer was extracted with ethyl 
acetate (3×30 mL). The combined organic layer was washed with brine, dried over anhydrous 
MgSO4. The solvents were removed under reduced pressure. The crude mixture was purified 
by column chromatography on silica gel (ethyl acetate : petroleum ether, 1:5). The product 19 
was obtained as a colourless solid (2.01 g, 68%). 
mp 93-95 °С; νmax (neat)/cm
-1 3292, 2863, 1148, 1042; δH (400 MHz; d6-acetone) 5.02 (s, 4 
H, C2H4-7,8), 6.17 (d, 2 H, J = 2.0 Hz, PhH-2,6), 7.20 (t, H, J = 2.1 Hz, PhH-4), 7.18-7.49 
(m, 10 H, Ph2C4H4OPh), 8.41 (s, 1 H, OH); δC (100 MHz; d6-acetone) 73.2 (C2H4-7,8), 95.0 
(CH-4), 96.6 (CH2-2,6) 127.8, 128.2, 128.8, 136.9 (Ph2C2H4OPh), 157.6 (C-1), 160.9 (C-
3,5).   
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3.2.4 methyl 3,4,5-tris(Benzyloxy)benzoate (21)
 4
 
 
Benzyl bromide (10.32 mL, 90 mmol) was added to a mixture containing methyl 3,4,5-
tris(benzyloxy)benzoate (5.00 g, 27 mmol) and K2CO3 (16.90 g, 122 mmol, in anhydrous 
dimethylformamide (60 mL). The reaction was stirred under a nitrogen atmosphere overnight 
at room temperature. After removing the organic solvent under reduced pressure, aqueous 
HCl (2M, 30 mL) was added to acidify the reaction mixture. The reaction was extracted with 
ethyl acetate (3×80 mL). The combined organic phases were dried over anhydrous MgSO4, 
and concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel (ethyl acetate- petroleum ether, 5:1) to afford the desired compound as a 
colourless solid (10.94 g, 89%). 
mp 160-163 °С; νmax (neat)/cm
-1 2948, 2897, 1715, 1427, 1331, 1108, 751; δH (400 MHz; 
CDCl3) 3.88 (s, 3 H, CH3-8), 5.11 (s, 2 H, CH2-11), 5.12 (s, 4 H, C2H4-9,10), 7.18-7.51 (m, 
17 H, Ar-H); δC (100 MHz; CDCl3) 52.5 (CH3-8), 71.4 (C2H4-9.10), 75.3 (CH2-11), 109.2 
(CH-2,6) 125.4, 127.8, 128.16, 128.24, 128.3, 128.4, 128.8, 136.9, (Ph3C6H6O3Ph), 137.7 (C-
1), 142.5 (C-4), 152.8 (C-3,5), 166.9 (COH-7). 
 
3.2.5 [3,4,5-Tris(Benzyloxy)phenyl]methanol (22)
 4 
 
Methyl 3,4,5-tris(benzyloxy)benzoate 10 (5.00 g, 11.4 mmol) ester was dissolved in 
anhydrous tetrahydrofuran (40 mL) in an oven-dried 250 mL round-bottomed flask. LiAlH4 
(0.65 g, 17.1 mmol) was periodically added at 0 °С (ice bath), under a funnel of nitrogen. The 
124 
 
reaction was left to stir overnight. It was monitored by TLC with ethyl acetate and petroleum 
ether (Rƒ = 0.39). The reaction was quenched by the cautious addition of water (20 mL) 
followed by dilute aqueous HCl (1M, 20 mL). The reaction was stirred for a further 30 min. 
The mixture was extracted with diethyl ether (4x30 mL). The combined organic layers were 
washed with a saturated solution of NaHCO3 (20 mL), brine (100 mL) and dried over 
anhydrous MgSO4. The solvents were removed under reduced pressure to give the desired 
compound as a colourless solid (4.18 g, 90%). 
mp 163-165
 °C; νmax (neat)/cm
-1 
3263, 2935, 1229, 1121, 734; δH (400 MHz; CDCl3) 1.75 (s, 
1 H, OH), 4.55 (s, 2 H, CH2-7), 5.02 (s, 2 H, CH2-9), 5.08 (s, 4 H, C2H4), 6.65 (s, 2 H, ArH-
2,6), 7.24-7.49 (m, 15 H, Ph3C2H6O); δC (100 MHz; CDCl3) 65.5 (CH2-7), 71.3 (C2H4-8,10), 
75.5 (CH2-9), 106.4 (CH2-2,6), 127.6, 128.0, 128.1, 128.4, 128.7, 128.8, 137.0, 137.3 
(Ph3C6H6O3Ph), 137.7 (C-4), 138.0 (C-1), 153.1 (C2-3,5). 
 
 3.2.6 3,4,5-tris(Benzyloxy)benzaldehyde (23)
 4 
 
3,4,5-tris(Benzyloxy)benzaldehyde (1.51 g, 3.54 mmol) was dissolved in dichloromethane. 
Pyridinium chlorochromate (2.27 g, 5.25 mmol) was added in one portion to the mixture. The 
reaction was stirred under a nitrogen atmosphere at a room temperature overnight and 
followed by TLC (ethyl acetate/petroleum ether, 3/1, Rƒ = 0.53). Diethyl ether (50 mL) was 
added to precipitate out the chromium salts. The resulting suspension was filtered through a 
pad of celite, silica gel and sand. The solvents were removed under reduced pressure to give 
the desired aldehyde 23 as a colourless solid (1.22 g, 81%). 
mp 156-158 °С; νmax (neat)/cm
-1 2933, 1692, 1591, 1436, 1385, 1328, 1235, 1143, 1119; δH 
(400 MHz; CDCl3) 5.16 (s, 4 H, C2H4-8,9), 5.19 (s, 2 H, CH2-10), 7.20 (s, 2 H, ArH-2,6), 
7.24-7.51 (m, 15 H), 9.80 (s, 1 H, COH-7); δC (100 MHz; CDCl3) 72.7 (C2H4-8,9), 76.4 (CH2-
10), 112.2 (CH2-2,6) 127.4, 128.4, 128.6, 128.80, 128.83, 129.0, 133.8, 137.1, 
(Ph3C6H6O3Ph), 138.8 (C-1), 144.6 (C-4), 156.2 (C2-3,5), 196.0 (COH-7).  
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3.2.7 (3,4,5-Tris-benzyloxy-phenyl)-prop-2-yn-1-ol (24) 
 
3,4,5-tris-Benzyloxybenzaldehyde 23 (0.25 g, 0.56 mmol) was dissolved in anhydrous 
tetrahydrofuran and the solution was cooled to – 78 °С. Ethynylmagnesium bromide (0.5M in 
THF, 6.00 mL) was cautiously added to the solution. The reaction was allowed to warm to 
room temperature, and left to stir for 2 hours. The reaction was quenched using a solution of 
NH4Cl (5 mL). The excess THF was removed under reduced pressure. The residue was 
extracted with ethyl acetate (3×10 mL), washed with dilute aqueous HCl (1M, 5 mL), and 
dried over anhydrous Na2SO4. The solvents were removed under reduced pressure and the 
residue was purified using column chromatography on silica gel with ethyl acetate -petroleum 
ether (1:2) to give compound 24 as a yellow solid (241 mg, 91%). 
mp 178-180 °С; νmax (neat)/cm
-1 
3303, 3019, 2867, 2140, 1331, 1124, 729; δH (400 MHz; 
CDCl3) 2.19 (d, 1 H, J = 6.2 Hz, OH), 2.63 (d, 1 H, J = 2.2 Hz, CH-9), 5.02 (s, 2 H, CH2-11), 
5.11 (s, 2 H, C2H4-10,12), 5.33 (dd, 1 H, J = 6.2, 2.2 Hz, CH-7), 6.85 (s, 2 H, ArH-2,6), 7.17-
7.32 (m, 15 H, Ph3C3H6O); δC (100 MHz; CDCl3) 64.3 (CH-7), 71.2 (C2H4-10-12), 74.9 
(CH2-11), 75.2 (C-9), 83.2 (C-8), 106.2 (CH2-2,6), 127.5, 127.8, 128.2, 128.5, 128.6, 128.7, 
128.8, 135.6, (Ph3C3H6O3Ph), 137.0 (C-1) 137.8 (C-4), 153.0 (C2-3,5); m/z found for 
[M+NH4]
+
: 468.2163; [C30H26O4+NH4]
+
 requires 468.2169.  
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3.2.8 (((5-(1-(3,5-bis(Benzyloxy)phenoxy)prop-2-yn-1-yl)benzene-1,2,3-
triyl)tris(oxy))tris(methylene))tribenzene (25) 
 
Method A 
The propargyl alcohol 24 (0.77 mmol, 350 mg) was dissolved in anhydrous dichloromethane 
and the resulting solution was added slowly into a dilute solution of camphorsulfonic acid 
(2.62 g, 10.5 equiv.) in anhydrous dichloromethane. The mixture changed to a light green 
colour. After 10 min, alcohol compound 19 (330 mg, 1.14 mmol) was added dropwise, and 
the reaction mixture turned into an apple red colour. The reaction was stirred for 48 hours. 
The solvent was evaporated under reduced pressure. The organic residue was dissolved in 
ethyl acetate (20 mL) and the organic layer was then washed with a solution of NaHCO3 and 
brine (5 mL), dried using anhydrous MgSO4 and the solvent was removed under reduced 
pressure. The crude product was recrystallised using toluene and the mother liquor was 
purified using flash chromatography on silica gel with toluene-ethyl acetate as eluent (35/1). 
The product 25 was obtained as a colourless powder (0.46 g, 58%). 
m.p. 200-202 °С; νmax (neat)/cm
-1 
2983, 2934, 2120, 1265, 738; δH (400 MHz, CDCl3,): 2.56 
(d, 1 H, J = 2.7 Hz, CH-15), 4.93-5.06 (m, 10 H, C5H10-16,17,18,19,20), 5.68 (d, 1 H, J= 2.7 
Hz, CH-7), 6.24 (t, 1 H, J = 2.4 Hz, CH-2), 6.29 (d, 2 H, J = 2.4 Hz, CH2-6,4), 6.76 (s, 2 H, 
CH2-13,9), 7.08-7.69 (m, 25 H, Bn5O5-16,17,18,19,20); δC (100MHz; CDCl3), 70.3 (CH-7), 
70.8 (CH2-18), 71.2 (C2H4-16,17), 73.7 (C2H4-19,20), 75.5 (C-15), 83.9 (CH-14), 94.0 (C2H2-
4,6), 96.4 (CH-2), 107.0 (C2H2-13,9), 127.7, 127.9, 128.41, 128.43, 128.7, 128.0, 128.5, 
128.8, 128.9, 135.3, 136.9, 137.51, (Ph5C5H10O5Ph2) 137.52, (C-8)138.1 (C-11), 152.9 (C2-
10,12), 156.4 (C2-1,3), 156.9 (CH-5); m/z found for [M+NH4]
+
: 756.3320 [C50H42O6+NH4]
+
 
requires: 756.3320.  
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Method B 
A suspension of the propargyl alcohol 14 (90 mg, 0.19 mmol), alcohol compound 8 (122 mg, 
0.40 mmol) and acidic Al2O3 (1g) in anhydrous toluene (20 mL per g of acidic Al2O3) was 
heated under reflux for 24h. The apple red solution was allowed to cool, transferred to a 
separating funnel and extracted with dichloromethane (2 x 40 mL). The organic layers were 
combined and washed with a NaHCO3 solution (40 mL, saturated aqueous) and then dried 
over anhydrous MgSO4. The solvents were removed under reduced pressure and the residue 
was purified by flash chromatography on silica gel with toluene-ethyl acetate as eluent (35/1) 
to furnish the title compound as a colourless powder (61 mg, 21%). 
 
3.2.9 5-Hydroxy-1,3-phenylene diacetate (32) and benzene-1,3,5-triyl triacetate (34)
 5 
Method A:
 
  
A solution of phloroglucinol (400 mg, 3.1 mmol) was dissolved in a mixture of pyridine and 
dichloromethane (2:1) and was stirred for 15 min under a nitrogen atmosphere. Acetic 
anhydride (0.6 mL, 6.3 mmol) was then added into the solution. The white solution turned 
yellow as the reaction was heated under reflux for 22h. After cooling, the solvent was 
removed in vacuo and water (16 mL) was added to the resulting residue. The aqueous phase 
was extracted with ethyl acetate (3×20 mL). The organic layer was washed with an aqueous 
solution of copper sulfate, brine and dried over MgSO4. The solvents were removed under 
reduced pressure and the residue was purified by silica gel flash chromatography using ethyl 
acetate /light petroleum (1:2.5) to yield 23 as a colourless solid (380 mg, 58%) and 34 as a 
colourless solid (135 mg, 27%) 
5-Hydroxy-1,3-phenylene diacetate 32: 
 mp 50-52 °С; νmax (neat)/cm
-1 
3288, 2967, 1608, 968; δH (500 MHz, CDCl3): 2.12 (s, 6 H, 
C2H6CO-9,10), 6.26 (d, 2 H, J = 2.0 Hz, C2H2-1,5), 6.28 (t, 1 H, J = 2.0 Hz, CH-3), 6.69 (s, 1 
H, COH-6); δC (125 MHz, CDCl3): 21.1 (C2H6CO-9,10), 107.0 (C2H2-1,5), 112.8 (CH-3) 
151.1 (C2O2-2,4), 157.5 (C-6), 169.7 (C2O2-7,8). 
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Benzene-1,3,5-triyl triacetate 34: 
mp 35-37 °С; νmax (neat)/cm
-1 
2879, 1690, 1601, 832; δH (500 MHz, CDCl3): 2.22 (s, 9 H, 
C3H9CO-9,10,12), 6.26 (s, 3 H, C3H3-1,3,5); δC (125 MHz, CDCl3): 20.9 (C3H9CO-9,10,12), 
112.8 (C3H3-1,3,5), 151.1 (C3O3-2,4,6), 168.5 (C3O3-7,8,11). 
 
Method B: 
  
Benzene-1,3,5-triyl triacetate 34 (100 mg, 0.39 mmol) was dissolved in dimethylformamide 
under a nitrogen atmosphere. Sodium hydride (6.6 mg, 0.27 mmol) was added into the 
solution, and the reaction mixture stirred for 1h followed by heating for 6h at 60 °C. After 
cooling, H2O (4 mL) was added and the mixture heated under reflux for 30 min. The resulting 
solution was extracted with Et2O (3× 20 mL), the organic layers were combined, washed with 
brine, dried over MgSO4and the solvents were removed under reduced pressure. The residue 
was purified by silica gel flash chromatography using ethyl acetate /Light petroleum (1:4) to 
yield 32 as a colourless solid (44 mg, 53%). 
 
3.2.10 ((1-(3,4,5-tris(Benzyloxy)phenyl)prop-2-yn-1-yl)oxy)-1,3-phenylene diacetate (31) 
 
Method A: 
A solution of the propargyl alcohol 24 (200 mg, 0.44 mmol) and of phenol 32 (100 mg, 0.48 
mmol) in anhydrous dichloromethane (6 mL) was added slowly into a solution of 
camphorsulfonic acid (0.44 g, 2 equiv.) in anhydrous dichloromethane under a nitrogen 
atmosphere. After 5 min, the reaction turned purple. The reaction was left to stir until it was 
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determined to have gone to completion by TLC. The reaction mixture was quenched by 
addition of water and transferred into a separating funnel containing saturated aqueous 
NaHCO3 (6 mL). The mixture was extracted with dichloromethane (2x10 mL). The combined 
organic layers were washed with a NaHCO3 solution, brine (5 mL) and dried using Na2SO4, 
filtered, and concentrated under reduced pressure. The resulting oil was purified by flash 
column chromatography on silica gel (ethyl acetate: toluene, 1:15) to give the title compound 
18 as a brown oil (97 mg, 16%) 
 
Method B: 
The propargyl alcohol 24 (174 mg, 0.39 mmol), triphenylphosphine (101 mg, 0.39 mmol,) 
and the phenol 32 (89 mg, 0.42 mmol) were dissolved in anhydrous tetrahydrofuran under 
argon atmosphere at 0 °C. Diethyl azodicarboxylate (0.060 mL, 67 mg, 0.386 mmol) was 
then added dropwise. The reaction was stirred overnight at 0 °C. After evaporation of the 
solvent, the residue was dissolved in diethyl ether. The organic layer was washed with water 
(8 mL), brine (10 mL), dried over anhydrous MgSO4 and the solvents evaporated under 
reduced pressure. Flash column chromatography on silica gel (ethyl acetate:toluene, 1:15) 
gave the desired compound as a brown oil (174 mg, 65%) 
νmax (neat)/cm
-1 
2929, 2379, 2114, 1714, 1262, 861; δH (500 MHz, CDCl3,): 2.25 (s, 6 H, 
C2H6-17,18), 2.66 (d, 1 H, J = 2.1 Hz, CH-15), 4.96 (s, 2 H, CH2-22), 5.00 (s, 4 H, C2H4-
20,21), 5.56 (d, 1 H, J = 2.1 Hz, CH-19), 6.64 (t, 1 H, J = 2.0 Hz, C2H2-6,4), 6.51 (d, 2 H, J = 
2.0 Hz, CH-2), 6.81 (s, 2 H, C2H4-14,10), 7.21-7.34 (m,15 H); δC (125 MHz, CDCl3): 21.0 
(C2H6-18,19), 70.5 (CH-6), 71.3 (CH2-22), 75.3 (C2H4), 77.9 (CH-6), 80.2 (C-7), 107.2 
(C2H4-14,10), 107.4 (C2H4-6,4), 109.2 (CH-2), 127.6, 127.9, 128.1, 128.3, 128.4, 128.6, 
132.2, 137.0 (Ph3C3H6O3Ph), 137.9 (C-9), 139.1 (C-12) 151.1 (C2-13,11), 153.0 (C2-1,3), 
159.0 (C-5), 168.9 (C2O2-19,18). 
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3.2.11 (((5-vinylbenzene-1,2,3-triyl)tris(oxy))tris(methylene))tribenzene (36) 
 
Ether 31 (200 mg, 0.311 mmol) was dissolved in freshly distilled toluene (20 mL) under 
argon atmosphere at room temperature and palladium diacetate (15 mg, 0.05 mmol) was 
added. The reaction was heated under reflux overnight. The progress of the reaction was 
monitored by TLC. The palladium diacetate was filtered off on a pad of silica/celite, the 
solvents were removed under reduced pressure and the residue was purified by column 
chromatography on silica gel (light petroleum ether:ethyl acetate 12:1), to furnish 36 as a 
colourless powder (174 mg, 10%). 
mp 111-113 °С; νmax (neat)/cm
-1 
3068, 2990, 1272, 755; δH (500 MHz; CDCl3) 4.99 (s, 2 H, 
CH2-10), 5.05 (s, 4 H, C2H4-9,10), 5.11 (dd, 1 H, J = 10.8, 0.7 Hz, CH2-8), 5.52 (dd, 1 H, J = 
17.5, 0.7 Hz, CH2-8), 6.50 (dd, 1 H, J = 17.5, 10.8 Hz, CH2-7), 6.53 (s, 2 H, ArH-2,6), 7.50 
(m, 15 H, BnH-9,10,11); δC (125 MHz, CDCl3) 71.4 (C2H4-10,12), 75.3 (CH2-11), 106.0 
(C2H2-2,6), 112.1 (CH2-8), 127.4, 127.8, 128.2, 128.5, 128.6, 128.8, 137.0, 
137.2(Ph3C3H6O3Ph), 137.9 (C-7), 138.2 (C-4), 142.5 (C-1), 152.5 (C2-3,5); m/z found for 
[M+NH4]
+
: 440.2216; [C50H42O6+NH4]
+
 requires: 440.2216. 
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3.2.12 1-(2,4-bis(Benzyloxy)-6-hydroxyphenyl)ethanone (43)
 4
 
 
Method A 
2,4,6-Trihydroxyacetophenone 42 (1.00 g, 5.96 mmol) was dissolved in dimethylformamide 
and anhydrous K2CO3 (1.64 g, 11.86 mmol) was added. The mixture was stirred for 10 
minutes and benzyl bromide (1.41 mL, 11.86 mmol) was then added slowly. The reaction 
was heated for 1 hour at 80-85 °C. It was allowed to reach room temperature and the K2CO3 
was filtered. The solvent was removed under reduced pressure and the residue was dissolved 
in dichloromethane (20 mL). The organic layer was washed with water (20 mL), diluted 
aqueous HCl (1M, 10 mL), brine (5 mL) and dried over anhydrous MgSO4. The solvents 
were removed under reduced pressure and the residue was purified by silica gel flash 
chromatography (ethyl acetate/light petroleum ether 1:9) to afford the desired product 43 as a 
yellow solid (0.91 g, 46%). 
Rf= 0.25; mp 198-200 °C; νmax (neat)/cm
-1 
3450, 2836, 1731, 1246, 848; δH (400 MHz, 
CDCl3): 2.55 (s, 3 H, CH3CO-8), 5.01 (s, 2 H, CH2-9), 5.03 (s, 2 H, CH2-10), 6.09 (d, 1 H, 
J= 2.3 Hz, Ar-H-3), 6.16 (d, 1 H, J = 2.3 Hz, ArH-5), 7.34-7.41 (m, 10 H, Ph2CH2O2-2,4); δC 
(100 MHz, CDCl3): 33.6 (CH3-8), 70.4 (CH2O-9), 71.3 (CH2O-10), 92.7 (CH-3), 94.9 (CH-
5), 106.5 (C-1), 127.9, 128.2, 128.6, 128.7, 128.98, 129.05, 135.8, 136.1, (Ph2C2H6O2Ph), 
162.2 (C-4), 165.3 (C-2), 167.8 (COH-6), 203.4 (C-7); m/z found for [M+H]
+
: 349.1435; 
[C22H20O6+ H]
+
: requires 349.1434 
 
Method B 
2,4,6-Trihydroxyacetophenone (300 mg, 1.78 mmol) was dissolved in tetrahydrofuran in an 
oven-dried round-bottomed flask under argon. The solution was cooled to −78 °C in a dry 
ice/acetone bath. n-Butyllithium (2.5 M, 1.5 mL, 3.5 mmol,) was added dropwise over 10 
min directly into the solution. The reaction was stirred for 1 hour at −78 °C and benzyl 
bromide (0.42 mL, 0.61 g, 3.5 mmol) was slowly added. The reaction mixture was then 
allowed to reach to room temperature and was stirred overnight under argon. The reaction 
mixture was then cooled to −78 °C and a saturated aqueous ammonium chloride solution (5 
mL) was added dropwise using a syringe. The solvents were removed under reduced 
pressure. The residue was dissolved in dichloromethane (3×10 mL), washed with dilute 
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aqueous HCl (1M, 5ml), and dried over anhydrous MgSO4. The resulting compound was 
purified using flash column chromatography on silica-gel (ethyl acetate -light petroleum ether 
1:3) to give the compound 43 as a colourless solid (347 mg, 46%). 
 
3.2.13 1-(2,4,6-tris(Benzyloxy)phenyl)ethanone (44)
 4 
 
2,4,6-Trihydroxyacetophenone 42 (0.50 g, 2.97 mmol) was dissolved in anhydrous 
dimethylformamide (17 mL). Anhydrous K2CO3 (1.84 g, 17. 8 mmol) and benzyl bromide 
(2.11 mL, 17.8 mmol) were added to the mixture. The reaction was heated at 100 °C for 18h, 
and then allowed to cool to room temperature. The dimethylformamide was removed under 
reduced pressure and the oily residue was extracted using ethyl acetate (2×20 mL), the 
organic layers were combined, washed with dilute aqueous HCl (2M, 5 mL), brine and dried 
over anhydrous MgSO4. The solvents were removed under reduced pressure and the residue 
was purified by column chromatography on silica gel (ethyl acetate : petroleum ether, 1:6) to 
afford the desired compound as a yellow liquid (1.17 g, 90%). 
mp 207-209
 °C; νmax (neat)/cm
-1 
2853, 1721, 1248, 740; δH (400 MHz; CDCl3) 2.40 (s, 3 H, 
CH3-8), 4.96 (s, 2 H, CH2-9), 5.01 (s, 4 H, C2H4-10,11), 6.20 (s, 2 H, ArH-3,5), 6.65 (m, 15 
H, Ph3C3H6O); δC (100 MHz; CDCl3) 32.8 (CH3-8), 70.5 (CH2-9), 70.8 (C2H4-11,10), 93.6 
(CH2-3,5), 115.2 (C-1), 127.3, 127.7, 128.2, 128.4, 128.8, 128.9, 136.6, 136.7, 
(Ph3C3H6O3Ph) 157.4 (C2-2,6), 161.3 (C-4), 201.8 (CO-7). 
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3.2.14 1-(3-benzyl-4,6-bis(Benzyloxy)-2-hydroxyphenyl)ethanone (45)
 7 
2,4,6-tris(Benzyloxy)phenyl)ethanone 44 (500 mg, 1.14 mmol) was treated with titanium(IV) 
chloride (0.087 ml, 151 mg) in freshly distilled dichloromethane at 0 ˚C. After 155 min of 
stirring, the mixture was slowly poured into a separating funnel containing aqueous saturated 
NaHCO3. The organic layer was separated and washed with water and brine, dried anhydrous 
Mg2SO4 and concentrated under reduced pressure. The residue was crystallized from ether, 
and the mother liquor was purified by column chromatography on silica gel, using ethyl 
acetate/light petroleum (1:4) providing 43 (202 mg, 51%), and by-product 45 (39 mg, 8%). 
Compound 45:  
mp 214-216
 °C; νmax (neat)/cm
-1 
3454, 2953, 1738, 1248, 818; δH (400 MHz, CDCl3): 2.47 (s, 
3 H, CH3CO-9), 3.98 (s, 2 H, CH2-10), 5.03 (s, 2 H, CH2-11), 5.07 (s, 2 H, CH2-12), 6.05 (s, 
1 H, CH2-3), 7.26-7.45 (m, 15 H). 
 
3.2.15 (2E)-1-[2,4-Bis(Benzyloxy)-6-hydroxyphenyl]-3-[3,4,5-tris(benzyloxy)phenyl]-2-
propen-1-one (46)
 4
 
Compound 43 (370 mg, 1.06 mmol) was dissolved in dimethylformamide and NaH (38 mg, 
1.6 mmol) was added. A solution of 3,4,5-tris(benzyloxy)benzaldehyde 32 (539 mg, 1.2 
mmol) in dimethylformamide was then added dropwise over a 15 min period, and the 
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reaction stirred for a further 6 h at room temperature. Water (5 mL) was then added to quench 
any unreacted NaH, followed by removal of the solvents under reduced pressure. The 
resulting residue was dissolved in 20 mL of dichloromethane and washed with water (10 
mL), dilute aqueous HCl (1M, 5 mL), and brine. The organic layer was dried over anhydrous 
MgSO4 and evaporated. The residue was crystallized from ether to give 46 as a yellow solid 
(440 mg, 55%). 
m.p. 234-236 °С; νmax (neat)/cm
-1 
3130, 1668, 1235, 1004, 937; (400 MHz, CDCl3): 4.84 (s, 4 
H, CH2-20,21), 5.12 (s, 2 H, CH2-18), 5.14 (s, 4 H, CH2-17,19), 6.18 (d, 1 H, J = 2.4 Hz, 
CH-2), 6.25 (d, 1 H, J = 2.4 Hz, CH-6), 6.60 (s, 2 H, CH2-12,16), 7.26-7.46 (m, 25 H, 
Ph5CH5O5-17,18,19,20,21), 7.66 (d, 1 H, J = 15.7 Hz, CH-9), 7.78 (d, 1 H, J = 15.7 Hz, CH-
10); δC (100 MHz, CDCl3): 71.0 (CH2O-18), 71.3 (C2H4O-17,19), 75.2 (C2H2-20,21), 93.0 
(CH-2), 95.1 (CH-6), 108.9 (C2H2-12,16), 110.0 (C-4), 125.3 (CH-9), 127.1, 127.2, 127.3, 
127.4, 128.1, 128.2, 128.28, 128.32, 128.4, 128.6, 128.88, 130.77, (Ph5C5H10O5Ph), 131.8, 
(C-11), 136.8 (C-1), 137.3 (C-3), 140.3 (CH-10), 152.9 (C-14), 153.3 (C-13,15), 168.2 
(COH-5), 191.0 (C=O). 
 
3.2.15 5,7-Bis(Benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]-2H-chromene (28)
 4 
Chalcone 46 (280 mg, 0.379 mmol) was dissolved in a mixture of tetrahydrofuran:methanol 
(2:1) at 0 ˚C and sodium borohydride (0.568 mmol, 21 mg) was added. The reaction was 
stirred over period of time (6 h) and then heated at 70 ˚C under a nitrogen atmosphere for 20 
h, monitored by TLC until complete conversion of the starting material was observed. The 
solution was cooled and evaporated under reduced pressure. The residue was dissolved in 
dichloromethane and washed with water and brine. The organic layer was dried over 
anhydrous Na2SO4, the solvents removed under pressure and the residue was purified by 
silica gel flash column chromatography using ethyl acetate / petroleum ether (1:9) giving the 
desired compound as a colourless solid (38 mg, Rf 0.16, 14%). 
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m.p. 195-196 °С; νmax (neat)/cm
-1 
2972, 2876, 2043, 1964, 1138, 840, 661; δH (300 MHz, 
CDCl3): 5.00 (s, 2 H, CH2-19), 5.05 (s, 2 H, CH2-20), 5.07 (s, 2 H, CH2-21), 5.10 (s, 4 H, 
C2H2-17,18), 5.55 (dd, 1 H, J = 10.0, 3.0 Hz, CH-9), 5.74 (dd, 1 H, J = 3.0, 2.0 Hz, CH-8), 
6.14 (d, 1 H, J = 2.0 Hz, CH-2), 6.24 (d, 1 H, J = 2.0 Hz, CH-6), 6.80 (s, 2 H, C2H2-12,16), 
6.90 (dd, 1 H, J = 10.0, 2.0 Hz, CH-10), 7.26-7.46 (m, 25 H, Ph5CH5O5); δC (75 MHz, 
CDCl3): 70.1 (PhCH2O-21), 70.2 (PhCH2O-20), 71.1 (Ph2C2H4O-17,18), 75.2 (PhCH2O-19), 
77.3 (CH-8), 93.9 (CH-2), 95.0 (CH-6), 104.9 (C2H2-12,16), 107.0 (C-4), 119.1 (CH-10), 
119.9 (CH-9), 127.4, 127.6, 127.8, 127.9, 128.07, 128.14, 128.22, 128.23, 128.57, 130.5 
136.7, 137.6, (Ph5C5H10O5Ph), 138.0, (C-11), 138.6 (C-5), 153.0 (C-13,15), 155.0 (C-14), 
155.5 (C-3), 160.5 (C-1); m/z found for [M+NH4]
+
: 756.3319; [C50H42O6+NH4]
+
 requires: 
756.3320. 
 
3.2.16 1-(2-hydroxy-4,6-bis((2-methoxyethoxy)methoxy)phenyl)ethanone (53)
8
 
 
Method A:  
2,4,6-Trihydroxyacetophenone monohydrate (600 mg, 3.5 mmol) was dissolved in anhydrous 
dichloromethane (15 mL) under a nitrogen atmosphere. The solution was cooled to 0 ˚C and 
diisopropylamine (1 mL, 8.4 mmol) was added. 2-Methoxyethoxymethyl chloride (1.7 mL, 
9.8 mmol) was added into the mixture. The solution was stirred at 0 ˚C for the indicated time 
(16 h), and then left to stir at room temperature overnight. Water (10 mL) was then added and 
the aqueous layer was extracted with ethyl acetate (3×20 mL) and washed with dilute 
aqueous HCl (1M, 1mL). The combined organic layers were washed with water (3×10 mL) 
and brine (10 mL) and dried over anhydrous MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel 
(petroleum ether / ethyl acetate, 2:1) to give 53 as a colourless oily product (417 mg, 43%). 
 
Method B: 
2,4,6-Trihydroxyacetophenone monohydrate (850 mg, 5.0 mmol) and N,N-
diisopropylethylamine (2.6 mL, 15 mmol) were dissolved in anhydrous dichloromethane (20 
mL) under an atmosphere of argon and the reaction mixture was cooled to 0 ˚C. 2-
Methoxyethoxymethyl chloride (1.3 mL, 12 mmol) was then added dropwise. The yellow 
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mixture was stirred at 0 ˚C over 60 min and then was allowed to stir overnight at room 
temperature. The solution was quenched with water (10 mL) and washed with dilute aqueous 
HCl (1M, 1mL). The aqueous layers were extracted with ethyl acetate (3x25 mL); the 
combined organic extracts were dried over anhydrous Na2SO4, and evaporated under reduced 
pressure. The residue was purified through column chromatography on silica gel (ether 
petroleum / ethyl acetate, 2:1), to give the desired compound as a colourless oil (1.56 g, 
90%). 
νmax (neat)/cm
-1 
3289, 2946, 1578, 1441,1167, 889; δH (500 MHz, CDCl3): 2.55 (s, 3 H, CH-
8), 3.29 (s, 3 H, CH-13), 3.31 (s, 3 H, CH2-17), 3.47 (t, 2 H, J = 4.4 Hz, CH-12), 3.50 (t, 2 H, 
J = 4.2 Hz, CH-16), 3.72 (t, 2 H, J = 4.4 Hz, CH-11), 3.76 (t, 2 H, J = 4.2 Hz, CH-15), 5.18 
(s, 2 H, CH-10), 5.26 (s, 2 H, CH-14), 6.18 (d, 2 H, J = 2.3 Hz, CH-5), 6.19 (d, 2 H, J = 2.3 
Hz, CH-3), 13.62 (s, 1 H, COH-2); δC (125 MHz, CDCl3): 32.4 (CH3-8), 54.1 (CH3-13), 58.0 
(CH3-17), 66.5 (CH2-15), 67.2 (CH2-11), 68.2 (CH2-16), 68.6 (CH2-12), 71.4 (CH2-14), 71.7 
(CH2-10), 95.2 (CH-5), 96.7 (CH-3), 106.6 (C-1), 160.7 (C-6), 163.7 (C-4), 166.7 (C-2), 
203.3 (CO-7). 
 
3.2.17 (E)-1-(2-hydroxy-4,6-bis((2-methoxyethoxy)methoxy)phenyl)-3-(3,4,5-
tris(benzyloxy)phenyl)prop-2-en-1-one (54) 
Compound 53 (750 mg, 2.17 mmol) was dissolved in anhydrous dimethylformamide. NaH 
(104 mg, 4.35 mmol) was then added. A solution of 3,4,5-tris(benzyloxy)benzaldehyde 23 
(1.1 g, 2.60 mmol) in dimethylformamide was then added dropwise. The reaction mixture 
was then stirred overnight at room temperature. Water (5 mL) was used to quench any 
unreacted NaH, followed by the removal of the solvents under reduced pressure. The 
resulting residue was dissolved in ether (20 mL) and washed with water (10 mL), dilute 
aqueous HCl (1M, 1mL), and brine. The organic layer was dried over anhydrous MgSO4 and 
the solvents were removed under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (toluene/ethyl acetate, 3:1) to give 39 (1.14 g, 70%) as a pale 
yellow solid. 
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m.p. 145-147°С; νmax (neat)/cm
-1 
3626, 2851, 1992, 1713, 1026, 843; δH (500 MHz, CDCl3): 
3.20 (s, 3 H, CH-15), 3.31 (s, 3 H, CH-10), 3.41 (t, 2 H, J = 4.2 Hz, CH-14), 3.50 (t, 2 H, J = 
4.4 Hz, CH-9), 3.71(t, 2 H, J = 4.2 Hz, CH-13), 3.77 (t, 2 H, J = 4.4 Hz, CH-8), 5.04 (s, 2 H, 
CH-26), 5.07 (s, 4 H, CH-22,25), 5.20 (s, 2 H, CH-12), 5.22 (s, 2 H, CH-7), 6.19 (d, 2 H, J = 
2.3 Hz, CH-1), 6.26 (d, 2 H, J = 2.3 Hz, CH-3), 6.83 (s, 2 H, CH-20,24), 7.31 (m, 15 H, 
ArH), 7.56 (d, 1 H, J = 15.5 Hz, CH-17), 7.66 (d, 1 H, J = 15.4 Hz, CH-18), 13.67 (s, 1 H, 
COH-6); δC (125 MHz, CDCl3,): 59.0 (CH3-15), 59.1 (CH3-10), 68.3 (CH2-14), 68.8 (CH2-9), 
71.3 (CH2-26), 71.5 (CH2-22,25), 75.3 (CH2-8) 77.0 (CH2-13), 93.1 (CH-12), 94.3 (CH-7), 
95.0 (CH-3), 97.6 (CH-1), 106.6 (CH-20,24), 107.6 (CH-5), 126.70 (CH-17), 126.75 (C-19), 
127.4, 127.97, 128.05, 128.2, 128.58, 128.61, 130.99, 131.00 (Ph3C3H6O3Ph), 136.8 (CH-
18), 142.3(CH-22), 153.1 (C-23,21), 159.8 (C-6), 163.5 (C-4), 167.2 (C-2), 192.7 (C=O); m/z 
found for [M+H]
+
: 751.3110; [C44H46O11+H]
+
 requires: 751.3113.  
 
3.2.18 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethanone (57).
9 
 
2,4,6-Trihydroxyacetophenone (400 mg, 2.37 mmol) and K2CO3 (690 mg, 4.99 mmol) were 
dissolved in acetone (12 ml). The mixture was heated under reflux for 1 h under a nitrogen 
atmosphere. The reaction mixture was allowed to reach room temperature. Dimethylsulfate 
(0.33 mL, 448 mg, 3.55 mmol) was added and the solution stirred under a nitrogen 
atmosphere at 65 °С overnight. The solvents were evaporated under reduced pressure. The 
residue was dissolved in dichloromethane and washed using a saturated solution of NaHCO3 
and brine. The organic layer was dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The residue was subjected to column chromatography on silica gel 
using petroleum ether /ethyl acetate (4:1) to afford 57 as a colourless solid (420 mg, 90%). 
m.p. 96-97 °C; νmax (neat)/cm
-1 
3453, 2951, 1731,1246, 1105, 831; δH (500 MHz, CDCl3): 
2.61 (s, 3 H, CH3-8), 3.82 (s, 3 H, CH3-9), 3.85 (s, 3 H, CH3-10), 5.93 (d, 1 H, J = 2.3 Hz, 
ArH-3), 6.06 (d, 1 H, J = 2.3 Hz, ArH-5), 14.06 (s, 1 H, OH-6); δC (125 MHz, CDCl3): 33.0 
(CH3-8), 55.6 (C2H6-9,10), 90.5 (CH-5), 93.5 (CH-3), 105.9 (C-1), 162.9 (C-2), 166.0 (C-4), 
167.7 (C-6), 203.1 (CO-7). 
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3.2.19 (2E)-1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-
one (59)
 10
 
 
Acetophenone 57 (720 mg, 3.68 mmol) and 3,4,5-trimethoxybenzaldehyde (930 mg, 4.78 
mmol) were dissolved in ethanol (3 mL). The solution was heated at 80 °С and aqueous KOH 
(1 g KOH/10 mL EtOH) was added slowly. The reaction turned into a clear red solution and 
was left to stir at room temperature overnight. The mixture was acidified with concentrated 
dilute aqueous HCl (1M, 7mL) in an ice bath and the resulting precipitate filtered off, washed 
with cold water and cold ethanol. The yellow solid was purified by recrystallization with 
ethanol to yield chalcone 59 (1.27 g, 93%). 
m.p. 201-203 °С; νmax (neat)/cm
-1 
3350, 3053, 2836, 1733, 1247, 739; δH (500 MHz, CDCl3): 
3.88 (s, 3 H, CH3-19), 3.95 (m, 12 H, C4H12-16,17,18,20), 6.00 (d, 1 H, J = 2.0 Hz, ArH-6), 
6.15 (d, 1 H, J = 2.0 Hz, ArH-2), 6.88 (s, 2 H, ArH-11,15), 7.74 (d, 1 H, J = 15.5 Hz, CH-8), 
7.84 (d, 1 H, J = 15.5 Hz, CH-9), 14.36 (s, 1 H, OH-5); δC (125 MHz, CDCl3): 55.6 (CH3-
19), 55.8 (CH3-18), 56.2 (C2H6-16.17), 61.0 (CH3-20), 91.5 (CH-6), 93.9 (CH-2), 105.6 
(C2H2-11,15), 106.3 (C-4), 126.9 (CH-8), 131.2 (C-10), 140.1 (CH-9), 142.4 (C-5), 154.4 
(C2-14,16), 162.4 (C-13), 166.3 (C-3), 168.5 (C-1), 192.4 (CO-7).  
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3.2.20 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-2H-chromene (60)
 10
 
 
Chalcone 59 (160 mg, 0.427 mmol) was dissolved in a mixture of anhydrous tetrahydrofuran 
and ethanol (10 mL). Sodium borohydride (64 mg, 1.7 mmol) was added and the mixture was 
then heated at 80 °C for 1 h. The reaction was then heated at 50 °C overnight. Dilute aqueous 
HCl (2M, 30 mL) was added and the resulting solution was allowed to stir for 30 min. The 
yellow mixture turned purple. The solvent was removed and the residue dissolved in ethyl 
acetate (50 mL), the organic phase was washed with brine (30 mL), dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The crude residue was then purified by 
column chromatography on silica gel (petroleum ether-ethyl acetate 5:1) to furnish 60 as a 
colourless powder (30 mg, 20%). 
m.p. 178-180 °С; νmax (neat)/cm
-1 
3054, 2987, 2126, 1265,739; δH (500 MHz, CDCl3): 3.77 
(s, 3 H, CH3-20), 3.95 (s, 3 H, CH3-19), 3.87 (s, 3 H, CH3-18), 3.88 (s, 6 H, C2H6-16,17), 
5.61 (dd, 1 H, J = 9.9, 3.2 Hz, CH-8), 5.78 (dd, 1 H, J = 3.2, 2.0 Hz, CH-9), 6.07 (d, 1 H, J = 
2.3 Hz, ArH-2), 6.10 (d, 1 H, J = 2.3 Hz, ArH-6), 6.73 (s, 2 H, ArH-11,15), 6.84 (dd, 1 H, J 
= 9.9, 2.0 Hz, CH-7), δC (125 MHz, CDCl3): 55.4 (CH3-20), 55.6 (CH3-19), 56.1 (C2H6-
16.17), 60.8 (CH3-18), 77.5 (CH-9), 91.9 (CH-2), 93.7 (CH-6), 104.3 (C2H2-11,15), 104.4 (C-
4), 119.2 (CH-8), 119.7 (CH-7), 136.6 (C-10), 137.9 (C-5), 153.4 (C2-14,12), 154.9 (C-13), 
156.4 (C-3), 161.3 (C-1). 
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3.2.21 1-(2,4-Bis[dimethyl(2-methyl-2-propanyl)silyl]oxy}-6-hydroxyphenyl)ethanone 
(62)
 11
 
 
2,4,6-Trihydroxyacetophenone (300 mg, 1.78 mmol) was dissolved in anhydrous 
dichloromethane under a nitrogen atmosphere at room temperature. Triethylamine (0.75 mL, 
5.34 mmol) and 4-dimethylaminopyridine (20 mg, 0.17 mmol) were added slowly. The 
mixture was stirred for 20 min and turned into a clear yellow solution. tert-
Butylchlorodimethylsilane (600 mg, 3.9 mmol) was added. The reaction was stirred for 18 h 
at room temperature. The reaction was quenched with water (5 mL). The organic layer was 
washed with water (20 mL) and brine (5 mL), dried over anhydrous MgSO4. The solvents 
were removed under reduced pressure and the residue was purified by silica gel flash 
chromatography using ethyl acetate/toluene (1/10) to furnish the desired product as a 
colourless oil (636 mg, 90%). 
 m.p. 156 °C; νmax (neat)/cm
-1 
3453, 2933, 1739, 1248, 1197, 985; δH (500 MHz, CDCl3): 
0.01 (s, 6 H, SiC2H6-11,12), 0.12 (s, 6 H, SiC2H6-9,10), 0.74 (s, 9 H, C3H9-18,19,20), 0.74 (s, 
9 H, C3H9-15,16,17), 2.40 (s, 3 H, CH3-8), 5.62 (d, 1 H, J = 2.3 Hz, ArH-3), 5.80 (d, 1 H, J = 
2.3 Hz, ArH-5), 13.31 (s, 1 H, OH-5) δC (125 MHz, CDCl3): -4.3 (SiC2H6-11,12), -3.5 
(SiC2H6-9,10), 18.3 (C-14), 18.9 (C-13), 25.5 (SiC3H9-18,19,20), 26.1 (SiC3H9-15,16,17), 
32.9 (CH3-8), 101.8 (CH-5), 102.7 (CH-3), 109.0 (C-1), 159.5 (C-2), 162.4 (C-4), 166.4 (C-
6), 203.4 (CO-10). 
 
 
 
  
141 
 
3.2.22 (E)-1-(2,4-bis((tert-butyldimethylsilyl)oxy)-6-hydroxyphenyl)-3-(3,4,5-
trimethoxyphenyl)prop-2-en-1-one (63) 
 
1-(2,4-bis((tert-Butyldimethylsilyl)oxy)-6-hydroxyphenyl)ethanone 62 (250 mg ,0.63 mmol) 
and 3,4,5-trimethoxybenzaldehyde (185 mg, 0.94 mmol) were dissolved in anhydrous 
tetrahydrofuran at 0 ˚C. NaH (12 mg, 0.50 mmol) was then added and the reaction mixture 
stirred for 50 minutes at room temperature. The mixture was diluted with water, and extracted 
with dichloromethane (20 mL ×3). The organic layer was successively washed with water 
and brine, dried over anhydrous Na2SO4, and evaporated under reduced pressure. The residue 
was purified by silica gel column chromatography (petroleum ether / ethyl acetate, 8:1) to 
give yellow solid 63 (76 mg, 21%). 
m.p. 113-115 °С; νmax (neat)/cm
-1 3298, 2957,1646, 1604, 1318, 1143, 1091, 996; δH (500 
MHz, CDCl3): 0.01 (s, 6H, SiC2H6-21,22), 0.12 (s, 6H, SiC2H6-19,20), 0.71 (s, 9H, C3H9-
25,27,26), 0.76 (s, 9H, C3H9-28,29,30), 3.67 (s, 6H, C2H6-16,17), 3.68 (s, 3H, CH3-18), 5.67 
(d, 1H, J = 2.30 Hz, ArH-6), 5.88 (d, 1H, J = 2.30 Hz, ArH-2), 6.61 (s, 2H, ArH-11,15), 7.41 
(d, 1H, J = 15.60 Hz, CH-8), 7.51 (d, 1H, J = 15.60 Hz, CH-9), 12.31 (s, 1H, OH-5) δC (125 
MHz, CDCl3): - 4.7 (SiC2H6-22,21), - 3.7 (SiC2H6-19,20), 18.2 (C-24), 18.6 (C-23), 25.5 
(SiC3H9-25,26,27), 25.9 (SiC3H9-28,29,30), 56.1 (C2H6-16.17), 61.00 (CH3-18), 102.2 (CH-
6), 104.1 (CH-2), 105.8 (C2H2-11,15), 110.5 (C-4), 126.5 (CH-8), 130.7 (C-10), 140.1 (CH-
9), 142.7 (C-13), 153.3 (C2-14,16), 158.6 (C-3), 162.4 (C-1), 165.7 (C-5), 192.4 (CO-7); m/z 
found for [M+H]
+
: 575.2850; [C30H46O7Si2+H]
+
 requires: 575.2855.  
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3.2.23 ((2-(3,4,5-trimethoxyphenyl)-2H-chromene-5,7-diyl)bis(oxy))bis(tert-
butyldimethylsilane) (66) 
 
A suspension of chalcone 63 (140 mg, 0.258 mmol) in a mixture of anhydrous 
tetrahydrofuran and ethanol (2/1: 10 mL) was heated at 90 °C for 5 min. Sodium borohydride 
(30 mg, 0.77 mmol) was added and the mixture was then heated at 90 °C for 10 min. a 
reaction was quenched with 30 mL of water and left to stir for 10 minute. After dilution with 
ethyl acetate (50 mL), the organic phase was washed with brine (30 mL), dried over 
anhydrous Na2SO4 and evaporated. The crude residue was then purified by column 
chromatography, eluting with petroleum ether-dichloromethane (3:1), to furnish 63 as a beige 
powder (14 mg, 10%). 
mp 98-101 °С; νmax (neat)/cm
-1 
2963, 2100, 1325, 1126, 1067, 1030, 818; δH (500 MHz, 
CDCl3): 0.01 (s, 6H, SiC2H6-21,22), 0.048 (s, 3H, CH3-20), 0.050 (s, 3H, CH3-19), 0.77 (s, 
9H, C3H9-25,27,26), 0.83 (s, 9H, C3H9-28,29,30), 3.65 (s, 3H, CH3-18), 3.66 (s, 6H, C2H6-
16,17), 5.41 (dd, 1H, J = 9.9, 3.2 Hz, CH-8), 5.54 (m, 1H, CH-9), 5.74 (d, 1H, J = 2.2 Hz, 
ArH-2), 5.85 (d, 1H, J = 2.2 Hz, ArH-6), 6.50 (s, 2H, ArH-11,15), 6.58 (dd, 1H, J = 9.9, 1.6 
Hz, CH-7), δC (125 MHz, CDCl3): - 4.3 (SiC2H6-22,21), - 4.26 (SiCH3-20), - 4.23 (SiCH3-
19), 18.2 (C-24), 18.3 (C-23), 25.6 (SiC3H9-25,26,27), 25.7 (SiC3H9-28,29,30), 56.0 (C2H6-
16.17), 60.7 (CH3-18), 77.3 (CH-9), 101.9 (CH-6), 104.2 (CH-2), 104.6 (C2H2-11,15), 10.94 
(C-4), 119.7 (CH-7), 120.3 (CH-8), 136.6 (C-10), 137.9 (C-5), 152.2 (C2-14,16), 153.3 (C-
13), 154.8 (C-3), 156.82 (C-1).  
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3.2.24 5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)chroman-4-one (68) 
 
Chalcone 63 (130 mg, 2.26 mmol) was dissolved in a mixture of methanol (6 mL) and 
tetrahydrofuran (6 mL) at room temperature. Hydrogen bromide (48% in H2O, 3 mL) was 
then added. The reaction was heated under reflux for 16 h. The organic solvents were 
evaporated under reduced pressure. The aqueous mixture was extracted with ethyl acetate 
(2x60 mL). The organic layer was washed with water (2x10 mL), dried over anhydrous 
Na2SO4, and concentrated under reduced pressure. The residue was flash chromatographed 
over a silica gel column, with ethyl acetate /petroleum ether (5:1) as eluent to afford the 
desired product (76 mg, 97%). 
mp 263-265 °С; νmax (neat)/cm
-1 
3583, 3054, 1711, 915; δH (500 MHz, DMSO-d6): 2.71 (dd, 
1 H, J = 17.1, 2.9 Hz, CH2-8), 3.03 (dd, 1 H, J = 17.1, 13.1 Hz, CH2-8), 3.75 (s, 3 H, CH3-
18), 3.83 (s, 6 H, C2H6-16,17), 5.29 (dd, 1 H, J = 13.0, 2.9 Hz, CH-9), 5.28 (d, 1 H, J = 2.7 
Hz, CH-6), 5.30 (d, 1 H, J = 2.7 Hz, CH-2), 6.66 (s, 2 H, ArH-11,15), 10.30 (s, 1 H, OH-1), 
11.99 (s, 1 H, OH-3), δC (125 MHz, DMSO-d6): 43.4 (CH2-8), 56.2 (C2H6-16.17), 60.6 (CH3-
18), 79.2 (CH-9), 95.6 (CH-6), 96.7 (CH-2), 102.2 (C-4), 103.5 (C2H2-11,15), 134.4 (C-10), 
137.9 (C-5), 153.4 (C2-14,16), 162.8 (C-13), 164.1 (C-3), 167.1 (C-1) 195.3 (CO-7); m/z 
found for [M+H]
+
: 347.1127; [C18H18O7 +H]
+
 requires: 347.1125. 
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3.2.25 General procedure of demethylation for 5,7-dimethoxy-2-(3,4,5-
trimethoxyphenyl)-2H-chromene. (61)  
 
Compound 60 (400 mg, 1.11 mmol) was dissolved in anhydrous dichloromethane (10 mL) 
under argon. The solution was cooled to −78 °C. Boron tribromide (1M solution in 
dichloromethane, 0.6 mL, 3.34 mmol) was added dropwise using a syringe at −78 °C. The 
reaction mixture was allowed to stir for 1h at −78 °C. The reaction was then allowed to reach 
room temperature and left to stir overnight. Water (5 mL) was then added. The mixture was 
extracted with ethyl acetate (2x20 mL); the organic layers were combined and washed with 
water (2x10 mL), dried over anhydrous Na2SO4, and then concentrated under reduced 
pressure.  
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3.2.26 2-acetylbenzene-1,3,5-triyl tris(4-methylbenzenesulfonate) (71) 
 
2,4,6-Trihydroxyacetophenone (1.0 g, 5.94 mmol) and K2CO3 (1.8 g, 13 mmol) were 
suspended in acetone. 4-Toluenesulfonyl chloride (3.4 g, 18 mmol) was then added to the 
reaction mixture. The mixture was heated under reflux for 24h under a nitrogen atmosphere. 
The reaction was allowed to reach room temperature and the solvent was evaporated under 
reduced pressure. Water was added and the resulting mixture was extracted with 
dichloromethane. The organic layer was washed with water (100 mL), dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The residue was subjected to 
column chromatography on silica gel using petroleum ether/ethyl acetate (2:1) to afford 
compound 71 as a colourless solid (3.56 g, 95%). 
m.p. 214-216 °C; νmax (neat)/cm
-1 
2979, 1707, 1368, 1144, 911, 848; δH (500 MHz, CDCl3): 
2.23 (s, 3 H, CH3-8), 2.41 (s, 9 H, CH3-9,10,11), 6.85 (s, 2 H, ArH-3,5), 7.30 (d, 4 H, J = 7.5 
Hz, CH2-14,15,22,23), 7.35 (d, 2 H, J = 7.0 Hz, CH2-18,19), 7.58 (d, 4 H, J = 7.5 Hz, CH2-
12,13,20,21), 7.66 (d, 2 H, J = 7.0 Hz, CH2-17,16), δC (125 MHz, CDCl3): 21.7 (C3H9-
9,10,11), 31.5 (CH3-8), 116.1 (C2H2-3,5), 128.3 (C4H4-12,13,20,21), 129.0 (C2H2-16,17), 
130.22 (C4H414,15,22,23), 130.29 (C2H2-18,19), 131.1 (C-28), 131.2 (C2-27,29), 146.3 (C2-
24,26), 146.6 (C-25), 146.7 (C2-2,6), 149.9 (C-4), 195.0 (CO-7). 
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3.2.27 (E)-5-hydroxy-4-(3-(3,4,5-trimethoxyphenyl)acryloyl)-1,3-phenylene 
bis(4-methylbenzenesulfonate) (72) 
 
Compound 71 (1.00 g, 1.58 mmol) and 3,4,5-trimethoxybenzaldehyde (0.62 g, 3.17 mmol) 
were dissolved in anhydrous tetrahydrofuran under an argon atmosphere. NaH (0.08 mg, 3.16 
mmol) was added in 2 times at room temperature. The reaction was stirred overnight at room 
temperature. Water (5 mL) was added into the reaction. The residue was dissolved in 
dichloromethane (3x20 mL). The combined organic layers were washed with brine (20 mL), 
dried over anhydrous Na2SO4, and evaporated under reduced pressure. The residue was 
purified by silica gel column chromatography (petroleum ether/ethyl acetate, 1:1) to give 72 
as a yellow oil (228 mg, 22%). 
νmax (neat)/cm
-1 
3293, 1607, 1471, 1276, 1140, 869; δH (500 MHz, CDCl3): 3.39 (s, 3 H, 
CH3-29), 3.45 (s, 3 H, CH3-28), 3.91 (s, 6 H, CH3-15-17), 3.92 (s, 3 H, C2H6-16), 6.48 (d, 1 
H, J = 2.4 Hz, ArH-3), 6.51 (d, 1 H, J = 2.4 Hz, ArH-5), 6.89 (s, 2 H, ArH-11,12), 7.20 (d, 2 
H, J = 8.4 Hz, CH2-22-23), 7.35 (d, 2 H, J = 8.4 Hz, CH2-18-19), 7.57 (d, 2 H, J = 8.7 Hz, 
CH2-24-25), 7.61 (s, 1 H, CH-8), 7.70 (s, 1 H, CH-9), 7.73 (d, 2 H, J = 8.7 Hz, CH2-20-21), 
12.97 (s, 1 H, OH-6), δC (125 MHz, CDCl3): 21.71 (CH3-28), 21.74 (CH3-29), 56.2 (C2H6-
15,17), 61.0 (CH3-16), 106.1 (C2H2-11,12), 108.2 (CH-5), 110.5 (CH-3), 114.2 (C-1), 124.4 
(CH-8), 128.4 (C2H2-24-25), 128.6 (C2H2-22-23), 130.0 (C2H2-20,21), 130.1 (C2H2-18-19), 
131.0 (C-27), 131.8 (C-31), 140.0 (C-26), 146.1 (C-35), 146.2 (C-4), 146.6 (C-2), 149.9 (CH-
9), 153.4 (C2-13,14), 153.5 (C-30), 164.5 (C-6), 191.8 (C-7); m/z found for [M+H]
+
: 
655.1299; [C32H30O11S2+H]
+
 requires: 655.1302. 
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3.2.28 2-(3,4,5-trimethoxyphenyl)-2H-chromene-5,7-diyl-bis(4-methylbenzenesulfonate) 
(70) 
  
Method A 
 
Sodium borohydride powder (38 mg, 1.01 mmol) was added to a solution of 68 (112 mg, 0.33 
mmol) in anhydrous Methanol. The reaction was heated under reflux until full conversion 
was observed by TLC analysis. The solvents were removed under reduced pressure. 
Anhydrous toluene was added to the residue and the flask was fitted with a Dean-Stark 
apparatus. The resulting solution was heated under reflux. Any MeOH remaining in the 
mixture was collected in the attached Dean-Stark apparatus. The mixture was allowed to cool 
to a room temperature and camphorsulfonic acid (234 mg, 1.01 mmol) was added. The 
reaction mixture was again heated to reflux and the water that evolved was collected in the 
Dean-Stark apparatus as the reaction proceeded for 1 h. The reaction was allowed to reach 
room temperature and the solvents removed under reduced pressure. The crude was re-
dissolved in ethyl acetate and washed with saturated aqueous NaHCO3 followed by brine. 
The organic layer was dried over anhydrous MgSO4, filtered, and the solvents were removed 
under reduced pressure. The residue 65 and K2CO3 (182 mg, 1.23 mmol) were dissolved in 
acetone. 4-Toluenesulfonyl chloride (234 mg, 1.23 mmol) was then added. The mixture was 
heated under reflux for 24h under a nitrogen atmosphere. The reaction mixture was allowed 
to reach room temperature. The solvent was evaporated under reduced pressure. The residue 
was dissolved in dichloromethane and washed with water (100 mL). The organic layer was 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue 
was purified using column chromatography on silica gel using petroleum ether/ethyl acetate 
(2:1) to afford the compound 70 as a colourless solid (140 mg, 65%).  
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Method B 
Sodium borohydride powder (346 mg, 9.16 mmol) was suspended in anhydrous 
tetrahydrofuran under argon at 0 °C. Compound 72 (200 mg, 3.05 mmol) was dissolved in a 
mixture of tetrahydrofuran/ethanol (2: 1) and the resulting solution was added to the sodium 
borohydride suspension. The reaction mixture was heated to reflux for 18h. The reaction was 
monitored by TLC until completion as observed. The solution was allowed to reach room 
temperature and the solvents were evaporated under reduced pressure. The residue was 
dissolved in diethyl ether and washed with water and brine. The organic layer was dried over 
anhydrous Na2SO4 and the residue was purified by silica gel flash chromatography using 
ethyl acetate / petroleum ether (1:5) to give the title compound as a colourless solid (189 mg, 
Rf = 0.22, 97%).  
m.p. 128-130 ˚С; νmax (neat)/cm
-1
 2925, 1938, 1464, 1030, 903; δH (500 MHz, CDCl3): 2.36 
(s, 3 H, CH3-30), 2.37 (s, 3 H, CH3-29), 3.74 (s, 3 H, C2H6-31) 3.77 (s, 6 H, CH3-16,17), 
5.71 (d, 1 H, J = 6.5 Hz, CH-9), 6.08 (dd, 1 H, J = 15.7, 6.5 Hz, CH-8), 6.17 (d, 1 H, J = 2.3 
Hz, ArH-2), 6.35 (d, 1 H, J = 2.3 Hz, ArH-6), 6.40 (dd, 1 H, J = 15.7, 0.9 Hz, CH-7), 6.44 (s, 
2 H, ArH-11,15), 7.26 (m, 4 H, ArH-22,23,24,26), 7.64 (m, 4 H, ArH-18,19,20,21); δC (125 
MHz, CDCl3): 21.2 (CH3-30), 21.7 (CH3-29), 56.2 (C2H6-16,17), 60.8 (CH3-31), 77.5 (CH-
9), 104.5 (C2H2-11,15), 109.6 (CH-2), 109.7 (CH-6), 115.4 (C-4), 118.0 (CH-8), 125.4 (CH-
7), 128.4 (C2H2-24-26), 129.4 (C2H2-22-23), 130.1 (C2H2-20,21), 131.9 (C2H2-18-19), 132.0 
(C-28), 134.4 (C-27), 145.2 (C-25), 145.9 (C-32), 146.1 (C-5), 149.1 (C-13),153.5 (C2-
12,14), 154.2 (C-3), 158.0 (C-1). 
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3.3 Experimental Procedures Related to the Synthesis of 3-flav-3-ene 
methyl analogues.  
 
3.3.1 2-(3,4,5-tris(Benzyloxy)phenyl)propan-2-ol (86) 
 
Methyl 3,4,5-tris-benzyloxybenzoate (1.00 g, 2.2 mmol) was dissolved in anhydrous 
tetrahydrofuran (20 mL) and cooled to 0 °С under an argon atmosphere. Methylmagnesium 
bromide (3.0M in diethyl ether, 2.4 mL) was slowly added to the solution. After stirring for 
2h at room temperature, the reaction mixture was quenched with diluted aqueous HCl (1M, 
1mL). The reaction mixture was extracted with diethyl ether (3x30 mL), and the combined 
organic layers were washed with brine (10 mL), and dried over anhydrous Na2SO4. After 
evaporation of the solvent, the residue was purified by column chromatography on silica gel 
with ethyl acetate-petroleum ether (1:4) to give the desired compound as a colourless solid 
(970 mg, 97% yield). mp 173-177 °С; νmax (neat)/cm
-1
3378, 2970, 1200, 731; δH (500 MHz; 
CDCl3) 1.38 (s, 6 H, C2H6-8,9), 2.01(s, 1 H, COH-7), 4.94 (s, 2 H, CH2-11), 4.98 (s, 4 H, 
C2H4-10,12), 6.69 (s, 2 H, ArH-2,6), 7.28 (m, 15 H, BnH); δC (125MHz; CDCl3) 31.8 (C2H3-
8,9), 71.5 (C2H4-10,12), 72.6 (CH2-11), 75.4 (C-7), 105.0 (C2H2-2,6), 127.7, 127.9, 128.0, 
128.3, 128.6, 128.7, 137.3, 137.4 (Ph3C3H6O3Ph), 138.1 (C-1), 145.2 (C-4), 152.5 (C2-3,5); 
m/z found for [M+H]
+
: 455.2213; [C30H30O4+H]
+
 requires: 455.2217. 
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3.3.2 (((5-(prop-1-en-2-yl)benzene-1,2,3-triyl)tris(oxy))tris(methylene))tribenzene (87) 
 
Camphorsulfonic acid (613 mg, 2.63 mmol) was added to a solution of 86 (400 mg, 0.87 
mmol) in anhydrous toluene. The reaction was heated under reflux and followed by TLC 
until completion. The reaction was allowed to reach room temperature and the solvents were 
removed under reduced pressure. The crude mixture was re-dissolved in diethyl ether and 
washed with saturated aqueous NaOH followed by brine. The organic layer was dried over 
anhydrous MgSO4, filtered, and the solvents were removed under reduced pressure. The 
residue was purified by column chromatography on silica gel with ethyl acetate -petroleum 
ether (1:8) to give the desired compound as a colourless solid (272 mg, 71% yield). 
mp 167-169 °С; νmax (neat)/cm
-1 
3020, 2980, 1673, 1280, 980; δH (500 MHz; CDCl3) 2.0 (d, 
3 H, J = 0.6 Hz, CH3-9), 4.95 (m, 1 H, CH-8), 4.98 (s, 2 H, CH2-12), 4.94-4.95 (m, 1H, CH-
8'), 5.05 (s, 4 H, C2H4-10,11), 5.16 (m, 1 H, CH-8), 6.69 (s, 2 H, ArH-2,6), 7.27 (m, 15 H, 
BnH); δC (125MHz; CDCl3) 21.9 (CH3-9), 71.5 (C2H4-10,11), 75.3 (CH2-121), 106.0 (C2H2-
2,6), 112.1 (CH2-8), 127.5, 127.8, 127.9, 128.2, 128.5, 128.6, 137.0, 137.2 (Ph3C3H6O3Ph), 
137.9 (CH-7), 139.4 (C-1), 143.0 (C-4), 152.5 (C2-3,5); m/z found for [M+H]
+
: 437.2112; 
[C30H28O3+H]
+
 requires: 437.2111. 
 
3.3.1 3-(3,4,5-tris(Benzyloxy)phenyl)ethanol (97) 
 
 3,4,5-Tris-benzyloxybenzaldehyde (1 g, 2.35 mmol) was dissolved in diethylether (30 mL) 
and the solution was cooled to 0 °С. Methylmagnesium bromide (3.0M in diethyl ether, 2.4 
mL, 3 equiv.) was cautiously added to the solution under a nitrogen atmosphere. The reaction 
was allowed to reach room temperature, and left to stir for 3h. The reaction was quenched 
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using a solution of NH4Cl (10 mL). The excess of the solvent was removed under reduced 
pressure. The residue was extracted with dichloromethane (3×20 mL), washed with diluted 
aqueous HCl (1M, 1mL), and dried over Mg2SO4. The resulting compound was triturated 
with petroleum ether to allow precipitation of a colourless solid. Filtration followed by a light 
petroleum wash and air drying gave compound 97 as a cottony solid (0.9 g, 87%). 
mp 168-170 °С; νmax (neat)/cm
-1
, 3367, 3930, 2856, 1105, 936. δH (400 MHz; CDCl3) 1.41 
(d, 3 H, J = 6.4 Hz, CH3-8), 1.96 (s, 1 H, OH-7), 4.75 (q, 1 H, J = 6.4 Hz, CH-7), 5.03(s, 2 H, 
CH2-11), 5.09 (s, 4 H, C2H4-9,10), 6.66 (s, 2 H, ArH-2,6), 7.38 (m, 15 H, ArH); δC (100 
MHz; CDCl3) 25.4 (CH3-8), 70.6 (CH-7), 71.4 (C2H4-9,10), 75.4 (CH2-11), 105.2 (C2H2-2,6), 
127.6, 127.9, 128.1, 128.3, 128.7, 128.8, 137.3, 137.8 (Ph3C3H6O3Ph), 138.0 (C-1), 141.8 (C-
4), 153.0 (C2-3,5); m/z found for [M+NH4]
+
: 458.2325; [C29H28O4+NH4]
+
 requires: 458.2326. 
 
3.3.4 1-(3,4,5-tris(Benzyloxy)phenyl)ethanone (98)
12
 
 
Pyridinium chlorochromate (3.0 g, 14 mmol) was dissolved in anhydrous dichloromethane at 
0 °С under a nitrogen atmosphere. 3,4,5-Tris(benzyloxy)benzaldehyde (3.0 g, 6.8 mmol) was 
slowly added as a solution in anhydrous dichloromethane, the reaction mixture turned from 
orange to dark brown. The reaction mixture was allowed to reach room temperature, stirred 
for 7h, and followed by TLC (ethyl acetate/petroleum ether, 4/1, Rƒ = 0.40) till complete 
consumption of the starting material. Diethyl ether (30 mL) was added to precipitate out the 
chromium salts and the solution was left stirring at 35 °С for 1 h. The reaction mixture was 
filtered through a pad of silica gel (middle) and celite (top, bottom). The solvents were 
removed under reduced pressure to give the desired compound as a colourless solid (2.7 g, 
90%). 
mp 167-168 °С; νmax (neat)/cm
-1 
2974, 1708, 1129, 817, 750 ; δH (400 MHz; CDCl3) 2.34 (s, 
3 H, CH3-8), 4.98 (s, 4 H, C2H4-9,10), 5.00 (s, 2 H, CH2-11, 2H), 7.10-7.29 (m, 17 H, ArH); 
δC (100 MHz; CDCl3) 26.7 (CH3), 71.6 (C2H6-9,10), 75.4 (CH2-11), 108.5 (C2H2-2,6), 127.8, 
128.30, 128.36 , 128.5, 128.8, 128.9, 132.70, 136.9 (Ph3C3H6O3Ph), 137.6 (C-1) 143.1 (C-4), 
152.9 (C2-3,5), 197.1 (CO-7).  
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3.3.5 2-(3,4,5-tris(Benzyloxy)phenyl)but-3-yn-2-ol (99) 
 
Compound 98 (580 mg, 1.3 mmol) was dissolved in a mixture of anhydrous 
tetrahydrofuran/diethylether and the solution was cooled to 0 °С. Ethynylmagnesium bromide 
(3.0M in tetrahydrofuran, 18.75 mL, 10 equiv.) was cautiously added to the solution. The 
reaction was allowed to reach room temperature, and left to stir for 2h. The reaction was 
quenched using a solution of NH4Cl (5 mL). The solvents were removed under reduced 
pressure. Water was added and the mixture was extracted using dichloromethane (3×10 mL), 
and the combined organic layers washed with diluted aqueous HCl (1M, 1mL), dried over 
anhydrous Mg2SO4 and the solvents were removed under reduced pressure. The residue was 
purified using silica-gel column chromatography with ethyl acetate-petroleum ether (1:4) to 
give 99 as a yellow oil (0.33 g, 55%). 
νmax (neat)/cm
-1 
3270, 2942, 2159, 1052, 986 δH (400 MHz; CDCl3) 1.80 (s, 3 H, CH3-10), 
2.70 (s, 1 H, CH-9). 2.87 (s, 1 H, HO-7), 5.14 (s, 2 H, CH2-2), 5.17 (s, 4 H, C2H4-11,12), 
7.07 (s, 2 H, ArH-2,6), 7.26-7.52 (m, 15 H, ArH); δC (100 MHz; CDCl3) 33.5 (CH3-10), 70.1 
(C-7), 71.5 (C2H4-11,12), 73.5 (CH2-13), 75.5 (C-9), 87.5 (C-8), 105.2 (C2H2-2,6), 127.9, 
128.1, 128.2, 128.4, 128.5, 128.8, 128.9, 137.4 (Ph3C3H6O3Ph), 138.2 (C-1) 141.1 (C-4), 
152.8 (C2-3,5). 
 
3.3.6 General procedure for chlorination or bromination  
 
Hydrochloric acid (37% w/w, 1.1 equiv.), cuprous chloride (10 mol%), copper powder (10 
mol%) were added to a 2L three neck flask at 0 °C; the reaction mixture was then purged 
with argon for 10 minutes. A solution of propargyl 24 alcohol (1 equiv.) in cold 
dichloromethane was added and the reaction was left to stir for 1 hour at 0 – 5 °C. The 
organic layer was separated, washed with cold water (3x30 mL), and a solution of NaHCO3 
(20 mL) and dried on magnesium sulfate. 
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 3.3.7 General procedure for the Hetero-Diels–Alder reaction 
 
Phenol 19 (1.3 equiv.) and formaldehyde (3 equiv.) were placed into an oven-dried flask, 
equipped with a stirrer bar under argon in acetic acid (1 mL). A solution of substituted alkene 
87 in acetic acid (1 mL) was added. The mixture was stirred for 3 h at 100 °C. The reaction 
mixture was dissolved in ethyl acetate (3 mL) and neutralized with an aqueous solution of 
NaOH (2N). The upper organic phase was separated, and the bottom aqueous phase was 
extracted twice with ethyl acetate (2 mL). All organic phases were then combined, dried over 
anhydrous Na2SO4, and concentrated under reduced pressure. The reaction mixture was then 
filtered and concentrated under reduced pressure, the crude oil was purified by column 
chromatography on silica gel, eluting with petroleum ether and ethyl acetate. 
 
3.3.8 General procedure for acetalisation 
 
The aldehyde 113 (1 equiv.) was dissolved in anhydrous ethanol (4 mL). Solid ammonium 
nitrate (0.25 equiv.) and triethylorthoformate (1.1 equiv.) were added directly to the solution. 
The solution was allowed to stir under a nitrogen atmosphere at room temperature for 24 h. 
The mixture was then quenched with saturated aqueous sodium hydrogen carbonate (4 mL). 
The acetal product was extracted three times using dichloromethane (10 mL), the combined 
organic extracts were dried over anhydrous MgSO4, and the organic solvents removed under 
reduced pressure. The reaction mixture was then filtered and concentrated under reduced 
pressure, the crude was purified by column chromatography, eluting with petroleum ether and 
ethyl acetate. 
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3.3.9 (E)-1,2,3-trimethoxy-5-(penta-2,4-dien-2-yl)benzene (113) 
 
5-Iodo-1,2,3-trimethoxybenzene (120 mg, 0.4 mmol), AgOAc (136 mg, 0.81 mmol), and 
Pd(OAc)2 (5 mol%) were dissolved in anhydrous acetonitrile in an oven-dried flask. The 
mixture was then purged with nitrogen for 10 min. Crotonaldehyde (0.04 mL, 0.48 mmol) 
was then added. The reaction temperature was stirred at 100 °С for 19 h. The reaction 
mixture was allowed to reach room temperature and the solvents were removed under 
reduced pressure. The residue was suspended in dichloromethane and the suspension was 
then filtered through a short pad of celite followed by several rinses using dichloromethane. 
The solution was then washed with water (3x10 mL), brine (10 mL), dried and the solvents 
removed under reduced pressure. The residue was purified by flash column chromatography 
on silica gel (toluene/ethyl acetate, 3:1) to yield the desired compound as a pale yellow oil 
(42 mg, 44%). 
νmax (neat)/cm
-1
3034, 2943, 1730, 1665, 1213, 732; δH (400 MHz, CDCl3): 2.49 (d, 3 H, J = 
1.2 Hz, CH3-8), 3.82 (s, 3 H, CH3-12), 3.83 (s, 6 H, C2H6-11-13), 6.30 (dq, 1 H, J = 7.9, 1.2 
Hz, CH-9), 6.69 (s, 2 H, ArH-4-6), 10.10 (d, 1 H, J = 7.9 Hz, COH-10); δC (100 MHz, 
CDCl3): 16.5 (CH3-8), 56.4 (C2H6-11,13), 60.8 (CH3-12), 103.8 (C2H2-4,6), 126.9 (CH-5), 
136.1 (CH-9), 140.0 (CH-7), 153.5 (C-2), 157.5 (C-1,3) 191.2 (CO-10); m/z found for 
[M+H]
+
: 237.1115; [C13H16O4+H]
+
 requires: 237.1121. 
 
3,3.10 -dimethoxyphenyl acetate (125)
13
 
 
Compound 113 (200 mg, 0.74 mmol) and 3,5-dimethoxyphenol (25 mg, 0.62 mmol) were 
dissolved in freshly distilled toluene in an oven-dried 50-mL flask fitted with a Dean-Stark 
apparatus. Phenylboronic acid (75 mg, 0.62 mmol) and glacial acetic acid (1 mL) were then 
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added. The reaction mixture was heated at 130 °C under a nitrogen atmosphere for 24 h. 
After cooling, the reaction mixture was quenched by addition of a saturated solution of 
NaHCO3 (30 mL). The aqueous layers were extracted with ethyl acetate (3x10 mL) and the 
combined organic layers were washed with saturated NaCl (10 mL), dried over anhydrous 
MgSO4 and the solvents were removed under reduced pressure. The residue was purified 
through column chromatography on silica gel (ether petroleum/ethyl acetate, 7:1), to give 8 
as a yellow solid (28 mg, 90%); νmax (neat)/cm
-1
2943, 1707, 1151, 1026, 847; δH (400 MHz, 
CDCl3): 2.20 (s, 3 H, CH3-8), 3.70 (s, 6 H, C2H6-12), 6.19 (d, 2 H, J = 2.2 Hz, ArH-5,1), 
6.27 (t, 1 H, J = 2.2 Hz, ArH-3), δC (100 MHz, CDCl3): 20.1 (CH3-8), 54.4 (C2H6-10,9), 97.2 
(CH-3), 99.2 (C2H2-5,1), 151.2 (C-6), 160.1 (C-4,2), 168.3 (CO-7).  
 
3,3.11 General procedure for Aldol reaction  
 
LDA (1.1 equiv.) was added to a solution of 52 (1.1 equiv.) in anhydrous tetrahydrofuran at 
−78 °C over 15 min. The mixture was stirred for 30 min. A solution of 23 (1 equiv.) in 
anhydrous tetrahydrofuran at −78°C was added via cannula, over 10 minutes. The resulting 
solution was stirred at −78 °C for 1h and quenched by addition aqueous NH4Cl (20 mL). The 
reaction mixture was extracted with diethyl ether (2 x 30 mL) and dried over anhydrous 
MgSO4. After the solvent was evaporated under reduced pressure, the residue was purified by 
column chromatography on silica gel (petroleum ether/ethyl acetate 4:1). 
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3.4 Experimental procedures related to synthesis of iminium-salt catalyst 
 
3.4.1 2,2'-bis(bromomethyl)-1,1'-biphenyl (50) 14 
 
2,2’-Biphenyldimethanol 49 (1 g, 4.67 mmol) was added to diluted HBr (48%, 25 mL) and 
the mixture heated under reflux until complete consumption of the starting material was 
observed by TLC. The reaction was allowed to cool to ambient temperature and diethyl ether 
(50 mL) added. The organic layer was washed with saturated brine (3 x 30 mL), saturated 
aqueous NaHCO3 (3 x 30 mL), and water (3 x 30 mL), and dried over anhydrous MgSO4. 
The solvent was removed under reduced pressure to afford the desired product as colourless 
crystals (1.42 g, 90%). 
mp 91-93 °С; νmax (neat)/cm
-1 
2940, 1673, 1427, 1673, 821, 612; δH (500 MHz; CDCl3) 4.20 
(d, 2H, J = 10.1 Hz, CHHBr-13,14), 4.36 (d, 2H, J = 10.1 Hz, CHHBr-13,14), 7.38 (dd, 2H, 
J = 7.5, 5.5 Hz, ArH-6,10), 7.44-7.52 (m, 4H, ArH-2,5,8,11), 7.64 (dd, 2H, J = 7.5, 5.5 Hz, 
ArH-1,9). δc (125 MHz; CDCl3) 32.1 (C2H4-13,14), 128.4, 128.8, 130.2, 130.8 (ArH-
1,2,6,5,8,9,10,11), 135.9 (C2-3,7) 139.5 (C2-4,12). 
 
3.4.2 6-Isopropyl-5H-dibenzo[c,e]azepin-6-ium tetraphenylborate (52)  
 
2,2'-bis-Bromomethylbiphenyl 50 (1.25 g, 3.67 mmol) and K2CO3 (1.52 g, 11 mmol) were 
added to stirred solution of isopropylamine (0.215 g, 0.311 ml, 3.67 mmol) in anhydrous 
acetonitrile (25 mL) under a nitrogen atmosphere at room temperature. The reaction mixture 
was heated under reflux for 16 h. The solvent was removed under reduced pressure and the 
resulting residue dissolved in ethyl acetate (50 mL). The combined organic layers were 
washed with water (3 x 30 mL), and saturated brine (3 x 30 mL), and dried over anhydrous 
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MgSO4. The solvents were removed under reduced pressure to yield the azepine in good 
purity as yellow foam 51. N-Bromosuccinimide (0.9 g, 5.056mmol) was added to a stirred 
solution of azepine 51 (1 g, 4.213 mmol) in chloroform (10 mL) at ambient temperature. The 
reaction was monitored by TLC and once complete consumption of the azepine was 
observed, typically 15 min, the solvent was removed under reduced pressure to yield the 
iminium bromide salt intermediate. The salt was dissolved in ethanol (5 mL) and sodium 
tetraphenylborate (1.44 g, 4.213 mmol) was added in a minimal volume of acetonitrile. The 
reaction was allowed to stir at room temperature for 20 min. The solvents were removed 
under reduced pressure and dissolved in chloroform (25 mL). The combined organic layers 
were washed with water (3 x 10 mL), and saturated brine (3 x 10 mL) and dried over 
anhydrous MgSO4. The solvent was removed under reduced pressure and the resultant 
residue was recrystallized from ethanol to yield iminium salt catalyst 52 as a yellow powder 
(1.42 g, 90%), mp 131-134 °С; δH (400 MHz; DMSO-D6) 1.41 (d, 6H, J=2.8 Hz, C2H6-
15,16), 4.35 (s, 1H, CHH-12), 4.56 (sep, 2H, J = 2.8 Hz, CH-14), 5.12 (s, CHH-12), 6.76-
7.18 (m, 20H, ArH),7.60-8.05 (m, 8H, ArH-1,2,5,6,8,9,10,11), 9.35 (s, 1H, N CH-13); δc 
(100 MHz; DMSO-D6) 23.1 (C2H6-15,16), 52.61 (CH-14), 65.91 (CH2-12), 119.1, 120.8, 
122.1, 124.5 126.0, 128.9, 129.2, 129.8, 130.3, 130.7, 134.3, 134.8, 136.1, 137.5,141.1, 164.7 
(ArH), 167.6 (CH-13); m/z found for the iminium cation: 230.1430; [C17H18N]
+
 requires 
230.1430.  
 
3.4.3 (5S,6S)-N-formyl-5-amino-6-phenyl-2,2-dimethyl-1,3-dioxane (75) 15 
 
Methyl formate (0.3 ml, 4.48 mmol) and sodium methoxide (0.016 ml, 0.30 mmol) were 
added to a solution of (1S,2S)–(+)–2-amino-1-phenyl-1,3-propanediol (0.5 g, 2.99 mmol), in 
anhydrous methanol. After 24h, the resulting solution was evaporated under reduced pressure 
to afford the formyl-protected amine (74) as a yellow oil. The oil was dissolved in acetone 
and camphorsulfonic acid (0.10 g, 0.45 mmol) and 2,2-dimethoxypropane (3.7 ml, 9.90 
mmol) were added. The reaction mixture was again heated to reflux overnight. The reaction 
was allowed to reach room temperature and the solvents removed under reduced pressure to 
yield 75 as a yellow oil (0.54 g, 77%). 
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 δH (500 MHz; CDCl3), 1.48 (s, 3H, CH3-12,), 1.52 (s, 3H, CH3-11), 3.79 (dd, 1H, J = 10.5, 
1.6 Hz, CHH-9) 4.17 (dd, 1H, J = 10.5, 1.6 Hz, CHH-9), 4.21 (d, 1H, J = 1.6 Hz, CH-10), 
5.15 (s, 1H, CH-7), 6.48 (s, 1H, NH), 7.14- 7.27 (m, 5H, ArH), 7.89 (s, 1H, CH-13). δc (125 
MHz, CDCl3) 17.5 (s, CH3-12), 28.7 (s, CH3-11), 44.4 (s, CH-10), 63.6 (s, CH-9), 70.6 (s, 
CH-7), 98.9 (C-8), 124.2, 125.5, 126.6, 137.0, (ArH-1,2,3,4,5,6), 159.5 (C=O-13). 
  
3.4.4 (5S,6S)-5-Amino-5-amino-6-phenyl-2,2-dimethyl-1,3-dioxane (76) 15 
 
The compound 75 (0.43 g, 1.827 mmol) was dissolved in aqueous hydrazine monohydrate 
(85%, 7 mL) and the mixture heated under reflux for 2 h. The reaction mixture was extracted 
with ethyl acetate (3x 10), and the combined organic layers were washed with water (2 x 20 
mL) and dried over anhydrous MgSO4. The solvents were removed under reduced pressure to 
give the desired amine 76 as a yellow oil (0.33 g, 89%). 
[]20D +40.5 (c = 2.33, CHCl3); νmax (neat)/cm
-1 
3411, 2984, 1421, 1264, 896; δH (500 MHz; 
CDCl3) 1.35 (s, 3H, CH3-12,), 1.38 (s, 3H, CH3-11), 2.53 (d, 1H, J = 1.3 Hz, CH-10), 3.69 
(dd, 1H, J = 11.6, 1.3 Hz, CHH-9), 4.06 (dd, 1H, J = 11.6, 1.3 Hz, CHH-9), 4.89 (s, 1H, CH-
7), 6.92- 7.43 (m, 5H, ArH). δc (125 MHz, CDCl3) 18.5 (CH3-12), 29.9 (CH3-11), 49.4 (CH-
10), 65.8 (CH2-9), 73.5 (CH-7), 98.8 (C-8), 125.5, 126.2, 127.1, 128.2 (ArH-1,2,3,4,5,6). 
 
3.4.5 (-)-6-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-5H-dibenzo[c,e]azepinium 
tetraphenylborate
16 
 
2,2’-bis(Bromomethyl)biphenyl 50 (0.32 g, 0.94 mmol) and (5S,6S)-5-Amino-5-amino-6-
phenyl-2,2-dimethyl-1,3-dioxane 76 (0.19 g, 0.94 mmol) were dissolved in acetonitrile (21 
mL). The mixture was stirred under a nitrogen atmosphere and Cs2CO3 (0.61 g, 1.88 mmol) 
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was added at room temperature. The reaction was submitted to reflux for 24 h, cooled, diluted 
with dichloromethane (30 mL), the resulting suspension was filtered into a separating funnel 
to remove Cs2CO3. The mixture was extracted with water (2x 50 mL), brine (2x 50 mL). The 
organic phase was separated, dried over MgSO4 and the solvents were then removed under 
reduced pressure to give 77. Amine 77 (0.51 g, 1.32) was then dissolved in anhydrous 
dichloromethane (10 mL), to which N-bromosuccinimide (0.25 g, 1.45 mmol) was added, and 
left to stir for 6 h. the solvent was removed under reduced pressure, and the remaining solid 
was re-dissolved in ethanol (5 mL). Sodium tetraphenylborate (0.5 g, 1.45 mmol) was 
dissolved in a minimum amount of acetonitrile and added to the stirring solution at room 
temperature. After 10 minutes, the reaction was stopped and excess organic solvents removed 
under reduced pressure. The resulting foam was then recrystallized from ethanol. The yellow 
solid was filtered off and washed with cold ethanol followed by petroleum ether affording 78 
(0.33 g, 89%). 
[]20D -44.3 (c = 1.05, CH3CN); νmax (neat)/cm
-1 
3411, 2984, 1421, 1264, 896; δH (500 MHz; 
Acetone-D
6
) 1.79 (s, 3H, CH3-12,), 1.83 (s, 3H, CH3-11), 4.41 (d, 1H, J = 11.3 Hz, CHH-9), 
4.73-4.70 (m, 1H, CH-10), 4.51 (d, 1H, J = 11.3 Hz, CHH-9),) 4.70-4.73 (m, 1H, CH-10), 
4.80 (d, 1H, J = 12.1 Hz, CHH-25), 4.84 (d, 1H, J = 12.1 Hz, CHH-25), 5.96 (d, 1H, J = 2.6 
Hz, CH-7), 6.75 (t, 4H, J = 7.3 Hz, ArH), 6.90 (t, 8H, J = 7.3 Hz, ArH), 7.20-7.25 (m, 8H, 
ArH), 7.28-7.32 (m, 8H, ArH), 7.42-7.53 (m, 4H, ArH-14,15,21,22), 7.64-7.73 (m, 4H, ArH-
16,17,23,24), 8.01-8.11(m, 5H, ArH-1,2,3,4,6), 9.09 (s, 1H, NH-26). δc (125 MHz, CDCl3) 
18.5 (CH3-12), 28.7 (CH3-11), 56.9 (CH2-25), 61.4 (CH2-9), 67.4 (CH-10), 71.8 (CH-7), 
100.3 (C-8), 120.4, 124.1, 124.4, 124.5, 126.3, 126.4, 127.4, 127.9, 128.0, 128.2 128.4, 129.3, 
129.4, 129.6, 132.6, 133.6, 135.0, 135.2, 142.5, 162.4 (ArH), 170.98 (CH-26). 
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3.5 Experimental procedures related to synthesis of Synthesis of (3S,4R)-
trans-3,4-dihydroxy-3,4-dihydromollugin 129 
 
3.5.1 Methyl 1-hydroxy-4-methoxy-2-naphthoate (143) 17 
 
1,4-Dihydroxy-2-naphthoic acid (1.1 g, 5.38) was dissolved in methanol (12 ml) in a flask 
equipped with a stirring bar, and dilute aqueous H2SO4 (1M, 5mL)was then added slowly at 0 
°C. The resulting brown solution was heated under reflux for 2 h. The reaction was quenched 
by the slow addition of water (6 ml). After removal of solvent, the mixture was dissolved in 
ethyl acetate (20 ml) and transferred to a separating funnel and washed with brine (10 ml). 
The organic layer was isolated and dried over anhydrous MgSO4. The residue was purified 
through column chromatography (petroleum ether / ethyl acetate, 5:1), to give 143 as a white 
solid (1.12 g, 90%) and 141 as a yellow solid (58 mg, 5%) 
 
Methyl 1-hydroxy-4-methoxy-2-naphthoate 143: 
mp 130-132 °С; νmax (neat)/cm
-1 
3384, 2924, 1713, 1461, 846; δH (500 MHz, CDCl3): 4.01 
(s, 3 H, CH3-12), 4.04 (s, 3 H, CH3-13), 7. 14 (s, 1 H, CH-1), 7.60 (ddd, 1 H, J = 8.2, 6.9, 2.1 
Hz, CH-6), 7.67 (ddd, 1 H, J = 8.2, 6.9, 2.1 Hz, CH-7), 8.23 (dd, 1 H, J = 8.2, 2.1 Hz, CH-8), 
8.23 (dd, 1 H, J = 8.2, 2.1 Hz, CH-5), 11.65 (s, 1 H, OH-1); δC (125 MHz, CDCl3): 52.3 
(CH3-12), 55.7 (CH3-13), 100.4 (CH-3), 104.2 (C-2) 121.9, 123.8, 125.5, 126.4, 129.0, 129.8 
(ArH-5,6,7,8,9,10), 147.7 (C-1), 155.6 (C-4), 171.3 (CO-11). 
 
Methyl 1,4-dihydroxy-2-naphthoate 141: 
mp 151-153 °С; νmax (neat)/cm
-1 
3434, 2981, 1635, 1376, 929; δH (500 MHz, Acetone-D6): 
4.00 (s, 3 H, CH3-12), 7.18 (s, 1 H, CH-1), 7.62 (t, 1 H, J = 7.6 Hz, CH-6), 7.67 (t, 1 H, J = 
7.6 Hz, CH-7), 8.24 (d, 1 H, J = 8.3 Hz, CH-5), 8.36 (d, 1 H, J = 8.3 Hz, CH-8), 8.70 (s, 1 H, 
OH-4), 11.57 (s, 1 H, OH-1); δC (125 MHz, Acetone D6): 52.8 (CH3-12), 105.0 (CH-3), 
105.6 (C-2) 123.1, 124.3, 126.3, 127.1, 129.5, 130.3 (ArH-5,6,7,8,9,10), 145.8 (C-4), 155.1 
(C-1), 172.0 (CO-11). 
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3.5.2 Methyl 1,4-dihydroxy-2-naphthoate 141: 
 
Method A 
Compound 143 (0.43 g, 1.85 mmol) was suspended in anhydrous dichloromethane in an oven 
dried flask under a nitrogen atmosphere. AlCl3 (0.49 g, 3.70 mmol) was then added at 0 °C. 
The mixture was stirred for 2h at 0 °C. The reaction was then quenched by slow addition of 
water (2 ml), followed by dilute aqueous HCl (1M, 1mL). The title compound was extracted 
from the aqueous layer with dichloromethane (3×10 ml). The combined organic layers were 
washed with brine (2×10 ml) and dried over anhydrous Na2SO4. Solvents were removed 
under reduced pressure to yield brown crude mixture. The mixture was purified through 
column chromatography (petroleum ether / ethyl acetate, 3:1), to give 141 as a yellow solid 
(0.36 g, 91%) 
 
Method B 
4-Dihydroxy-2-naphthoic acid (0.20 g, 0.9 mmol) and anhydrous NaHCO3 (0.10 g, 1.1 
mmol) were suspended in anhydrous dimethylformamide and the suspension was stirred for 
30 minutes under a nitrogen atmosphere at room temperature. Methyl iodide (0.20 g, 0.09 ml, 
1.4 mmol) was transferred using a syringe. The reaction was allowed to stir for 22 hours until 
all the starting material was consumed. The reaction was quenched with saturated brine (10 
mL), dilute aqueous HCl (1M, 6mL). The reaction mixture was extracted with diethyl ether 
(30 ml × 3) and the organic phases were dried over anhydrous MgSO4, and the solvents 
evaporated under reduced pressure. The residue was purified using flash column 
chromatography (petroleum ether / ethyl acetate, 4:1), to give 141 as a yellow solid (0.21 g, 
96%).  
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3.5.3 Mollugin (128)
 18 
 
Method A 
Phenylboronic acid (0.25g, 2.00 mmol) was added to a solution of methyl 1,4-dihydroxy-2-
naphthoate (0.45g, 2.00 mmol) in toluene. Glacial acetic acid (3 mL) was added to the 
reaction mixture by syringe, and followed by a dropwise addition of 3-methyl-2-butenal (0.30 
ml, 3.00 mmol). The reaction was heated under reflux with a Dean-Stark trap under a 
nitrogen atmosphere for 18 h. After cooling, the reaction mixture was quenched by addition 
of sodium bicarbonate (30 mL). The aqueous layers were extracted with ethyl acetate (30 ml 
× 3) and washed with brine (10 mL); the combined extracts were dried over anhydrous 
MgSO4. Evaporation of the solvent afforded a brown solid. The residue was purified through 
column chromatography (petroleum ether / ethyl acetate, 11:1), to give 129 as a yellow solid 
(0.31 g, 56%). 
mp 176-178 °С; νmax (neat)/cm
-1 
3435, 2986, 2305, 1712, 1264, 896; δH (500 MHz, CDCl3): 
1.45 (s, 6 H, C2H6-16,17), 3.91 (s, 3 H, CH3-12), 5.59 (dd, 1 H, J = 10.0 Hz, CH-15), 7.03 
(dd, 1 H, J = 10.0 Hz, CH-14), 7.41-7,45 (m, 1 H, CH-6), 7.51-7,54 (m, 1 H, CH-7), 8.09 (d, 
1 H, J = 8.3 Hz, CH-8), 8.29 (d, 1 H, J = 8.3 Hz, CH-5), 12.10 (s, 1 H, OH-1); δC (125 MHz, 
CDCl3): 26.87 (C3H6-16,17), 52.3 (CH3-12), 74.5 (C-13), 102.2 (C-3), 112.5 (C-2), 121.9 
(CH-15), 122.3, 124.0, 125.0, 126.3, 128.8, 129.0 (ArH-5,6,7,8,9,10), 129.3 (CH-14), 141.5 
(C-1), 156.5 (C-5), 172.53 (CO-11). 
 
Method B 
 
 
3-Methyl-2-butenal (1 ml, 10.3 mmol) was dissolved in anhydrous ethanol under an argon 
atmosphere. Solid ammonium nitrate (0.2 g, 2.5 mmol) and triethylorthoformate (2 ml, 12.36 
mmol) were added directly to the solution at 0 ºC, which turned to a brown colour after 3 h. 
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The reaction mixture was allowed to stir under an argon atmosphere for 24 h. The reaction 
was filtered through a pad of celite and anhydrous Na2SO4, and the pad was washed through 
with diethyl ether. The solvents were removed under reduced pressure at 0 ºC to yield the 
compound 145 as brown oil (0.78 ml, 48%). The acetal 145 was used directly after 
preparation without further purification due to the instability of the acetal on silica. The 
required diethyl acetal (0.55 ml, 6.6 mmol) and methyl 1,4-dihydroxy-2-naphthoate 141 (1.43 
g, 6.6 mmol) were dissolved in p-xylene (10 ml). The mixture was stirred under a nitrogen 
atmosphere for 20 min. 3-Picoline (0.16 ml, 1.65 mmol) was then added and the reaction was 
heated under reflux for 24h. During the reflux, the solution turned black. The solution was 
then allowed to reach room temperature. The mixture was dissolved in diethyl ether and 
washed with water. The organic layer was separated and charcoal was added. The mixture 
was filtered through a pad of celite to afford an oily residue. The crude residue was purified 
by column chromatography on silica gel (petroleum ether / ethyl acetate, 13:1), to give 129 as 
yellow solid (1.2 g, 56%).  
 
Method C 
 
3.5.4 3-Chloro-3-methylbut-1-yne (150)
 19 
 
Calcium chloride (23.0 g, 209 mmol), cuprous chloride (20.0 g, 204 mmol) and copper 
powder (0.4 g, 6.67 mmol) were charged in a flask and cold HCl (37%, 250 mL) was added. 
The dark green solution was placed under an argon atmosphere and stirred at 0 °C for 5 min. 
While maintaining the reaction between 0 - 5 °C, 2-methyl-3-butyn-2-ol (65.0 mL, 667 
mmol) was added slowly to the acidic solution. After complete addition of the alcohol, the 
reaction was stirred at 0 °C for 1 h. The biphasic reaction mixture was transferred to a 
separating funnel and the aqueous layer was removed. The remaining organic layer was then 
washed with dilute aqueous HCl (1M, 3 x 150 mL), cold water (2 x 150 mL) and saturated 
aqueous NaHCO3 (150 mL). The remaining cloudy organic fraction was dried over anhydrous 
MgSO4 and filtered to yield the compound as a clear colourless liquid (12.7 g, 56 %),; δH 
(500 MHz, CDCl3): 1.86 (s, 6H, C2H6-5,4), 2.63 (s, 1H, CH-1), δC (125 MHz, CDCl3): 34.51 
(C2H6-5,4), 56.51 (C-3), 71.91 (C-2), 86.49 (C-1).  
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Mollugin (128)
 
 
 
Methyl 1,4-dihydroxy-2-naphthoate (0.53 g, 2.43 mmol), cuprous chloride (0.24 g, 2.43 
mmol) and fine copper powder (7.7 mg, 0.12 mmol) were placed in a flame-dried flask, under 
a nitrogen atmosphere equipped with a condenser. Anhydrous toluene and K2CO3 (0.67 g, 
4.86 mmol) were then added. The mixture was stirred vigorously and 3-chloro-3-methyl-but-
1-yne (0.7 g, 7.38 mmol) was slowly added in one portion. The reaction was heated under 
reflux until the starting material was consumed by TLC (24h). The reaction was allowed to 
reach room temperature, and water (10 ml) was added. The solution was extracted with 
diethyl ether (3 × 15 ml). The ethereal layer was isolated and washed with saturated aqueous 
NaHCO3 (10 ml) and brine (5 ml). The organic layer was dried over anhydrous MgSO4 and 
removed under reduced pressure to yield yellow oil. The oil was purified by column 
chromatography on silica gel (petroleum ether / ethyl acetate, 9:1) to furnish 129 as a yellow 
powder (0.56 g, 81 %).  
 
3.5.5 Methyl 6-acetoxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate (157) 
 
Mollugin 129 (0.66 g, 2.3 mmol) was dissolved in anhydrous dichloromethane at room 
temperature. Acetic acid anhydride (4.16 ml, 44 mmol) and pyridine (3.5 ml, 44 mmol) were 
then added. The reaction was then allowed to stir overnight under an argon atmosphere. The 
reaction was quenched with a large amount of water and extracted with diethyl ether (3 x 50 
mL). The organic phases were separated, combined, dried over anhydrous Na2SO4, and the 
solvents were removed under reduced pressure. The residue was purified using flash column 
chromatography on silica gel (toluene / ethyl acetate, 10:1), to give 157 as a yellow oil (0.71 
g, 95%). 
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νmax (neat)/cm
-1 
2952, 1976, 1759, 1338, 793; δH (400 MHz, CDCl3): 1.43 (s, 6H, C2H6-
16,17), 2.31 (s, 3H, CH3-19), 3.84 (s, 3H, CH3-12), 5.60 (d, 1H, J = 10.0 Hz, CH-15), 6.52 
(d, 1H, J = 10.0 Hz, CH-14), 7.36-7.47 (m, 2H, ArH2-6,7), 7.36-7.47 (m, 1H, ArH-8), 8.11-
8.14 (m, 1H, ArH-5); δC (100 MHz, CDCl3): 20.6 (CH3-19), 27.7 (C3H6-16,17), 52.4 (CH3-
12), 77.4 (C-13), 119.4 (C-3), 120.11 (C-2), 122.1 (CH-15), 122.4, 126.7 126.9, 127.3, 127.4, 
129.7 (ArH-5,6,7,8,9,10), 130.0 (CH-14), 139.0 (C-4), 146.8 (C-1), 166.1 (CO-18), 169.4 
(CO-11); m/z found for [M+NH4]
+
: 344.1497; [C19H18O5+NH4]
+
 requires 344.1492. 
 
3.5.6 Methyl 6-(benzyloxy)-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate 
20 
 
Mollugin (0.13 g, 0.45 mmol) and anhydrous K2CO3 (0.1 g, 0.7 mmol) were dissolved in 
dimethylformamide. Benzyl bromide (0.09 ml, 0.7 mmol) was then added. The resulting 
mixture was heated at 70 °C under a nitrogen atmosphere for 4 h. The reaction was then 
allowed to reach room temperature. Brine (10 mL) and dilute aqueous HCl (1M, 2 mL)were 
added and the solution was extracted with diethyl ether (2 x 50 ml). The combined organic 
extracts were washed with brine, dried over anhydrous MgSO4, filtered, and the solvents 
were removed under reduced pressure. The residue was purified by column chromatography 
on silica gel (petroleum ether / ethyl acetate, 12:1) to give the compound 155 as a yellow 
solid (0.14 g, 86%). 
mp 182-184 °С; νmax (neat)/cm
-1 
2952, 1765, 1718, 1133, 819; δH (400 MHz, CDCl3): 1.42 
(s, 6H, C2H6-16,17), 3.79 (s, 3H, CH3-12), 5.01 (s, 2H, CH2-18), 5.59 (d, 1H, J = 9.9 Hz, 
CH-15), 6.35 (d, 1H, J = 9.9 Hz, CH-14), 7.21-7.46 (m, 7H, ArH7-6,7,21,22,23,24,25), 7.94-
8.00 (m, 1H, ArH-8,), 8.07-8.17 (m, 1H, ArH-5), δC (100 MHz, CDCl3): 27.7 (C2H6-16,17), 
52.4 (CH3-12), 77.4 (CH2-13), 77.8 (CH2-18), 112.51 (C-3), 119.91 (C-2), 121.00 (CH-15), 
122.5, 122.7, 127.8, 128.11, 128.18, 128.5, 126.81, 126.88, 126.90, 137.42 (ArH), 130.29 
(CH-14), 145.15 (C-4), 146.36 (C-1), 167.79 (CO-11). 
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3.5.7 Experimental procedures related to epoxidation reaction  
 
3.5.7.1 Tetraphenylphosphonium monoperoxysulfate 
21
 
  
Oxone
(R)
 triple salt (2KHSO5:KHSO4:K2SO4) (15 g, 48.8 mmol) was dissolved in cold 
deionised water (300 mL) at 10 °C. A solution of tetraphenylphosphonium chloride (15 g, 
40.0 mmol) dissolved in cold dichloromethane (300 mL) was added. The biphasic mixture 
was left to stir for 30 min. The organic layer was separated and the organic phase was washed 
with deionised water. The organic layer was dried anhydrous MgSO4 and filtered. Light 
petroleum was added until cloudiness developed, and the resulting solution was left in the 
freezer at –20 °C for 24 hours. A white precipitate of salt was filtered and measured to be 
94% pure in peroxide, (12.87 g, 71%): 
1
H NMR (500 MHz,CDCl3): δH = 7.65 (s, ArH,8H), 
7.78 (s, 8H, ArH), 7.89 (s, 4H, ArH,), 9.08 (s, HO-SO4
-
, 1H).  
 
Purification of meta-Chloroperoxybenzoic acid 
meta-Chloroperoxybenzoic acid was dissolved in diethyl ether at 0 °C. The organic layer was 
placed in separating funnel, washed with ice-cold water (2×10 mL), dried over anhydrous 
Na2SO4 and filtered. The solvent was removed under reduce pressure at 0 °C to yield a white 
solid.  
 
3.5.7.2 General procedure for the formation of racemic epoxides with m-CPBA 
 
meta-Chloroperoxybenzoic acid (1 equiv.) and NaHCO3 (2 equiv.) were suspended in 
anhydrous dichloromethane at 0 °C. A solution of the desired alkene in dichloromethane was 
slowly added to the reaction mixture. The reaction was stirred until complete conversion of 
the alkene was observed by TLC. The reaction was quenched with the addition of saturated 
aqueous NaHCO3 and the mixture transferred to a separating funnel. The organic layer was 
separated, washed with brine and saturated aqueous NaHCO3, dried over anhydrous MgSO4 
and filtered. The solvents were removed under reduced pressure at room temperature. The 
residue was purified using column chromatography on silica gel typically eluting with light 
petroleum / ethyl acetate (10:1), buffered with 3% TEA. 
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3.5.7.3 General procedure for the formation of racemic epoxides with iminium salt 52. 
 
Method A 
NaHCO3 (4 equiv.) was dissolved to a mixture of acetonitrile/water (10:1) at 0 °C. Oxone
TM
 
(2 equiv.) was then added, followed by addition of the catalyst 52 (10 mol%) and the alkene 
(1 equiv.). The reaction was then left stirring, whilst being monitored by TLC. The reaction 
mixture was then diluted with diethyl ether and the resulting suspension filtered through a 
mixed pad of Na2SO3 and MgSO4. The solvents were then removed and the residue was 
purified by column chromatography on silica gel, typically eluting with petroleum ether / 
ethyl acetate (10:1), buffered with 3% TEA. 
 
Method B 
Tetraphenylphosphonium monoperoxysulfate (2 equiv.) was added to a solution of the 
catalyst 52 (10 mol%) in anhydrous dichloromethane at −20 °C. After 5 min of stirring, the 
alkene (1 equiv.) dissolved in chloroform (1 mL) was slowly added. The mixture was stirred 
at −20 °C until complete conversion of the alkene was observed by TLC. The reaction 
mixture was then diluted with diethylether (10 mL) and the resulting suspension filtered 
through a mixed pad of Na2SO3 and MgSO4. The solvents were removed under reduced 
pressure and the residue was purified by column chromatography on silica gel, typically 
eluting petroleum ether / ethyl acetate, buffered with 3% TEA. 
 
 
 
 
 
 
 
 
168 
 
3.5.7.4 General procedure for the formation of chiral epoxides with iminium salt 78 
under non-aqueous conditions. 
 
The alkene (1 equiv.) was dissolved in chloroform and the resulting solution was allowed to 
cool down to the required temperature. Tetraphenylphosphonium monoperoxysulfate (2 
equiv.) was added in one portion and the reaction mixture was stirred for 5 min. The catalyst 
78 (10 mol%) was then added as a solid in small portions over 2 min. Consumption of the 
starting alkene was observed by TLC. The reaction mixture was allowed to reach 0 °C then 
was diluted with diethylether to precipitate out the excess Tetraphenylphosphonium 
monoperoxysulfate and the inorganic materials. The suspension was filtered through a thin 
pad of celite and the solvents were removed under reduced pressure. The residue was purified 
by column chromatography on silica gel, typically eluting with petroleum ether / ethyl 
acetate, buffered with 3% TEA. 
 
3.5.8 Methyl-3-acetoxy-9,9-dimethyl-9,9a-dihydro-1aH-benzo[h]oxireno[2,3-
c]chromene-2-carboxylate (158) 
 
Oxone® (1.1 g, 1.8 mmol.), and NaHCO3 (0.308 g, 3.7 mmol), were added to solution of 
alkene 157 (0.300 g, 0.9 mmol) in acetonitrile (1 mL) and water (0.1 mL).Catalyst 52 (0.05 g, 
10 mol%) was then added at 0 °C. The crude product was purified using column 
chromatography on silica gel eluting with petroleum ether / ethyl acetate (12:1), buffered 
with 3% TEA, to yield the racemic epoxide 158 as a white solid (95 mg, 31%). 
mp 147-150 °C; νmax (neat)/cm
-1 
2936, 1690, 1392, 1234, 779; δH (400 MHz, CDCl3): 1.28 
(s, 3H, CH3-17), 1.64 (s, 3H, CH3-16), 2.35 (s, 3H, CH3-19), 3.50 (d, 1H, J = 4.5 Hz, CH-
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14), 3.91 (s, 3H, CH3-12), 4.26 (d, 1H, J = 4.5 Hz, CH-15), 7.45-7.56 (m, 2H, ArH2-6,7), 
7.73-7.68 (m, 1H, ArH-8), 8.11-8.17 (m, 1H, ArH-5); δC (100 MHz, CDCl3): 20.6 (CH3-19), 
25.5 (C3H6-16), 29.7 (C3H6-17), 48.2 (CH-14), 52.6 (CH3-12), 62.8 (CH-15), 74.0 (C-13), 
110.80 (C-3), 110.87 (C-2), 122.10, 122.14, 122.5, 127.3, 127.6, 128.0 (ArH-5,6,7,8,9,10), 
139.3 (C-4), 147.1 (C-1), 165.8 (CO-11), 169.3 (CO-11). 
 
3.5.9 Methyl 2,2-dimethyl-6-(((trifluoromethyl)sulfonyl)oxy)-2H-benzo[h]chromene-5-
carboxylate (159) 
 
Mollugin 129 (0.45 g, 1.58 mmol) was dissolved in anhydrous dichloromethane (20 mL) at 0 
°C under an argon atmosphere. Triethylamine (0.44 ml, 3.16 mmol) was then added. The 
resulting yellow solution was stirred for 20 min. Trifluoromethanesulfonic anhydride (0.8 ml, 
4.74 mmol) was then added causing the reaction mixture to turn brown. After the addition 
was completed, the reaction was allowed to stir at room temperature for 24 h. The reaction 
was quenched by the slow addition of water (5 ml), the resulting biphasic mixture was 
transferred to separating funnel and the organic layer was separated, washed with brine (7 
ml), dried over anhydrous Na2SO4 and filtered. The solvents were removed under reduced 
pressure. The residue was purified by column chromatography on silica gel using petroleum 
ether / ethyl acetate (7:1) to give the compound 159 as a colourless oil (0.59 g, 91%). 
νmax (neat)/cm
-1 
2976, 1724, 1149, 819, 751; δH (500 MHz, CDCl3): 1.38 (s, 6H, C2H6-
16,17), 3.86 (s, 3H, CH3-12), 5.59 (d, 1H, J = 10.1 Hz, CH-15), 6.49 (d, 1H, J = 10.1 Hz, 
CH-14), 7.42-7.50 (m, 2H, ArH2-6,7), 7.88 (d, 1H, J= 8.1 Hz, ArH-8), 8.09 (d, 1H, J= 8.4 
Hz, ArH-5); δF (471 MHz, CDCl3): -73.34 (s, 3F, CF3-18); δC (125 MHz, CDCl3): 27.7 
(C3H6-16,17), 52.4 (CH3-12), 77.4 (C-13), 112.9 (C-3), 113.2, 114.8, 117.3, 119.9 (q, J= 
317.5 Hz, CF3-18), 119.4 (C-2), 122.43 (CH-15), 121.6, 121.7, 126.55, 126.59, 127.9, 128.5 
(ArH-5,6,7,8,9,10), 130.7 (CH-14), 135.6 (C-4), 148.7 (C-1), 166.9 (CO-11); m/z found for 
[M+NH4]
+
: 434.0872; [C18H15F3O6S+NH4]
+
 requires 434.0872. 
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3.5.10 Methyl 9,9-dimethyl-3-(((trifluoromethyl)sulfonyl)oxy)-9,9a-dihydro-1aH-
benzo[h]oxireno[2,3-c]chromene-2-carboxylate (160). 
 
Na2CO3 (0.13 g, 1.24 mmol) was added to the solution of 157 (0.26 g, 0.62 mmol) in 
anhydrous dichloromethane at 0 °C. The solution of m-CPBA (0.1 g, 0.62 mmol) was slowly 
added at 0 °C. Complete conversion of alkene was observed by TLC (2 h). The residue was 
purified using column chromatography on silica gel eluting with petroleum ether / ethyl 
acetate (4:1), buffered with 3% TEA, to furnish the racemic epoxide 160 as a white solid 
(0.21 g, 81%). 
mp 175-176 ˚C; νmax (neat)/cm
-1 
2976, 1724, 1149, 819, 751; δH (500 MHz, CDCl3): 1.32 (s, 
3H, CH3-17), 1.65 (s, 3H, CH3-16), 3.54 (d, 1H, J = 4.5 Hz, CH-14), 3.95 (s, 3H, CH3-12), 
4.37 (d, 1H, J = 4.5 Hz, CH-15), 7.54 (dd, 1 H, J = 8.1, 6.9, Hz, CH-6), 7.60 (dd, 1 H, J = 
8.4, 6.9, Hz, CH-7), 7.98 (d, 1 H, J = 8.4 Hz, CH-8), 8.18 (d, 1 H, J = 8.1 Hz, CH-5); δF (471 
MHz, CDCl3): -73.18 (s, 3F, CF3-18); δC (125 MHz, CDCl3): 23.0 (C3H6-17), 25.6 (C3H6-
16), 47.7 (CH-14), 53.6 (CH3-12), 62.8 (CH-15), 74.6 (C-13), 111.2 (C-3) 114.7, 117.3, 
119.8, 122.4 (q, J= 381.7 Hz, CF3-18), 121.8 (C-2), 122.6, 124.5, 127.2, 127.3, 128.2, 129.2 
(ArH-5,6,7,8,9,10), 135.8 (C-4), 149.1 (C-1), 164.6 (CO-11); m/z found for [M+H]
+
: 
433.0558; [C18H15F3O7S+H]
+
 requires 433.0563. 
 
3.5.11 (1S,9S)-methyl 9,9-dimethyl-3-(((trifluoromethyl)sulfonyl)oxy)-9,9a-dihydro-1aH-
benzo[h]oxireno[2,3-c]chromene-2-carboxylate (160). 
 
Water (0.2 mL), acetonitrile (2 mL) and Na2CO3 (0.19 g, 1.80 mmol) were placed to a test-
tube in an ice-bath at 0 °C. The mixture was stirred for 2 min, followed by Oxone® (0.44 g, 
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0.72 mmol) and the catalyst 78 (0.25g, 10 mol%) were added. After 5 min, a solution of 
alkene 159 (0.15 g, 0.36 mmol) in acetonitrile was added dropwise. The mixture was stirred 
at 0 °C until complete conversion of the alkene was observed by TLC (15 min). The reaction 
mixture was then diluted with diethylether (5 mL), the resulting suspension was filtered 
through a mixed pad of celite and Na2SO3. The solvents were removed under reduced 
pressure. The epoxide 160 was obtained by flash column chromatography on silica gel 
eluting with petroleum ether / ethyl acetate (7:1), containing 3% TEA. (0.14 g, 91%), []20D -
17 (c = 0.12, CHCl3); Chiral HPLC trace (99.5:0.5, hexane:iso-propanol, flow rate; 0.5 
mL/min); 22.22 min (14.75 %), 32.60 min (85.25 %). 
 
3.5.12 (3S,4R)-methyl 3,4-dihydroxy-2,2-dimethyl-6-(((trifluoromethyl)sulfonyl)oxy)-
3,4-dihydro-2H-benzo[h]chromene-5-carboxylate (163) 
 
Compound 160 (83 mg, 0.91 mmol) was dissolved in acetone (1 mL) at room temperature. 
Diluted sulfuric acid (1M, 0.5 ml) was added dropwise to the solution, and the mixture was 
stirred for 1h. The reaction was monitored by TLC till the starting material had been 
completely consumed. The reaction mixture was neutralized to pH 7 using NaHCO3. The 
solution was diluted with dichloromethane (10 ml) and water (5 ml). The organic layer was 
isolated and the aqueous was further extracted with dichloromethane (10 ml). The combined 
organic extracts were washed with brine (20 ml), and dried over anhydrous Na2SO4.The 
solvent was removed under reduced pressure. The residue was purified through column 
chromatography on silica gel using petroleum ether / ethyl acetate (1:1), to afford 161 as a 
white solid (68 mg, 74%). 
[]20D +11.4 (c = 0.22, CHCl3); mp 186-188 ˚C; νmax (neat)/cm
-1 
3283, 2850, 1765, 1230, 
893; δH (500 MHz, CDCl3): 1.27 (s, 3H, CH3-17), 1.46 (s, 3H, CH3-16), 3.59 (d, 1H, J = 7.3 
Hz, CH-14), 3.86 (s, 3H, CH3-12), 3.87 (s, 1H, OH-14), 3.91 (s, 1H, OH-15), 4.80 (d, 1H, J 
= 7.3 Hz, CH-15), 7.54-7.49 (m, 1 H, CH-6), 7.65-7.66 (m, 1 H, CH-7), 7.91 (d, 1 H, J = 8.4 
Hz, CH-8), 8.10 (d, 1 H, J = 8.1Hz, CH-5); δF (471 MHz, CDCl3): -73.22 (s, 3F, CF3-18); δC 
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(125 MHz, CDCl3): 19.4 (C3H6-16), 25.7 (C3H6-17), 53.2 (CH3-12), 68.6 (CH-14), 75.5 (CH-
15), 79.4 (C-13), 114.2 (C-3) 114.7, 117.2, 119.8, 122.3 (q, J= 380.2 Hz, CF3-18), 121.7 (C-
2), 123.0, 123.7, 126.6, 126.7, 128.1, 128.9 (ArH-5,6,7,8,9,10), 135.9 (C-4), 148.1 (C-1), 
166.8 (CO-11); m/z found for [M+NH4]
+
: 468.0925; [C18H17F3O8S+NH4]
+
 requires 468.0934. 
 
3.5.13 General procedure for the deprotection of trifluoromethanesulfonate (129).  
 
Method A 
163 (1 equiv.) was dissolved in mixture of water/ethanol (1:1). The solution was stirred at 
room temperature under a nitrogen atmosphere for 10 min. Potassium hydroxide (1 equiv.) 
was added. After 10 min, the reaction was heated under reflux for 30 min. The reaction was 
allowed to cool down and then was neutralized to pH 7 using diluted HCl (1M, 0.5 ml). The 
solution was extracted with ethyl acetate (3×10 ml), the organic layers were combined, 
washed with brine (10 ml), dried over anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure.  
Method B 
163 (1 equiv.) was dissolved in dioxane and diluted Et4NOH (2 equiv.) was then added under 
an argon atmosphere at room temperature. The solution was stirred until complete 
consumption of the starting material was observed by TLC. The reaction mixture was diluted 
with dichloromethane (20 ml), washed with diluted HCl (1M, 1 ml) water (10 ml) and brine 
(5 ml). The organic layer was dried over anhydrous Na2SO4. The solvent was removed under 
reduced pressure. 
Method C 
To a solution of 163 (1 equiv.) in toluene (5 mL) was added Cs2CO3 (3 equiv.). The reaction 
was heated at 80 ˚C) during 19 h. The crude mixture was quenched with ethyl acetate (10 
mL) and a saturated aqueous solution of NH4Cl (10 mL). The aqueous layer was extracted 
with ethyl acetate (2 ×10 mL). Organic layers were then combined, dried over anhydrous 
MgSO4 and concentrated under reduced pressure. 
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